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Abstract 
Quantum dots (QDs) are semiconductor nanocrystals (<100 nm), which are emerging as a novel class of 
multifunctional fluorescent probes for many potential biological and medical applications. In comparison 
to conventional organic fluorescent probes (organic dyes), QDs have substantial advantages, such as, 
bright fluorescence, narrow emission, broadband excitation, photostability and extended half-life. 
Imaging with diagnostic assessment, plays an important part in clinical settings for determining disease 
(cancer) progression and therapy. However, current imaging techniques have certain limitations, and they 
include insufficient sensitivity to detect low numbers of cancer cells at primary or metastatic sites and 
appropriate probes to detect specific cancer cell surface markers.  
To address these limitations, studies were conducted (1) to develop an aqueous synthesis of a series of 
near infrared (NIR) QDs, incorporating cadmium (Cd), tellurium (Te), cobalt (Co) and mercury (Hg) in 
its core (2) to minimize its potential toxicities, by developing coating strategies with a novel coating 
nanomaterial, mercaptopolyhedral oligomeric silsequioxane (MPOSS) while maintaining strong 
emission, stability and biocompatibility, (3) to apply conjugated NIR QDs as probes in targeting and 
detecting immunogenic apoptosis in cancer cells in vitro and mapping biodistribution in vivo. 
The inclusion of mercury (Hg (ClO4)2) and cobalt (Co) to the QD core resulted in NIR emission at 800 
nm with paramagnetic properties. Characterization by transmission electron microscopy (TEM) 
confirmed size of the QDs. Detoxification of QDs was demonstrated, by toxicity studies, using two 
different vital stains, Alamar Blue and Neutral Red on human umbilical vein endothelial cells (HUVECs), 
human breast cancer cells (MCF-7), colorectal cancer cells (SW620) and prostate cancer cells (PC3). A 
short synthetic peptide to calreticulin (CRT) was chemically synthesised and antibodies generated against 
the peptide (Anti-CRT) with specificity to the native CRT protein (a cancer cell immunogenic apoptosis 
marker). The presence of functional groups on the coatings of QDs provided an additional advantage for 
conjugation to Anti-CRT for targeting, and carbon nanotubes (CNT) for thermal strategy. 
QDs conjugated to Anti-CRT showed specificity to cancer cells in vitro undergoing apoptosis when 
exposed to the following: 1) Doxorubicin (an anticancer drug), 2) cadmium and 3) QD-CNT 
(photothermal effect). Characterization by Fourier Transform Infrared Spectrophotometry (FTIR) 
confirmed conjugation of QDs to Anti-CRT. Confocal microscopy images further confirmed targeted and 
non-targeted QDs in vitro, and NIR sensitive camera for in vivo imaging.  
These studies and findings demonstrate the feasibility of applying these engineered nanocrystals for 
clinical diagnostics, drug delivery and therapy.  
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1.1. Nanoparticles: An overview 
Nanomaterials are at the cutting edge of the rapidly developing field of nanotechnology. 
Nanoparticles (Appenzeller, 1991, Shirin Ghaderi, 2012) specifically have great 
potential in medical diagnostics and targeted therapeutics since they have unique 
characteristics that can be used in medicine, biological products, pharmaceutics, 
industries and cosmetics. Nanoparticles can be organic or inorganic and examples 
include fullerenes, buckyballs, carbon nanotubes (CNT), liposomes, nanoshells, 
dendrimers, quantum dots (QDs), superparamagnetic, gold, and silver nanoparticles. 
These nanoparticles are expected to bring great benefits as applied to biomedicine in 
areas as diverse as diagnosis and treatment of disease. Potential applications in the field 
of medicine include drug delivery, clinical diagnostics, diet industry and improved 
biocompatible materials. Nanomaterials are potential tools that can facilitate some of 
these applications (Alivisatos et al., 2005). 
Semiconductor and metal nanoparticles in the 2-10 nm size range have aroused great 
interest due to their unique size-dependent properties, which happen to also have similar 
dimensions to biological macromolecules (e.g. proteins and nucleic acids) (de Mel et 
al., 2012). This has added advantages in that, the similarities allow integration of 
nanotechnology and biology, thus promoting great advances in cell biology, molecular 
biology, targeted therapeutics and medical diagnostics. Current development in this 
field has allowed the linking of colloidal nanoparticles to nanoparticles (e.g. QDs, 
CNTs) (Bifeng Pan, 2006) and to  biomolecules such as proteins (John P. Zimmer, 
2000) peptides (Whaley et al., 2000) DNA (Pathak et al., 2001). These nanosized 
bioconjugates are used in the construction of hybrid materials for the development of 
multicolour fluorescent probes and bioassays (Dubertret et al., 2001) for ultrasensitive 
detection and imaging (Bentolila et al., 2005). This brief introduction will highlight 
recent developments of nanomaterials as applied to biology and medicine and the 
associated synthesis, optical properties, and biological applications. 
Semiconductor nanocrystals are also known as QDs and are often assembled from 
atoms from groups II-VI or III-V elements in the periodic Table. These particles when 
compared to their bulk have smaller exciton Bohr radius (EBR) that describes their 
definition (Zhou and Ghosh, 2007). This imposes what is described as quantum 
confinement (QC) when special optical and electronic properties are produced 
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compared to bulk. Major development in the past has concentrated on the photophysics 
of nanostructures mainly in microelectronics and optoelectronics (Alivisatos, 1996). 
However there has been great interest in developing nanoparticles for biological and 
medical applications (Klarreich, 2001, Rizvi et al., 2010). The key development that has 
allowed these applications are the advances in the synthesis of highly luminescent QDs 
with high yields, comprehending complex surface chemistry, adaptation to water 
solubility, biocompatibility and multicolour emission for multiplex optical detection of 
biomolecules. Recent developments have introduced multifunctional QDs for molecular 
and cellular imaging, nanoparticle drugs for targeted therapy, disease screening, 
detection and diagnosis (Shirin Ghaderi, 2012). Figure 1.1 illustrates the basic structure 
of a semiconductor based QD (cadmium–telluride, CdTe). 
 
 
 
 
Figure 1.1: Basic structure of an uncoated QD. 
1.2. Optical properties 
QDs have demonstrated significant advantages over traditional organic dyes and 
fluorescent proteins. As the QDs are assembled from semiconductor materials, their 
optical properties are influenced by the interactions between electrons, holes and 
environments. Semiconductor materials absorb photons when the energy of absorbance 
exceeds the difference of the valence and conduction band energy (band gap) (details in 
chapter 2). During this stage, electrons in the valence band are elevated to the 
conduction band leaving a ‘hole’. Light emission arises from the recombination of the 
returning electron and hole (exciton). By controlling the size, coating and composition 
of QDs, the emission wavelength can be tuned from the blue (ultraviolet) to the near 
infrared (NIR) region (Alivisatos et al., 2005, Aswathy et al., 2010). They can be 
stimulated to emit multicolour fluorescence with a single light source, with minimal 
spectral overlap, contributing to significant advantage for molecular multi-target 
imaging. 
Core Shell 
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1.2.1. In vitro and in vivo imaging 
The above-described properties of QDs are most promising for enhancing the sensitivity 
and the multiplexing capabilities of molecular histopathology and disease diagnosis. 
Recent developments in QDs have produced very bright and stable probes that have 
found applications in profiling genetic and protein biomarkers in intact cells and clinical 
tissue specimens. Because of inherent potential toxicity QDs have been generally 
excluded from a in vivo imaging applications. However, the use in immunohistological 
studies has found favour on in vitro or ex vivo clinical specimens. The utilization of 
multicolour QD probes in immunohistochemistry (IHC) will be a major contribution in 
clinical diagnostics in the coming years. 
In vivo imaging has traditionally used contrast agents as imaging probes that include 
radioisotope small molecules in positron emission tomography (PET) and single 
photoemissions computed tomography (SPECT), gadolinium compounds in magnetic 
resonance imaging (MRI), and isotope conjugated antibodies. The unique features of 
bioconjugated targeted QDs however can provide extraordinary capabilities that could 
enhance the sensitivity and specificity of diseased tissues and improve diagnosis. The 
inherent, size dependent optical and electronic features of QDs can be manipulated 
continuously by altering the particle size. This tunability feature facilitates the use of a 
broadband range of QDs, for simultaneous detection of multiple cancer cell surface 
biomarkers. Additionally the large surface to volume ratio of QDs allows 
multifunctional groups suitable for conjugation with multiple diagnostic (magnetic, NIR 
and radioisotope) and therapeutic (e.g. anticancer) ligands. This allows the development 
and design of multifunctional “intelligent” nanocrystals for multi-modal imaging 
combining therapy. There is evidence that nanoparticle in the range of 10-100 nm 
preferentially concentrate at tumour sites through a phenomena defined as enhanced 
permeability retention (EPR) (Sinha et al., 2006).  
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1.3. Nano-drugs 
Developing QDs as drugs and additional to drug delivery carriers and targeting probes 
is challenging and important in the arena of nanotechnology. Introducing nanosize 
range has improved the efficacy and toxicity profile of chemotherapeutic drugs by 
virtue of their desirable surface properties. Additionally it facilitates dispersibility of 
drugs that are otherwise poorly soluble in aqueous medium. Traditional drug 
formulations suffer from bioavailability with poor release mechanisms. 
1.4. Synthesis 
Various approaches to synthesis of QDs have been attempted. Traditionally their 
synthesis has been carried out in organic solvents such as toluene or chloroform at high 
temperatures in the presence of surfactants (Shirin Ghaderi, 2012). This method 
produced hydrophobic nanocrystals due to surface modifications, which are 
incompatible with aqueous biological environment (Smith et al., 2006). In biological 
environment, water is the main solvent and water-soluble nanocrystals will be an 
attractive proposition. To take full advantage of their optical properties for biosensing 
and bioimaging applications, they must possess minimum toxicity and monodispersible 
in aqueous biological environments. Novel strategies have been developed to make 
them water soluble and biocompatible, whereby the surface layer is exchanged or 
additional layer added with hydrophilic properties. These include the adsorption of 
small molecules such as mercaptoacetic acid or cysteine to QD surface (Jin et al., 2008) 
silica (Bharali et al., 2005) or wrapping within micelles (Maysinger et al., 2007), 
liposomes (Schroeder et al., 2007) and amphiphilic polymers. To overcome, the 
bioincompatibility and instability, development in hybrid coatings have been 
investigated in the followings studies. The hydrophilic coatings may have reactive 
functional groups for binding to the core at one end and for conjugation at the other end. 
These allow conjugation to specific molecules for in vitro and in vivo targeted delivery 
and imaging. 
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1.5. Conclusions 
In summary, the advent of semiconductor fluorescent nanocrystals QDs as a new class 
of molecular imaging agents has made a great impact in medical research and new 
applications are continually developed. With suitable novel coatings the QD is now 
presented as a basic building block for further fabrication of multifunctional 
nanostructures and nano-devices. Multifunctional imaging probes can be constructed by 
incorporating QDs with NIR emission, paramagnetic or super-paramagnetic 
nanomaterials. Indeed, this laboratory has incorporated into its NIR QD core, cobalt 
(Co) for imaging purposes. Imaging deep tissues with suitable ultrasensitive optical 
imaging, tiny tumours could be visually identified with complete removal by surgeons. 
Medical imaging technology such as PET and X-ray can locate tumour and disease 
noninvasively and also provide visual guidance during surgery. The optimistic success 
currently observed with QDs in terms of toxicity reduction, and added multimodality 
can only further progress biomedical applications in order to understand the entire 
aspect of QDs for clinical usage. 
This thesis presents an in depth background chemistry of QD synthesis and its 
applications, followed by specific aims and description of the work undertaken. Results 
and relevant discussions are presented in specific chapters and an overall discussion 
outlines the way forward in this exciting field.  
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2.1. Introduction (quantum dots and nanotechnology) 
The primary aim of this introduction is to explain key concepts of nanoscience and 
nanotechnology with its basic theoretical underpinnings. Many of scientists will see the 
tremendous applications of such technologies within our lifetimes, and various 
technologies are already on the market today. Because of their impact, a basic 
understanding of nanoscience and nanotechnology and how it affects our lives is 
presented. 
Nanoparticles (‘The Science’) as nanoscience is defined as the study of materials at 
length scales smaller than those where conventional physics (classical) apply (less than 
1 µm) but larger than those where atomic physics dominate (more than a few tenths of a 
nanometer). It incorporates contributions from many scientific disciplines, including 
biology, chemistry, physics, optics, engineering, computer sciences and mathematics. 
Nanoparticles (‘The Technology’) as nanotechnology are defined as the application of 
nanoscience by practical engineering of structures at the nanoscale level and integrating 
them into materials, devices and products. There is not a definite length scale defining 
nanoscience and nanotechnology, but it typically ranges from several tenths of a 
nanometer to several hundred nanometers. 
Currently, nanoparticles in the size range of 0.1 nm to 500 nm have received enormous 
attention from both science and industry, as new information about these particles and 
their potential benefits are established. Nanoparticles can be classified into three major 
groups, namely (1) natural, (2) incidental and (3) engineered (Table 1). 
Table 2.1: Some major groups of nanotparticles.  
They can be divided into three groups: (1) nanoparticles occurring naturally such as volcanic, (2) 
nanoparticles happening accidently such as mining and (3) engineered nanoparticles such as quantum 
dots.  
Natural Ocean spray, meteorite, volcanic ash, Biogenic magnetite: mollusks, bacteria, arthropods, fish, birds and brain 
Incidental Combustion products, frying, cooking, sandblasting, mining, metal working, biomaterial degradation 
Engineered QDs, CNTs, fullerenes, semiconductor wires, sun screen pigments 
Naturally-occurring nanomaterials such as volcanic ash, ocean spray, magnetotactic 
bacteria, mineral composites, and others are ubiquitously found in the environment. 
Incidental nanoparticles are often the end-products of the manufacturing industries. The 
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engineered nanoparticles include materials that are specifically designed for function, 
such as fullerene (C60) used in fuel cell technology and semiconductors for the 
electronic and solar cell technology. 
As mentioned earlier, nanotechnology has a broad description, in that the processes and 
the technologies applied produce materials that are deliberately engineered by the 
manipulation of atoms. The main criterion for nanotechnology is that any chemically 
stable structure that does not violate existing laws of physics can be manipulated and 
engineered. By exploiting the basic properties of atoms, products with less bulkiness, 
with strong structure have been created and applied appropriately. 
There are four basic groups of nanoscale materials that are commercially available. 
They are metal oxides, nanoclays, nanotubes and QDs or nanocrystals. The metal oxides 
include ceramics from oxides of zinc, iron, cerium and zirconium. Also chemical 
polishing material from semiconductor wafers; including scratch resistant coatings for 
glass, cosmetics and sunscreens are the major products incorporating nanomaterials. 
Nanoclays are naturally found as plate-like clay particles that enhance strength, 
hardness, heat resistance and flame retardant of materials, also barrier films in plastic 
beverage bottles, paper juice cartons and tennis balls. 
Nanotubes are incorporated in coatings to dissipate and reduce static electricity in fuel 
lines and hard disk handling trays. They are also part of flame retardant fillers for 
plastics, and field emitter sources in flat panel displays. 
QDs are currently used in exploratory medical diagnostics and pre-clinical therapeutics 
and solar cells and nanoeletronics. 
There has been vast growth and expansion of research and applications in the fields of 
nanoscience and nanotechnology. The outcomes in these disciplines are materials 
emphasized earlier, which are known as Nanoparticles. Engineered nanoparticles 
include fullerenes, buckyballs, carbon tubes (CNT), liposomes, nanoshells, dendrimers, 
QDs, ultra-small paramagnetic iron oxide, gold and silver nanoclusters (Chaloupka K, 
2010, Iga et al., 2007, Malam et al., 2009). Furthermore, their applications extend to fast 
growing fields ranging from aerospace, military, energy, electronic, food, medicine and 
many others. It is expected that the application of nanoparticles will bring great benefits 
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to biomedicine in areas as diverse as diagnosis and treatment of disease. Potential 
applications in the field of medicine include drug delivery, clinical diagnostics, diet 
industry and development of materials for surgical implants. This introduction will 
highlight nanoparticles derived from semiconductor materials, which act as 
fluorophores known as QDs or nanocrystals. 
In recent years, research in semiconductors has developed quite literally new 
dimensions. Their numbers are two, one and zero. Electrons in recently developed 
devices and materials can be confined to planes, lines and mathematical points i.e. QDs. 
In general, the energy of electrons in a semiconductor is limited by their temperature 
and by their properties of the material. When electrons are confined in a thin enough 
layer, however, the requirements of the uncertainty principle in effect override other 
considerations. That is to say, as long as the electrons do not have enough energy to 
break out of confinement, they become effectively two dimensional. Compared to bulk 
(three-dimensional) and quantum well (two-dimensional) structures, QDs are zero-
dimensional (Su et al., 2002) with their electronic states fully quantized, which are 
similar to a single atom or atomic system. This fully quantized system is stable against 
any thermal perturbation (Figure 2.1).  
    Quantum wire                              Quantum well                             Quantum dot                       
                        Figure 2.1: Different forms of nanomaterials with different dimensions.   
2: A CRITICAL REVIEW ON THE DEVELOPMENT OF ‘QDS’ AND THEIR BIOMEDICAL APPLICATIONS 
	   11	  
2.2 Historical perspective 
Earliest known nanoparticles (gold colloids) were already used in ancient times to 
colour glass (ruby glass) without scientific understanding. The first who scientifically 
investigated gold colloid formation was Michael Faraday in the mid-nineteenth century. 
He reduced a solution of HAuCl4 with elemental phosphorus resulting in the formation 
of ruby-red gold sols. Subsequently, the reason for this colour was explained: it was due 
to the interaction of visible light with surface electrons of the gold nanoparticles and 
also the influence of size, shape and surrounding medium. 
Colloidal semiconductor QDs were first prepared by Professor Louis Brus in 1982 (R. 
Rossetti, 1982, Alivisatos, 2008) and this marked the birth of a nanoscience building 
block. Their photophysical properties have been explored in great detail over the last 
two decades. Weller first described the quantum confinement effects of the colloidal 
semiconductor Q-particles in 1993 (Weller., 1993). During the same period, the 
Bawendi’s group developed a novel, reproducible method for the synthesis of high 
quality, monodisperse nanocrystals (C. B. Murray, 1993). 
Fluorescence QDs have great potentials in the field of electronics especially in 
photonics. In 1932, Rocksby found that the red or yellow colour of some silicate glasses 
could be linked to microscopic inclusions of CdSe and CdS (Rocksby, 1932) and in 
1985, Ekimov and others discovered that these changes in colour were linked to the 
energy states determined by quantum confinement in CdSe or CdS “QDs”.  
The term “QDs” refers to crystal structures with extremely small dimensions. When the 
size of the semiconductor nanocrystal becomes this small, the electronic structure of the 
crystal is governed by the laws of quantum physics. Due to its very small size, group 
(II-VI) semiconductor nanoparticle QDs, in the order of 2-10 nm, exhibit significantly 
different optical and electronic properties from their bulk counterparts self-organized 
QDs (Woll AR, 2002). Due to unique properties of QDs, considerable efforts have been 
made to fabricate QDs for use in different research fields. The desire to identify, 
understand and explore the size-dependent properties of QDs at the nanometre scale has 
literally been stimulated since 1985 and has accelerated QDs research development.  
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2.3 Quantum dot technology  
Research and development have focused on the synthesis, solubility and bioconjugation 
of highly luminescent stable QD. 
QDs are light emitting nanocrystals assembled from semiconductor materials, from the 
elements in the periodic groups of II-VI, III-V or IV-VI, for example cadmium telluride 
(Cd from group II and Te from group VI) and Indium Phosphamide (In from group III 
and P from group V). In nanotechnology, the main precursors used in the assembly of 
QDs is cadmium and tellurium forming the core which they are range in size from 2-10 
nm in diameter containing approximately 200-10000 atoms (Green and Howman, 
2005). Due to the effects of quantum confinement QDs posses unique optical properties 
such brighter, highly photo and chemical stable, with broad absorption, narrow and 
symmetric emission spectrum. An outstanding feature of QDs is that their emission 
wavelength can be tuned by adjusting their size and chemical composition. 
2.4 Structure of quantum dots 
Structurally, QD possess a metalloid crystalline core, which ultimately depending on its 
composition and size will confer the type of fluorescence it will emit. A bare 
nanocrystal core is highly reactive and toxic resulting in a very unstable structure that is 
prone to photochemical degradation. Also the core crystalline structure has surface 
irregularities that may lead to emission irregularities like blinking. The core is 
composed of materials such as cadmium–selenium (CdSe), cadmium-tellurium (CdTe), 
indium-phosphate (InP) or indium-arsenate (InAs)(Jamieson et al., 2007) (Figure 2.2). 
Semiconductor shells or coatings typically using zinc sulphide (ZnS) or 
mercaptosuccinic acid (MSA) not only stabilize the core, but further improves the 
optical, physical properties and bioavailability of the material but also reduce the 
toxicity of the core by shielding reactive Cd2+ and Te2- ions from being exposed to 
photo-oxidative environments e.g. exposure to UV and air (Jamieson et al., 2007). 
Additional capping or coatings with biocompatible material or polymer layers such as 
functionalised silica, phospholipid micelles, amphiphylic polymers (polyacrylic acid) 
have been introduced to render them soluble in aqueous media. Further coatings with 
POSS-PCU (Polyhedral Oligomeric Silsesquioxane-Polycarbonateurethane, (Kidane et 
al., 2009) or PEG (Polyethylene Glycol) to the QD core-shell promotes water solubility,  
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Figure 2.2: Structure of QDs modified with bioactive agents.  
Materials such as zinc sulphide (ZnS) have been used to coat QDs to reduce its toxicity and facilitate 
covalent conjugation to bioactive molecules such as antibodies and peptides.  
biocompatibility and desired bioactivity. The aqueous coating can then be tagged with 
various biomolecules of interest e.g. antibodies, peptides, nucleic acids with available 
methods of conjugation chemistries (Iga et al., 2007). 
2.5 Optical and electronic properties 
In natural semiconductor bulk material, the electrons (larger than 10 nm) exist in a 
range of energy levels. The energy levels are so compact that they can be described as 
continuous, meaning there is negligible energy difference between them. Also there is 
region where electrons do not reside or go and in known as “band gap”. This band gap 
is different for each type of bulk semiconductor material. Electrons in energy level 
below this band gap are known to be in the valence band while those occupying above 
are known to be in the conduction band. Also, the maximum amount of electrons 
resides in the valence band whilst a minimum amount of electrons in the conduction 
band. On acquiring a stimulus such as photon, voltage or heat can push the electrons 
from the valence band beyond the band gap to conduction band. By leaving the valence 
band the space left vacant is known as a “hole” which happens to be positively charged. 
This elevated electron and the hole as a pair, is known as an “exciton”. Conduction 
electrons and valence holes have an average physical distance and this is referred to as 
such as; POSS- 
Nanocomposite, 
Polyethylene Glycol 
Coating agent 
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the Exciton Bohr radius (EBR). These can vary with different materials. In bulk the 
distance is much larger than the EBR, which expands beyond its limit. This property 
also applies to QDs at the nanoscale level when it becomes equal to the EBR or less 
when the energy level is said to be discrete and not continuous anymore. This 
imposition of discrete energy is known as quantum confinement (QC) and at this stage 
the semiconductor material loses all resemblance to the bulk and adopts the structure of 
QD. This now alters the absorptive and emissive properties of the semiconductor 
material (Arya et al., 2005). Once excited to the conduction band, the electron falls back 
down across the band gap towards the valence band, in doing so electromagnetic 
radiation with a wavelength corresponding to the energy it loses in the transition is 
emitted (Figure 2.3). 
This emission frequency is perceived as fluorescence and depends on the size of the 
band gap, which can be altered by changing the size of the QD by changing the surface 
chemistry. It is important to note that the band gap in a QD will always be energetically 
higher and the radiation emitted is referred to being “blue shifted” thus producing a 
shorter wavelength. Hence, with QD, the size of the band gap is dependent on the size 
of the dot and wavelength of the emitted photons. Because the emission frequency of 
QD depends on the band gap, it is possible to control the output wavelength of the QD 
with extreme precision (Alivisatos, 2004). 
 
Figure 2.3: Schematic representation of the mechanism of emission by QDs. 
Excited electron in the valence band is elevated across the band gap onto the conduction band. As the 
raised electron in the conduction band falls back across the band gap to its valence energy level, a 
wavelength of light is emitted in this process.  
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This size tunable absorption and emission property of QDs is an extremely valuable 
property for biological imaging as they can be tuned all the way from the ultraviolet 
(UV) to the NIR of the spectrum such that smaller dots emit in the blue range and the 
larger dots in the red and NIR region (Figure 2.4). QDs have a broad excitation and 
narrow, discrete emission spectra. The peak emission wavelength of the QD is slightly 
longer than the first exciton peak or absorption onset, and this energy separation is 
known as the “Stoke's shift”. Also their peak emission wavelength is independent of the 
wavelength of excitation light. This means that variable sized QDs can be excited by a 
single wavelength of light, as long as this wavelength is shorter than the absorption 
onset. This can be used in multiplexed imaging where a number of different sized QDs 
with discrete emission peaks and hence different colours can be excited by a single 
wavelength of light. 
 
 
 
 
 
 
 
 
Figure 2.4: Shows size dependent multicolour fluorescence of QDs in aqueous solution. 
With such small sizes, QD show some unique and fascinating optical properties, such as 
sharp, symmetrical emission spectra, high quantum yield (QY), chemical and 
photostability and size dependent emission wavelength tunability. Their intrinsic 
brightness is often of many orders that observed for traditional organic fluorophores. 
Their large surface to mass ratio confers the particles the ability to absorb and carry 
many compounds. QDs have relatively large (functional) surface, able to bind, adsorb 
and carry compounds such as drugs, probes and proteins. Based on these desirable 
properties, QDs have the potential to improve the sensitivity of biological imaging at 
Ultraviolet Infrared 
wavelength 
Increasing size of Quantum Dots  
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the cellular level which includes cancer detection, progression and treatment, radio-and 
chemo- sensitizing agents, electron and x-ray contrast agent and targeted drug delivery. 
However, caution has to be exercised with these attractive applications as QDs contain 
substantial quantities of cadmium, which are reactive in an ionic state, and only limited 
studies are only available concerning the health risk of exposure to nanoparticles 
(Juzenas et al., 2008, Smith et al., 2008a). 
2.6. Quantum dot synthesis 
There are various ways of synthesis of colloidal QDs. Each method has its own 
challenges and involves the integration of quantum physics, materials science, synthetic 
chemistry and most importantly biology (Figure 2.5). 
 
 
 
 
 
 
 
 
 
Figure 2.5: The multi-role applications of QDs in biomedicine 
Currently, there are many methods for the synthesis of QDs including organic and 
aqueous synthesis in preparing highly luminescent nanocrystals. Additionally, there are 
reports of using microwave and hydrothermal methods (Yao He and Lian-Hui Wang, 
2007, Junling Duan) for rapid synthesis of QDs . Traditionally high-quality nanocrystals 
were prepared in organic solvents and they cannot be used directly in biosystems due to 
their hydrophobicity. The use of high temperatures and in the presence of surfactants to 
yield monodisperse and stable particles are a drawback (C. B. Murray, 1993, Peng and 
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Peng, 2001). However, the QDs produced by the organic phase are insoluble in aqueous 
media and therefore not applicable to biological systems. Water dispersible QDs that 
sustain strong fluorescence can be prepared by ligand exchange with a hydrophilic 
moiety. However, it is a difficult procedure but direct synthesis in an aqueous 
environment is possible for use in biological applications. A number of successful 
methods to solubilise organically synthesised QDs in aqueous media have been 
developed. Aqueous synthesis, on the other hand, produces water soluble QDs through 
a simpler, inexpensive and reproducible method that can easily be scaled up. However, 
the aqueous route to the synthesis of QDs have good average crystallinity, with low QY 
and Full Width Half Maximum (FWHM), (Figure 2.6) and long reaction times, making 
preparation a time-consuming and tedious process (Weng and Ren, 2006). The Ren 
group (Li et al., 2005) has recently described a new method of QD synthesis based on 
microwave irradiation with controllable temperatures. This allowed rapid production of 
size tunable QDs in 5-45 minutes, based on the reaction between Cd2+ and NaHTe 
solution (Weng and Ren, 2006).  
 
Figure 2.6: The bandwidth of the emission spectra,  
denoted as Full Width at Half maximum (FWHM) stems from the temperature, natural spectral line width 
of the QDs, and the size distribution of the population of QDs within a solution or matrix material. 
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This method showed significant advantages over the traditional aqueous synthesis like 
reduced toxicity, good reproducibility, inexpensive, excellent water solubility, stability 
and biological compatibility and a comparable QY to the organic synthetic route (Rizvi 
et al., 2010). 
2.6.1. Surface coatings and water-solubility 
One of the biggest challenges to the biological application of QDs is their 
biocompatibility. This dilemma is due to their hydrophobic surface chemistry, which 
makes them insoluble in aqueous biological media. In order to render QDs 
biocompatible, they have to be soluble in biological buffer, and over the years many 
scientists have discovered a wide array of surface coatings for solubilisation of QDs 
(Pinaud et al., 2006). The aim is to achieve an ideal surface chemistry that is stable in 
biological media and not alter the photophysical properties of the QDs, while at the 
same time retaining a small QD size and providing free reactive surface groups for 
binding and recognition of biomolecules. The techniques used to achieve solubilisation 
include ligand exchange, surface silanization and phase transfer methods. The “ligand 
exchange” method is based on the exchange of the hydrophobic surfactant molecules 
with bi-functional molecules, which are hydrophyllic on one side and hydrophobic on 
the other, to bind to the ZnS shell on the QD (Alivisatos et al., 2005). Most often thiols 
(–SH) as functional groups are used to bind to the ZnS and carboxyl (-COOH) groups 
are used as hydrophyllic ends. The resulting QDs are soluble in both aqueous and polar 
solvents. This is by far the simplest method to achieve solubilisation. “Surface 
silanization” involves the growth of a silica shell around the nanocrystal. As silica shells 
are highly cross-linked they are very stable. However, the drawback is that the process 
is laborious and the shell may be hydrolysed (Alivisatos, 2004). The “phase transfer” 
method uses amphiphyllic polymers to coat the QDs surface (Nann, 2005, Wang et al., 
2004). The hydrophobic alkyl chains of the polymer interdigitate with the alkyl groups 
on the QDs surface while the hydrophyllic groups orientate outwards to attain water 
solubility. However, coating with a polymer may increase the overall diameter of the 
QDs and this may reduce emission and limits their use biological applications (Uyeda et 
al., 2005). Various techniques of coating using phospholipids micelles, dithioretol, 
organic dendrons, and oligomeric ligands can be found in numerous publications 
(Benoit Dubertret, 2002, Kim et al., 2004). 
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2.6.2. Surface functionalization 
Once solubilisation is achieved, QDs can be functionalized by conjugation to a number 
of biological molecules including avidin, biotin, oligonucleotides, peptides, antibodies, 
DNA and albumin (Alivisatos et al., 2005) through surface reactive groups for specific 
targeted action. Methods of bioconjugation broadly fall into two categories: noncovalent 
and covalent conjugation (Xing et al., 2009). Noncovalent interactions include 
absorption, electrostatic interaction and mercapto-exchange. Biomolecules like 
oligonucleotide and various serum albumins (Lakowicz et al., 2000) can be absorbed on 
the surface of the water-soluble QDs. This process is non-specific and depends on pH, 
temperature, ionic strength and surface charge of the molecule (Alivisatos et al., 2005). 
QDs may be cationic or anionic and may interact with biomolecules through 
electrostatic interaction. The surface charge plays an important role in the cellular 
interaction of QDs and is determined by the free surface reactive groups. It has been 
demonstrated that proteins engineered with positively charged domains, can interact 
with the negative charges on the QDs surface coated with dihydrolipoic acid (DHLA) 
through electrostatic interaction (Clapp et al., 2006). These conjugates have greater 
photoluminescence but are also more stable than unconjugated dots. However, 
electrostatic interactions are nonspecific and relatively weaker compared to covalent 
bonding and this may pose a problem in the biological environment. Many biological 
molecules have a thiol group, which can be tagged on to the surface of a QD by a 
mercapto-exchange process (Alivisatos et al., 2005). However, the resulting bond 
between thiol and Zn is not only weak but also dynamic and this may lead to 
precipitation of the biomolecules in solution as they easily detach from the QD surface. 
Covalent linkage is the most stable of all the bioconjugation methods and utilises 
functional groups on the QDs surface like primary amine, carboxylic acids, and thiols to 
form a covalent bond with similar groups present on biomolecules or through the use of 
cross-linker molecules (Alivisatos et al., 2005). The commonest and convenient method 
of bioconjugation is via the avidin-biotin interaction. This is based on the high affinity 
interaction between avidin and biotin through a generic key-lock mechanism. Avidin is 
attached to antibodies and biotin can covalently bind to the surface of QDs and vice 
versa. As most of the commercially available biomolecules are avidin or biotin linked, it 
makes this process most convenient as well (Clapp et al., 2006, Weng and Ren, 2006) 
(Figure 2.7). 
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Figure 2.7: Schematic representation of different approaches to conjugation of QDs to biomolecules. 
(a) Use of a bifunctional ligand such as mercaptoacetic acid for linking QDs to biomolecules. (b) TOPO-
capped QDs bound to a modified acrylic acid polymer by hydrophobic forces. (c) QD solubilisation and 
bioconjugation using a mercaptosilane compound. (d) Positively charged biomolecules linked to 
negatively charged QDs by electrostatic attraction. (e) Incorporation of QDs into microbeads and 
nanobeads. 
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2.6.3. Bioimaging applications 
Microscopy especially fluorescence and confocal is an established technique of 
observing the microsructures and molecules within cells and QDs are increasingly being 
used as fluorescent labels for cellular and molecular imaging. QD application to this 
field is similar to that of organic fluorophores but with various advantages. They can 
facilitate in the visualization of cellular structures and receptors in both fixed and live 
cells. Although QDs have been used for a variety of biological applications (Table 2.2), 
their great potential for biomedical imaging and therapeutic remains unexplored. 
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        Table 2.2: Several biological applications of QDs 
 
Biological Applications of Quantum Dots 
Imaging 
In vitro imaging 
Fixed cell imaging 
Immunofluorescent labeling of proteins, biomarkers 
Immunohistochemical detection 
Fluorescence in situ hybridization 
Live cell imaging 
Single QD tracking of membrane receptors and signaling pathways 
Resonance energy transfer- fluorescence (FRET) 
Stem cell tracking 
In vivo imaging Cancer studies and cancer localization 
Labeling As well as labeling, quantum dots have potential for detecting 
Drug Delivery Loading biological compounds on QDs such as; any types of drugs 
Other Applications Photodynamic Therapy 
Pathogen toxin detection 
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2.6.4. In vitro cell imaging 
QD conjugates can substitute for several immunohistochemical applications and have 
various advantages over organic fluorophores, including increased photoluminescence, 
photostability, broad excitation and narrow emission spectra, also allowing multiplexed 
imaging (Table 2.2). Immunohistochemical detection of targeted molecules in fixed 
cells involves the use of primary antibodies that specifically interact and bind to the 
antigen of interest followed by the application of a labeled secondary antibody against 
the primary. Secondary antibodies are conjugated to organic fluorophores, radioisotopes 
or enzymes producing luminescence, counts or chemiluminescence at or near the site of 
the primary antibody, demonstrating amplification which can greatly increase the 
sensitivity of immunohistochemical detection (Akhtar et al., 2007).  
Detection of targeted molecules in their natural distribution requires fixation followed 
by permeabilization of the cell wall by fluorescent conjugated probes. As QDs are 
larger than organic dyes they may require permeabilisation (Ornberg and Liu, 2007). 
The timing of cell fixation i.e. before or after exposure to QDs determines their stability, 
localization within the cell as well as emission properties. While in fixed permeabilised 
cells, QDs are readily taken up regardless of the cell type, whereas in live cells 
previously incubated with QDs, the choice of fixative influences the fluorescence 
characteristics. A comparative analysis of gluteraldehyde, methanol and 
paraformaldehyde demonstrated that 2% paraformaldehyde was the fixative of choice 
(Williams et al., 2008). 
QD-Antibody conjugates have accurately and successfully identified membrane bound 
protein p-gp (glycoprotein) in fixed MCF7r breast adenocarcinoma cells (Weng and 
Ren, 2006). The localization of p-gp by confocal was reconstruction in a 3-D imaging 
which showed that QD-Antibody probe was highly sensitive and photostable compared 
to organic dyes like FITC, AlexaFluor488 and R-phycoerythrin. Using QD probes actin 
and microtubule fibres in the cytoplasm (Bruchez et al., 1998) and various nuclear 
antigens of fixed cancer cells have been located (Wu et al., 2003). Indirect 
immunofluorescence has been used to identify Her2, microtubules and nuclear antigens 
in fixed cancer cells by first incubating fixed cells with a primary antibody, then a 
biotinylated secondary antibody and finally with QD labeled streptavidin. This takes 
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advantage of the high affinity of streptavidin to biotin with amplification (Wu et al., 
2003).  
Fluorescence in situ hybridization (FISH) technology to evaluate DNA sequences in 
fixed biological specimens has been well established (Levsky and Singer, 2003). It uses 
fluorescently labeled DNA probes for gene mapping and probing subtle chromosomal 
abnormalities, which can provide diagnostic and prognostic results for particular 
chromosomal disorders. This technique adopts the concept of detection of a fluorescent 
signal at the site of hybridization of a fluorescent dye labeled probe with its matching 
chromosomal target (Rizvi et al., 2010). The disadvantage of using rapidly photo-
unstable multicolour organic dyes are spectral overlap which can be solved with QDs 
with their high photostability and discrete spectra permitting multiplexed imaging 
(Table 2.3). Xiao et al. used a QD-FISH probe to analyse human metaphase 
chromosomes using organic dyes like Texas-Red and FITC and found QDs were more 
photostable and significantly brighter making them a more stable and quantitative mode 
of FISH for research and clinical applications (Xiao and Barker, 2004). QDs are also 
suitable to probe single DNA and RNA molecules and their interaction with proteins 
allowing the study of dynamic processes. The application of QD conjugates to visualize 
single copy sequence DNA probes as short as 1500 nucleotides in length has been 
demonstrated (Knoll, 2007).This should find application in rapid gene mapping and 
DNA-protein interactions and for automation (Weng and Ren, 2006).  
Probing the molecular dynamics of various cellular processes poses great challenges in 
cell biology in live cells. This can contribute to the understanding of cellular and 
molecular interactions in real time over prolonged periods at high resolution. Applying 
QDs to live cells can function as a versatile tool in various applications especially in cell 
tracking leading to stem cell research and determining the metastatic potential of cancer 
cells. Their photostability permits long-term imaging applications like single molecule 
tracking in living cells exposing many cellular and molecular processes as have never 
been undertaken. 
Labeling of live cells with QDs is an important step prior to various imaging 
applications. There is a possibility that QDs can be passively taken inside cells or be 
bound nonspecifically to the extracellular surface. However, intracellular labeling could  
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Table 2.3: Advances of QDs over organic dyes 
Properties Organic dyes QDs Advantages of QD 
Excitation Spectrum Narrow Broad 
Organic dyes can be excited only by light of a specific wavelength due to the narrow excitation 
spectrum whereas. QDs which may be excited by light of a range of wavelengths, allowing multi-
colour QDs to be excited by a single wavelength of light. 
 
Emission Spectrum 
 
 
Broad and 
asymmetrical 
Narrow and 
symmetrical 
The broad emission spectra of organic dyes may overlap and this limits the number of fluorescent 
probes that can be tagged to biomolecules for simultaneous imaging in a single experiment. QDs 
have narrow emission spectra, which can be monitored by altering the size, composition and 
surface coatings of the dots. Therefore, multiple QDs emitting different colours can be excited by a 
single wavelength of light making them ideal for multiplexed imaging. 
 
Photobleaching 
threshold 
 
 
Low High 
Organic dyes bleach within a few minutes on exposure to light whereas QDs are extremely 
photostable due to their inorganic core, which is resistant to metabolic degradation and can 
maintain high brightness even after undergoing repeated cycles of excitation and fluorescence for 
hours. Hence they can be used for long-term monitoring and cell tracking studies. 
 
Decay lifetime 
 Fast (<5 ns) 
Slow (30-100 
ns) 
The fluorescence lifetime of QDs is considerably longer than typical organic dyes that decay within 
a few nanoseconds. This is valuable in overcoming the autofluorescence of background tissues 
hence improving signal to noise ratio. 
 
Quantum Yield Low High  
QDs have higher quantum yields, large absorbance cross section and large saturation intensity than 
organic fluorophores in aqueous environments making them much brighter probes for in vivo 
studies and continuous tracking experiments over extended periods of time. 
Absorbance cross 
section Low High 
Saturation intensity Low High 
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be encouraged by co-incubating cells with QDs via non-specific endocytosis (Hoshino et 
al., 2004b, Hanaki et al., 2003) or they may be linked to other biological compounds 
such as peptides or proteins on the cell surface that are specifically endocytosed (Chan 
and Nie, 1998). Alternatively, they can be introduced into the cell via electroporation or 
microinjection (Knoll, 2007, Dubertret et al., 2002, Jaiswal et al., 2003), which though 
complex and difficult, is the only technique that ensures uniform cytoplasmic 
distribution. Most convenient and efficient, peptide mediated intracellular delivery of 
QDs has been most commonly used. This approach relies on the fact that protein 
transduction domains (PTD) allow the passive delivery of drugs across the cell 
membranes as well as the blood brain barrier. There are documented studies of 
delivering a number of biomolecules including proteins, oligonucleotides, liposomes and 
magnetic nanoparticles into cells using PTDs (Lagerholm, 2007). It has been 
demonstrated that QDs can be delivered into cells using similar techniques. QDs have 
been coupled to PTDs via different approaches such as streptavidin-biotin link 
(Lagerholm, 2007), covalently (Hoshino et al., 2004a), by electrostatic adsorption or 
adsorption to synthetic PTDs like pep-1(Mattheakis et al., 2004). Of all the possible 
approaches for intracellular delivery, linking PTDs to QDs via a streptavidin-biotin 
bridge is most easily performed.  
Targeting membrane receptors and proteins via QD probes can provide specific imaging. 
Various biological processes and pathways like chemotaxis, synaptic regulation, or 
signal transduction are dependent on the trans-membrane receptors and signaling 
pathways. Plasma membranes have a complex and dynamic construct with various 
components that modulate the diffusion of endogenous proteins, lipids and peptides. 
Successful application of biotinylated peptide coupled to QDs to study the organization 
of the plasma membrane and the influence of lipid raft microdomains on the diffusion of 
raft-associated proteins in HeLA cells (cervical cancer cells) and MCF-7 cells (Breast 
cancer cells) (Pinaud et al., 2009) were carried out. QD probes have also allowed high-
resolution and long-term tracking of individual glycosyl-phosphatidyl-inositol-anchored 
avidin test probe (Av-GPI), and the classification of their various diffusive behaviors 
(Rosenthal et al., 2011).  
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2.6.4.1. Tracking biomolecules  
This technique allows the tracking of single molecules in real time to visualise the actual 
molecular dynamics in biological environment. This can be used to follow various 
biological molecules like lipids, membrane associated proteins and cytosolic motor 
proteins, as well as detailed descriptions of the compartment sizes of micro-domains and 
the time that individual macromolecules reside in each compartment. Apart from genetic 
encoded fluorescent proteins and organic dyes, various materials have been used for 
single particle tracking studies including latex or fluorescent microspheres (~20-500 nm) 
and colloidal gold nanoparticles (40 nm). Fluorescent proteins and organic dyes have 
low photoluminescence in a background of high cell autofluorescence and a low 
photobleaching threshold making long-term tracking difficult. Gold nanoparticles are 
good agents for single particle tracking but do not allow multiplexed imaging however, 
with the synthesis gold nanoclusters. 
2.6.4.2. Mapping stem cells  
As one of the most fascinating areas of contemporary biology stem cell research has a 
vast potential to treat a myriad of medical conditions. Currently, magnetic and 
superparamagnetic iron oxide (SPIO) nanoparticles are being used to achieve this 
objective through the use of MRI. However, the gradual loss of the MRI cell signal due 
to cell division poses a hindrance to long-term imaging studies. The application of QDs 
as nanomaterials for monitoring stem cells survival, distribution, differentiation and 
regenerative impact either in vitro or in vivo due to their inherent mesenchymal stem 
cells (hMSC) with RGD peptide conjugated QDs during differentiation into osteogenic 
cell lineages has been carried out (Figure 2.8) (Unpublished). 
 
 
 
 
Figure 2.8: Bone marrow mesenchymal cells labeled with conjugated QD-RGD (Unpublished)  
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Another group has also demonstrated that RGD-conjugated QD labeled hMSCs 
remained viable following multilineage differentiation as did the unlabeled hMSCs 
(Shah et al., 2007). The regenerative potential of stem cells to repair damaged cardiac 
tissue is being investigated but attempts at tracking the differentiation and distribution of 
stem cells in vivo have been hampered by the inherent autofluorescence of damaged 
cardiac tissue. QD labeled human mesenchymal stem cells can illuminate stem cells in 
histological sections for at least 8 weeks following delivery allowing a 3-D 
reconstruction of the location of all stem cells following injection into the heart (Rosen 
et al., 2007). While QDs labeled tracking of stem cells promises great advancements in 
the field of stem cell research, the effects of QDs on stem cell self-renewal and 
differentiation are largely unknown and need to be explored.  
2.6.4.3. Quantum dot uptake assays  
QDs have been used to demonstrate the metastatic potential of cancer cells to distinguish 
between invasive and noninvasive cancer cell lines (Pellegrino et al., 2003). Gu et al. 
have demonstrated a two-dimensional in vitro cell motility assay based on the 
phagokinetic uptake of QDs by cells as the move across a homogenous layer of QDs 
leaving behind a fluorescence free trail. The ratio of the trail area to the cell area has 
been proposed to distinguish between invasive and noninvasive tumour cells (Gu et al., 
2007, Gu et al., 2005).  
2.6.4.4. Energy transformation assays 
Fluorescence resonance energy transfer (FRET) is a process in which energy is 
transferred from an excited donor to an acceptor particle leading to a reduction in the 
donor’s emission and excited state lifetime and an increase in the acceptor’s emission 
intensity. This occurs whenever the distance between the donor and acceptor is minimal 
than the critical radius known as the Förster radius. FRET is sensitive to the distance 
between the donor and the acceptor and is used to measuring changes in distances rather 
than absolute distances. It is therefore suitable to study biomolecule conformation, 
dynamics and interactions e.g. monitoring protein conformational changes, protein 
interactions and assaying enzyme activity. Using organic dyes for FRET poses the 
problems of early photobleaching and significant emission overlap between the donor 
and acceptor and QDs provide an excellent alternative (Jamieson et al., 2007).  
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QD based FRET technology has found application in monitoring other biological 
processes like DNA replication and telomerisation for a fast and sensitive DNA 
detection and DNA array analyses (Patolsky et al., 2003). Most QDs based FRET probes 
are based on QDs as donors and organic fluorophores as acceptors. A single QD based 
nanosensor capable of detecting extremely low concentrations of DNA (50 copies) in a 
separation free format has been demonstrated. QDs were coupled to DNA probes to 
capture DNA targets. The target strand binds to a dye-labeled reporter strand thus 
forming a FRET donor-acceptor complex (Zhang et al., 2005).  
Another application of QD-FRET is the detection of enzyme activity in particular 
protease sensing. This is based on the inserting peptide sequences of various proteases 
between QDs and quenchers (or acceptor dyes) (Medintz et al., 2003). The QD 
fluorescence is quenched by the acceptor dye but cleavage of the peptide sequences by 
specific proteases causes removal of these acceptor molecules, and hence the QDs are 
switched on. A good example is rhodamine Red-X-dye-labeled peptide linked to 
CdSe/ZnS QDs used as FRET probes to monitor proteolytic ability of collagenases in 
normal and cancer cells. Hydrolytic cleavage of the peptide linked dye by the 
collagenases restored QD fluorescence allowing detection of specific enzyme activity 
over short periods of time (Shi et al., 2006). 
Bioluminescence resonance energy transfer (BRET) is a naturally occurring 
phenomenon, whereby a light emitting protein which acts as a donor (e.g. Renilla 
luciferase) non-radiatively transfers energy to a fluorescent protein as an acceptor (e.g. 
GFP) in close proximity. The process is similar to FRET except that the energy comes 
from a chemical reaction catalyzed by the donor enzyme (e.g. Renilla luciferase 
mediated oxidation of its substrate coelenterazine) rather than absorption of excitation 
photons. So et al. prepared self illuminating QDs by covalently coupling QDs (as 
acceptors) to a bioluminescent protein Renilla reniformis luciferase (as a donor). The 
protein emits a blue light at 480 nm upon addition of a substrate, coelenterazine. The 
QDs can be excited if they are in close proximity to the protein and emit at their 
emission maximum. These conjugates emit long-wavelength (from red to near infrared) 
bioluminescent light in cells and in animals, even in deep tissues, and are suitable for 
multiplexed in vivo imaging (So et al., 2006).  
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2.6.5. In vivo imaging 
Fluorescence imaging of live animals is limited by the poor transmission of visible light 
through the living tissues as well as by the intense autofluorescence of tissue 
chromophores. QDs can overcome these limitations through their high 
photoluminescence, enhanced photostability under prolonged laser illumination and size 
tunability to emit at longer wavelengths like the NIR, which is not subjected to 
scattering and absorption as light in the visible range. Also QDs have a two photon 
absorption cross section several times greater than organic dyes and this property makes 
them more efficient at probing thick tissue specimens by multiphoton microscopy. 
Green emitting QDs were injected in living mice intravenously and dynamically 
visualised by two-photon microscopy as they perfused through the skin capillaries 
several micrometers deep. Two-photon excitation allows greater tissue penetration due 
to excitation in the NIR range (Larson et al., 2003). Voura et al. used spectral imaging to 
trace intravenously injected tumour labeled QDs into mice as they extravastated into 
lung tissue, and found that the behavior of QD-labeled tumour cells in vivo was 
indistinguishable from that of unlabeled cells. Also QDs and spectral imaging allowed 
the simultaneous identification of five different populations of cells using a sophisticated 
multiphoton laser excitation application (Voura et al., 2004).  
2.6.5.1 Sentinel lymph node biopsy (SLNB) imaging 
This is a means of detecting cancer metastasis and is now the standard of care in breast 
cancer surgery. It is based on targeting the first draining lymph node, also called the 
sentinel lymph node (SLN) of a lymphatic basin at the cancer site to determine the 
extent of disease spread. A negative detection of metastasis in the SLN means that the 
disease is contained and extensive surgery can be avoided. Available tracers for SLN 
biopsy include blue dye and radioisotope. However, these have various limitations that 
can be improved by the use of QDs that emit in the NIR range (>700 nm). The main 
problem with live animal imaging is to overcome the background tissue known as 
autofluorescence. NIR imaging can overcome this problem based on the concept that 
normal tissue chromophores do not absorb or scatter light in the NIR range. NIR light 
can therefore penetrate deeper tissues without being scattered and is ideal for imaging in 
real time. NIR QDs have successfully been used to demonstrate in vivo SLN biopsy in 
mice and pigs (Kim et al., 2004) (Figure 2.9, 2.10). A subdermal injection of picomolar 
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quantities of NIR QDs infiltrated the lymphatics and the fluorescence could be traced to 
the SLN in real time by using a NIR imaging system. This allowed an accurate and 
sensitive localization and biopsy of the SLN with minimal tissue dissection.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.9: NIR QD at 800 nm upon excitation with a 630 nm light source.  
Within 3 minutes of intradermal injection the NIR QD entered the lymphatic tracts. The lymphatics are 
seen to converge to the groin and a small surgical incision at this site revealed the underlying lymph nodes 
with minimal dissection. A) Colour image B) NIR image 0 minutes C) NIR image 3 minutes D) NIR 
image 5 minutes. (Collaborative studies with Dr Sarwat Rizvi of surgery and interventional sciences 
department) 
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Figure 2.10: A schematic diagram of a NIR imaging system for SLNB in human breast cancer surgery.  
This has potential to be one of the major clinical applications of QDs in the future. The near-infrared light 
penetrates deep tissues with minimal scatter and excites the QDs that emit in the NIR range. A NIR 
camera detects the fluorescence from these dots, which is basically a regular camera with an infrared filter. 
These images can be superimposed with images from the colour camera on a PC to anatomically locate 
the exact position of the NIR QDs.  
2.6.5.2. Tumour targeting and therapy 
In vivo localization of cancer antigens using QDs bound to tumour-specific antibodies 
has been demonstrated in molecular imaging studies. Antibody specific to the prostate 
cancer cell marker PSMA was conjugated to QDs and injected into mice transplanted 
with human prostate cancer. This accurately homed in to the tumour, which was 
accurately imaged in vivo. Their bright luminescence and long lifetime allowed a more 
accurate and sensitive imaging compared to green fluorescent protein (GFP) (Gao et al., 
2004). QDs linked to alpha-fetoprotein (AFP) monoclonal antibody were injected 
intravenously and successfully targeted human hepatocellular carcinoma xenograft 
growing in nude mice (Chen et al., 2008). QDs conjugated to anti-EGFR antibodies 
were able to detect increase expression of EGFR levels, which correspond to early 
change from cervical dysplasia to cancer (Nida et al., 2005). This can have a huge 
impact on the early diagnosis and treatment of cancer. 
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2.6.6. Other applications 
2.6.6.1. Drug delivery 
Targeted QDs may find a “drug delivery” application as an ultrasensitive tool for early 
cancer diagnosis by loading the chemotherapeutic agents, and at the same time 
overcoming systemic side effects. Drugs can be passively targeted to tumors by the EPR 
effect and this concept has been applied to anticancer agents (Iga et al., 2007). QDs as a 
probe can target and accumulate in tumors by both the EPR effect and recognition of 
cancer cell surface biomarkers (active targeting). QDs are one of the many nanoscale 
platforms being developed as novel drug delivery systems (Cuenca et al., 2006) based on 
their ability to target specific sites at a molecular level and unique photophysical 
properties (Hild et al., 2008). 
 2.6.6.2. Photodynamic therapy (PDT) 
One of the major advances in minimally invasive therapies for cancer is photodynamic 
therapy (PDT). First discovered in the early 1900s, it is now an approved cancer 
treatment for various superficial malignancies including head and neck, basal cell 
carcinoma, oral, oesophageal and lung cancers (Hopper, 2000). It is based on the 
targeted localised destruction of diseased tissues via the generation of cytotoxic singlet 
oxygen (1O2) using a non-toxic photosensitizer (PS), activated by light of a specific 
wavelength in the presence of molecular oxygen (3O2). Singlet oxygen leads to cellular 
necrosis and apoptosis of target cells via oxidation and degradation of cellular 
components.  
Photofrin is the most commonly used photosensitizer for PDT and suffers from various 
drawbacks like instability in aqueous solution, prolonged cutaneous sensitivity, chemical 
impurities, and weak absorption at therapeutic wavelengths of > 630 nm which is 
essential for deep tissue penetration (Samia et al., 2006, Ogawa and Kobuke, 2008). The 
application of QD-PS complexes as therapeutic PDT agents was first reported by Burda 
et al. (Samia et al., 2003). QDs can be used in PDT either indirectly as energy donors to 
conventional photosensitizers by FRET mechanism or directly as they react with 
molecular oxygen by energy transfer mechanisms to generate reactive oxygen species 
(ROS) (Figure 2.11). With their high photoluminescence quantum efficiency, prolonged 
photostability, high molar extinction coefficients, tunable emission spectra at NIR 
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wavelengths they form ideal donors for the FRET process in PDT. Additionally, 
functionalization of the QD surface gives the advantage of enhanced solubility, 
biocompatibility and localization of the QD-PS pair to the exact cancer site for specific 
targeted action (Yaghini et al., 2009).  
 
 
Figure 2.11: Mechanism of PDT using QD; QD-PS FRET pair localizes to the site of cancer, 
and is activated by light of a specific wavelength in the presence of molecular oxygen (3O2) to generate 
singlet oxygen, which is toxic to cancer cells. Free radical are also generated directly by activation of the 
QD by light 
2.6.6.3. Medical microbiology and toxin detection  
Using the concept of multiplexed imaging, different food borne pathogenic bacteria have 
been simultaneously detected at low concentrations of 10-3 cfu/mL (colony form 
unit/mL) within 2 hours by using antibody conjugated QDs and magnetic microparticles 
(Zhao et al., 2009). When compared with organic green dye fluorescein isothiocyanate, 
CdSe/ZnS core/shell bioconjugates displayed brighter fluorescence intensities, lower 
detection thresholds, and better accuracy in analyzing bacterial cell mixtures composed 
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of pathogenic E. coli O157:H7 and harmless E. coli DH5alpha using flow cytometry. A 
novel method for an ultrasensitive, fluorescent detection of DNA and antigen molecules 
based on self-assembly of multiwalled CNT and CdSe QDs via oligonucleotide 
hybridization has also been described. Overall, the QD technology demonstrates great 
potential for a rapid and cost effective detection of pathogen and toxin contamination of 
food samples (Cui et al., 2008). 
2.7. Current status 
QD technology holds great potential and promise for applications in nanobiotechnology 
and medical diagnostics where they can be used as probes. However, the use in a clinical 
setting requires extensive research and development to determine the long-term effects 
of its use. Introduction of QDs to the biological milieu involves complex parameters like 
composition, toxicity, thrombogenicity, immunogenicity as well as ADME 
characteristics (absorption, metabolism, distribution and excretion). QD toxicity can also 
occur at different levels including composition of the core, surface coating, size and 
surface charge (Kirchner et al., 2005, Lovric et al., 2005a, Shiohara et al., 2004).  
2.7.1. Quantum dot and toxicity 
There is no consistent data on QD toxicity as there are many varieties of QD 
synthesised. Each QD type possesses its own inherent physicochemical properties (as it 
was described earlier), which in turn dictates its potential toxicity or lack of it. There is 
no systematic body of data currently in literature regarding the toxicity of QD and this 
can be attributed to a number of factors: absence of proper toxicology-based studies, the 
many types of QD dosage/exposure concentrations reported in scientific literature, and 
the diverse physicochemical properties of individual QD (Hardman, 2006). Data from 
studies primarily designed for toxicological assessment (e.g. dose, duration, frequency 
of exposure and mechanism of action) are far and few. To summarize QD toxicity, the 
general concepts were discussed pertaining to core, core shell and coating toxicities and 
animal studies. Two tables are presented that summarises some recent publications on 
QD toxicity (Table 2.4 and 2.5).  
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Table 2.4. Summary of QDs toxicity studies in vitro.  
QD 
Type 
Shell Coating 
Agent 
QD Size 
(nm) 
Concentration Wavelength 
(nm) 
Biological Model 
tested 
Assay Used Incubation 
time (h) 
Evaluated toxicity Outcome Year 
CdSe 
 
 
ZnS DHLA NR 400-600 nM NR Dictyostelium 
discoideum and 
HeLa cells 
NR <1 Cell growth was 
unaffected 
Not applicable. 
Absorbance is 350 
nm 
 
 
2003 
(Jaiswal 
JK, 
2003) 
 
CdSe 
 
 
ZnS None NR 10 pmol QD 
Approx 10 nM 
Eλ= 550 HeLa cells NR 10 Day 10 nM had minimal 
effect on cell so no 
cytotoxicity. 
 
Not applicable. 2004 
(Chen 
FQ, 
2004) 
CdSe ZnS COOH, 
OH/COOH, 
OH, H2/OH, 
NH2, CdSe-
MAA,TOPO 
NR 1-2µM 
62.5-1000µg/ml 
Eλ= 510-520 WTK1 cells 
Primary cultures 
of rat hepatocytes 
NR 12 
1-8 
DNA damage was 
detected when exposed 
to 2mM QD-COOH at 2 
h so there is a sign of 
cytotoxicity. 
Oxidative/photolytic 
influence was cytotoxic. 
There is no sign of 
cytotoxicity by capping 
the QD with ZnS. 
 
Not applicable.  
2004 
(Hoshino 
A and 
Suzuki 
K, 2004) 
 
 
CdSe 
 
 
 
ZnS MUA NR 0-0.4 mg/ml Eλ= 640 Vero and HeLa 
cell culture, 
primary cultures 
of human 
hepatocytes 
NR 24 Vero cells showed 
toxicity at 0.2 mg/ml, 
whereas, HeLa cells & 
hepatocytes at 0.1mg/ml. 
 
Not applicable. 2004  
(Shiohar
a A, 
2004) 
CdSe ZnS SSA NR 0.1-0.4 mg/ml Eλ= 520 EL-4 cells (mouse 
lymphocytes) 
 
NR 0-24 Cell growth was affected 
at 0.1 mg/ml. 
Not applicable. 2004  
(Hoshino 
A, 
2004b) 
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Table 2.4. Continued 
QD 
Type 
Shell Coating 
Agent 
QD Size 
(nm) 
Concentration Wavelength 
(nm) 
Biological Model 
tested 
Assay Used Incubation 
time (h) 
Evaluated toxicity Outcome Year 
CdTe None None 2.3, 2.2, 
5.7, 5.2 
0.01-100 µg/ml Eλ= 605 
Aλ= 518 
rat 
pheochromocyto
ma &murine 
microglial cell 
line 
MTT assay 2-24 At 10 µg/ml is cytotoxic. Pre-incubation of 
cells with antioxident 
N-acetylcysteine & 
bovine serum 
albumin significantly 
reduced QD induced 
cell death, also size 
plays an important 
part in cytotoxicity. 
 
2005  
(Lovric 
et al., 
2005a) 
 
CdTe None None 2-green, 
4-yellow, 
6-red 
0-100 µM NR Hep G2 (human 
hepatom) a cell 
line 
MTT assay 48 Concentrations in the 
range of 3.0µM, 4.8 µM 
& 19.1 µM induced 
reduction of 50% in 
MTT activity 
respectively. Free Cd 
was implicated in the 
observed cell 
cytotoxicity. 
 
Cytotoxicity is 
related to the size of 
QD. Higher 
cytotoxicity was 
related to smaller size 
than the larger QD in 
this particular 
experiment. 
Green 520 nm & 
yellow 519 nm 
2005  
(Lovric 
J, 2005)  
CdSe ZnS PEG 
Silanized 
NR 0, 8, 80 nM NR Human HSF-42 
(skin fibroblast) 
& INR-90 (lung 
fibroblast) cell 
culture. 
Cell 
proliferation, 
apoptosis 
and cell 
cycle 
distribution 
assays. 
 
48 No cytotoxicity. Minimal 
effect on cells integrity 
& molecular response of 
QD exposed to cell lines. 
 
Exposed QD was 
endocytosed by 
human skin & lung 
fibroblast. 
Gene expression was 
altered approximately 
0.2% of genes QD 
stimulated skin 
fibroblast compared 
to controls. 
2006  
(Zhang 
T, 2006) 
 
CdSe 
 
 
 
ZnS Peptide NR 15-250 nM Eλ= 510-550 HEK 239T/17 & 
COS-1 (African 
green Monkey) 
cell lines 
Cell Titer 
96- cell 
proliferation 
assay. 
1 & 24 Low toxicity at 1 h 
High toxicity at 24 h 
The toxicity is 
dependent on 
exposure duration 
and concentration. 
2006  
(Delehan
ty JB, 
2006) 
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Table 2.4. Continued 
QD 
Type 
Shell Coating 
Agent 
QD Size 
(nm) 
Concentration Wavelength 
(nm) 
Biological Model 
tested 
Assay Used Incubation 
time (h) 
Evaluated toxicity Outcome Year 
CdSe 
CdTe 
ZnS Cysteine, 
MPA, N-
acetyl 
cysteine 
NR 10 µg/ml Eλ= 517-554 MCF-7 (human 
breast cancer) cell 
culture. 
MTT & 
Trypan blue 
cell assays. 
1-24 Treatment of cells with 
all forms of CdTe QD 
resulted in significant 
cell death. Therefore, 
cytotoxicity has been 
shown. 
The CdTe QD is 
more toxic than 
CdSe/ZnS QD. It was 
established that free 
Cd is from CdTe 
induces cell death by 
free radical 
production. 
2007  
(Cho SJ, 
2007) 
CdSe None None 2.38 1, 10,20 nM NR Primary rat cell 
culture 
(hippocampal 
neuron) 
MTT assay 24 Cells exposed with QD: 
1nM - no toxicity, 10, 20 
reduced cell viability. 
 
Reactive Oxygen 
species has been 
caused the toxicity. 
2008 
(Tang M, 
2008) 
CdSe ZnS PEG NR 0.84-105 µM NR CaCo-2 (human 
colon carcinoma) 
cell culture. 
MTT assay 24 There is low cytotoxicity The toxicity of coated 
QD is increased with 
acid treatment due to 
the free Cd ions. 
 
2008  
(Wang L, 
2008) 
 
CdTe 
 
 
 
CdS, 
CdS/
ZnS 
None NR 0.2-3.0 µM NR K562 & HEK 
293T human cell 
lines 
MTT assay 48 Cells exposed to CdTe & 
CdTe/CdS QD were 
mostly nonviable, hence 
cytotoxicity was seen. 
However, no sign of 
cytotoxicity in 
CdTe/CdS/ZnS QD. 
ZnS shells may 
prevent the release of 
Cd2+ ions causing 
cytotoxicity. 
 
There is evidence that 
residual organic 
solvents in non-
aqueous QD 
preparations may 
have resulted in QD 
independent 
cytotoxic effects in 
other reports. 
2009  
(Su Y, 
2009) 
 
Keys: MTT: 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide); MUA: Mercaptoundecanoic acid; NR: not reported.    
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Table 2.5: Summary of quantum dots toxicity studies in vivo.  
QD 
Type 
Shell  Coating Agent 
 
QD 
Size 
(nm) 
Concentration Wavelength 
(nm) 
Biological Model 
tested 
Assay/s Used Incubation 
time (h) 
Evaluated 
toxicity 
Outcome Year 
InAs  
 
 
ZnSe DHLA/ 
PEG 
8.7 NR No longer 
than 800 
Subcutaneously 
& IV injected in 
to rats & mice.  
NR 5 min Toxicity was 
not observed. 
 QDs were accumulated to 
SLNs when they were 
applied subcutaneously. 
However, QDs injected 
intravenously were 
shown to extravagate 
from the vasculature. 
 
2006  
(Zimmer JP, 
2006) 
 
CdSe ZnS MAA/targeting 
peptides± PEG 
3.5 & 
5.5 
NR Eλ= 750-920 IVD into the tail 
of mouse.  
NR 20 min Toxicity was 
not observed. 
PEG prevents the 
nonspecific uptake of 
QD into the liver & 
spleen. Hence, PEG has 
an important role in QD. 
 
2006  
(Zimmer JP, 
2006) 
CdSe 
QD525 
& 
QD800 
ZnS ±PEG 21 & 
12 
25 pmol Eλ= 525 IVD in the 
mouse.  
NR 15 min  There is no 
sign of toxicity 
in this paper. 
QD/PEG coated had a 6 
min circulation time & 
without the 2 min. 
Presence of QD in the 
liver & spleen. The size 
of QD had no effect on 
biodistribution.  
 
2007  
(Schipper 
ML, 2007) 
 
CdTe ZnS Monoclonal 
antibody for 
lung 
NR NR NR IVD into the 
mouse.  
NR Up to 144  No acute 
toxicity was 
observed.  
The QD was removed 
from the body in a slow 
pace.  
2007 
(Woodward 
JD and 
Avenell J, 
2007) 
CdSe ZnS LM 
BSA 
25, 
80  
5 nmol  Eλ= 430 
Aλ= 350 
Intravenously 
injection into the 
rat.  
NR 240  No toxicity 
was observed 
BSA coated QD was 
almost distributed to the 
liver, spleen & other 
tissues in approximately 
less than 2 hours. 
 
2006 
(Fischer HC, 
2006) 
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Table 2.5: Continued 
QD 
Type 
Shell  Coating Agent 
 
QD 
Size 
(nm) 
Concentration Wavelength 
(nm) 
Biological Model 
tested 
Assay/s Used Incubation 
time (h) 
Evaluated 
toxicity 
Outcome Year 
CdSe 
 
CdS PEG 37 NR Eλ= 610-621 Intradermal 
injection into the 
mouse. 
NR 24  Not toxicity 
was assessed. 
QD mainly stayed in the 
injected site, they were 
detected in Lymph nodes  
 
2007  
(Gopee NV, 
2007) 
 
CdSe 
 
ZnS SSA/MUA NR 0.1 mg/ml NR EL-4 cells, 
injected into 
mouse. 
NR Up to 168 h Not toxicity  NR 2004 
(Hoshino A, 
2004b) 
CdTe None None 6 2 mM NR IVD into rat. Physiological, 
locomotion, 
behavioural 
assessment with 
histopathology 
24  According to 
this paper 
there are some 
signs of 
toxicity can be 
observed. 
NR  
2007 
(Zhang Y, 
2007) 
Keys: IVD: Intravenously delivered. 
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2.7.1.1. Core material toxicity  
The potential and main area of QD toxicity, especially the cadmium-based QD is from 
the cadmium located at the core of the nanocrystal. Data from uncoated QD and free Cd 
present in the colloid suspensions and core have affected cells intracellularly (Kirchner 
et al., 2005) concluded that CdTe QD were cytotoxic in rat pheochromocytoma cells 
(PC12) at 1 µg/mL level of concentration which induced apoptotic-type of cell death 
with chromatin condensation and membrane fragmentation. The toxicity effect observed 
in these studies resembled Cadmium ions (Cd2+) toxicity. Data collected from 
incubation of uncoated nanocrystals in rat hepatocytes cells suggest that cadmium is 
released via surface oxidation by biodegradation (Derfus AM, 2003). This study 
suggests that cadmium toxicity is from the core and is likely to contribute significantly 
to QD toxicity. 
QD derived from CdTe and CdSe are electronically active and as such are prone to 
photo and air oxidation (as it was described previously) which could potentially 
promote free radical formation which can instigate cytotoxicity (Ipe et al., 2005). There 
is evidence that free cadmium ions do not promote free radical formation but can 
increase oxidative stress, whereas the QD core does contribute to free radical 
generation. Studies have shown that using cadmium reactive dyes in cell culture, the 
cytotoxicity was not linked to cadmium release from QD but to free radical generation 
(Cho et al., 2007). There is also evidence that free radical generation promotes DNA 
damage in the absence and presence of light photon activation (Green and Howman, 
2005). Photoactivation of QD by visible or UV light or air oxidation was shown to 
increase free radical formation. The mechanism involved in these environments is that a 
photon of light excites the QD generating an excited electron that migrates to molecular 
oxygen generating singlet oxygen. In the presence of water and biological molecules, 
singlet oxygen readily initiates free radical formation (Figure 2.11). This is the 
rationale behind photodynamic therapy in cancer applications when QD are the 
participating material and its toxicity needs assessing when distributed to normal 
tissues. When normal tissue takes up QD nanoparticles and when activated by photons 
of light or other oxidative stress, free radical production can have detrimental effects on 
the tissues. 
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To circumnavigate this problem, tissue culture studies can provide some understanding 
of the process but unfortunately correlating the outcome to in vivo scenarios can 
overestimate or underestimate toxicity effects. Uncoated QD have also contributed to 
cytotoxicity comparable to cadmium toxicity and oxidative damage. Perturbations in 
gene expression and biochemical processes have all been implicated with QD toxicity 
suggesting a need for more thorough long-term studies of the effects of QD on cell 
signalling. This is vital for future applications, as long transit times encountered by QD 
in tissues and cells may cause damage.  
With the current knowledge based on fluorescent organic dyes to determine the fate of 
intracellular biomolecules, care has to be exercised. Numerous nanoparticles with their 
innate active electronic structure can interact with commonly used organic dyes. It is of 
utmost importance to conduct suitable controls to include data that nanoparticle activity 
is not due to its electronic interaction with organic dyes present in assays. 
2.7.1.2. Encapsulated quantum dots and their toxicity 
Studies have shown that encapsulation of the QD core with ZnS or alternative capping 
material tends to reduce toxicity, although more work in this area is needed 
investigating. Work on human breast cancer MCF-7 cells has shown that CdTe 
cadmium cellular damage is similar to cadmium toxicity, while CdTe/ZnS core-shells or 
CdTe capped with mercaptopropionic acid, cysteamine, and n-acetylcysteine minimized 
the effect, indicating that ZnS shells and capping materials are effective in the time 
scale studied (Bakalova et al., 2005). In the above studies, leaching of the free cadmium 
ion in the intracellular compartment was also minimized by ZnS, MSA and capping 
agents. The presence of ZnS shell not only reduced the process of apoptosis and 
biochemical activation of processes but also eliminated release of cadmium ions whilst 
in aqueous environment. It also showed that ZnS shells could also reduce free radical 
production generated by air oxidation. This clearly demonstrates that capping QD with 
ZnS or other capping material reduces toxicity implicated with free radical production 
or release of free cadmium. It is important to emphasize that to evaluate toxicity of shell 
or capped particles, the degradation of the shell or capping material, together with its 
cytotoxicity taken into consideration (Chan et al., 2006). 
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Previous studies have shown that fluorescence intensity of CdSe/ZnS decreased with 
time along with a shift towards the blue spectra within live cells over time. This 
indicates that ZnS core shell biodegrades within the intracellular milieu. Some studies 
have indicated that the ZnS shell did not fully eliminate cytotoxicity when air or photo-
oxidation was involved and that CdSe/ZnS QD may have promoted free radical 
production. It has been proposed by some researchers that although the ZnS shell 
shielded the CdSe core from oxidation, it could not inhibit the electron-induced radical 
generation in the aqueous environment suggesting that the ZnS underwent slow 
oxidation in the presence of air or water generating the sulphite (SO2-) radical (Kirchner 
et al., 2005).  
Applying capping materials such as ZnS to insulate QD core to reduce toxicity has been 
undertaken in many applications. In one study, CdTe QD coated with 
mercaptopropionic acid or cysteamine required a higher concentration to become toxic 
in PC12 cells as compared to uncoated QD. Equally, using the amino acid derivative N-
acetylcysteine as coating agent on CdTe a reduction in the induction of Fas upregulation 
involved in apoptosis (Lovric et al., 2005a) and a decrease in cytotoxicity in 
neuroblastoma cells. Using dihydroxylipoic acid (DHLA) coating on CdSe/ZnS (Voura 
et al., 2004) have shown reduction in toxicity of QD in several cell lines while 
maintaining the fluorescence for over a week with no adverse effects. Using a large 
protein such as bovine serum albumin coating on QD has also shown reduced toxicity. 
The majority of the effective capping materials all belong to antioxidants and this 
demonstrates the existence of oxidative stress in cadmium based QD toxicity. Capping 
materials in themselves must also be taken into account as potential toxic substances 
and several groups have shown increased toxicity associated with mercaptoacetic acid 
and TOP-(o-tri-n-octylphosphine oxide) (TOPO). Accumulated data suggest that the 
stability of shell and capping materials as well as toxicity requires intensive 
investigation for different QD preparations (Smith et al., 2008a). 
2.7.1.3. Functional coatings and toxicity of quantum dots 
QD incorporating shell and capping materials contain functional groups in order to 
target specific cells or tissues. These functionalized QD will need their toxicity and 
physicochemical parameters investigated as they may reduce toxicity when targeted to 
2: A CRITICAL REVIEW ON THE DEVELOPMENT OF ‘QDS’ AND THEIR BIOMEDICAL APPLICATIONS 
	   44	  
specific locations. The specificity of the targeting material needs evaluating, as 
migration to non-targeted tissue may generate toxicity especially when QD function as a 
photosensitizing agent or drug carrier. Despite many studies in the use of functionalized 
QD in vitro and in vivo, no detailed studies has been conducted to ascertain the toxicity 
of these nanoparticle derivatives or their presence in non-targeted tissues. Data as to the 
biostability of the coatings, their half-life in vivo and non-specific targeting needs 
investigating. All these queries need resolving before use of coated QD in human 
applications can be undertaken (Derfus AM, 2003). 
2.7.1.4. Toxicity studies of quantum dots in vivo 
Toxicity can be exploited for its benefit in regards to biomedical applications especially 
in directing cellular death of tumors or metastases (Juzenas et al., 2008). One can 
envisage QD being designed with a photoactivatable coating and a site-specific ligand. 
Toxicity induced by photoactivation is directed to specific sites (such as tumors). After 
excitation by a photon, QD can impart an excited electron to molecular oxygen in the 
vicinity thus initiating a chain reaction of free radical generation promoting cell death. 
Photodynamic therapy in oncology uses this rationale, and it must be borne in mind that 
non-specific distribution of QD to non-cancerous tissue such as skin or retina exposed 
to light taken into account.  
QD pharmacology and toxicology pertaining to animal studies are incompletely 
investigated. Uncoated CdTe QD injected in rats produced inconclusive results relating 
to toxicity and organ damage, and a thorough histological evaluation was absent. 
Disturbances to the motor function, when post injection of QD, indicating potential 
toxic effect to neural function (Zhang et al., 2008a). Future investigation should focus in 
this area particularly using long-term exposure studies, needs addressing. Studies with 
injected amphiphylic polycyclic acid polymer and PEG-coated QD in mice of 20 m-1g-1 
animal weight have indicated non-lethality up to the time of necropsy (133 days) and no 
indication of necrosis or damage at injection sites and no signs of QD degradation in 
vivo. Mice injected with 20 nM and 1 µM CdSe/ZnS showed no noticeable adverse 
effects (Larson et al., 2003). Absence of overt adverse effects is no indication that there 
is no toxicity. QD with polymer and amphiphilic coatings when injected was found to 
retard degradation of coatings over time in vivo, affecting fluorescence over time, 
indicating that toxicological effects can alter with residence time of QD in tissues. 
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Studies have shown depending on the coatings such as mercaptoundecanoic acid, lysine 
and BSA coated CdSe/ZnS QD when injected in rats show regional distribution. 
Interestingly detection of QDs in the urine or faeces were absent over the duration of 10 
days, indicating long transit time in the body. The particles indicated non-toxicity but 
not eliminated from the system either. The existing few studies show the need for short 
and long-term toxicity assessment that monitors multi-organ systems before QD be 
evaluated accurately (Gao et al., 2004). 
2.7.2. Parameters involved in the reduction of quantum dot 
toxicity 
QDs in comparison with pharmaceutical drugs undergo similar toxicity evaluation in 
terms of size, dose and exposure emphasizing the importance of stringent 
physicochemical characterization of QD. Particle size evaluation is vital to biological 
actions of nanoparticles. Numerous studies have demonstrated that for QD, particle size 
influences toxicity at the intracellular and animal level. Some studies have indicated that 
in cellular studies, 2.2 nm CdTe QD had greater toxicity as compared to larger, 5.2 nm 
particles (Lovric et al., 2005b). Interestingly, smaller particles localized in and around 
the nucleus of the cell, while the larger particles (approximately 2.5 nm) were located 
within the cytoplasm. 
At the nanoscale level, size and dose plays an important role, since surface area is 
critical for nanoparticle properties. In one study, it concluded that structure might play 
an important role in its activity when delivered via the dermal route. Relevant 
information needed for toxicological studies as applied to humans are, the level of 
exposure and dose (Zhang et al., 2008a). Studies done in vitro using milligram or 
microgram/ml quantities may indicate a high dose to correlate to physiological context, 
as QD used at low concentration when targeted. Until dosing parameters is 
standardized, current studies should include a wide range of concentrations, highest to 
the lowest and incorporate estimations of surface area and the number of particles 
delivered (Ryman-Rasmussen et al., 2007). 
Finally, exposure parameters require further evaluation. Most nanoparticles including 
QD have a tendency to distribute widely in tissues unless targeted, and most have 
minimal level of metabolism or excretion. Evidence of long residence time in tissues, 
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and long-term studies are vital to establish toxicological risk (Zhang et al., 2008b). In 
relevance to QD, the presence of electronically active cadmium in the structure may 
reside in tissues for a long duration perhaps years. As has been established that QD 
promote toxicity via the effects of cadmium and free radical generation, alteration on 
transcription, DNA synthesis, and signal transduction can go on for a long time. Recent 
studies have shown how relevant, low levels of free radical formation are integral to 
signal transduction pathways, and hence low-level radical production from QD may 
participate and alter with these pathways over time, as the various layers coating the 
toxic cadmium core are biodegraded (Tonks, 2005). 
2.8. Evaluating quantum dot location through blood 
brain barrier 
The blood brain barrier (BBB) is a barrier, which prevents diffusion of any unwanted 
substances from entering the vasculature of the brain, due to tight junctions. The 
disadvantage of this is that therapeutic drugs cannot reach the brain. There are special 
receptors or specific transporters that depend on the integrity of the capillaries for the 
transport of compounds across the barrier (Lockman et al., 2002).  
Nevertheless, the feasibility of the use of nanoparticles for drug delivery or even 
imaging of the brain through the BBB has great potential. Nanoparticles with 
appropriate ligands are able to cross the BBB to deliver therapeutic drug molecules into 
the brain, as well as maintaining their stability. Additionally, slow release of the drug 
may prevent or decrease the peripheral toxicity, which is the second desirable property 
of the nanoparticle. Due to lack of research in this area, there are many factors that have 
to be considered in order to use the nanoparticles for labelling purposes. In the late 19th 
century BBB work was carried out using trypan blue dye injected into small animals 
intravenously and results showed that the blue dye had been absorbed into the entire 
body except the brain. In the 1950s, similar experiments done on bigger animals such as 
rabbits and dogs when injected directly into the cerebrospinal fluid and electron 
microscopy showed trace of the blue dye in the brain. Finally, there is lack of studies 
currently conducted on QD and BBB. The lack of data in this area is because of 
inability of QD to cross the BBB or uptake and clearance by the reticuloendothelial 
system (RES) from the circulation. More experiments in this area with QDs have to be 
explored and established (Longmire et al., 2008). 
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2.8.1. Transit time of quantum dots in vivo 
It is important to consider the physiological aspect of nanoparticles in order to 
understand their clearance mechanism. Kidneys and liver are responsible for clearing 
the QD from different organs when taken up. It must be established that the injected QD 
have been removed from the body as they contain heavy metal such as cadmium and 
selenium. According to different reviews, QDs have varied half-life: for example one 
study has shown the existence of QDs in the liver and kidney for 28 days, and another 
study detecting the trace of QDs in the lymph node and bone marrow of mice for 133 
days, after intravenous injection (Ballou et al., 2004, Hardman, 2006). 
Generally, nanoparticles face several processes that eliminate them from the body 
through renal clearance. These processes involve of glomerular filtration, tubular 
secretion and finally elimination of the molecule (Deen et al., 2001). In addition to size, 
surface charge plays an important part in clearance of nanoparticles. The rate of 
filtration of nanoparticles depends on their hydrodynamic diameter in the glomerular 
filtration. Renal clearance of QDs has been studied in the past by monitoring the body 
fluid such as urine, bile and faeces (Choi et al., 2007). Nanoparticles with diameter less 
than 6 nm are freely filtered whereas size between 6-8 nm can be filtered depending on 
surface charge (Ohlson et al., 2001). Larger nanoparticles with size of 8 nm cannot be 
removed by the renal route however: studies have shown that RES may be involved in 
the uptake (Choi et al. 2007a). Additionally, the hepatobiliary system takes first priority 
in removing the large nanoparticles (> 8 nm). The renal system plays a vital part in the 
removal of QD from the body with hydrodynamic diameter ranging between 4 to 6 nm. 
It can be deduced that as the size of QD increases, the renal clearance decreases. One 
study has shown that the clearance of QD exhibited high level of QD conjugated with 
bovine serum albumin (BSA) in the liver (Schipper et al., 2007). 
By analysing the amount of QD retained in the body, dimensions of the nanocrystal can 
be estimated (Pelley et al., 2009). Excretion of QD from body circulation is inversely 
linked to their toxicity. High amount of QD in the body causes significant toxicity. This 
was confirmed by work done by Lin et al (Lin et al., 2008).  
Overall, more research is needed in order to gain a better understanding and thorough 
insight into fundamental issues of this topic. One needs to address a number of 
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fundamental issues. For instance, details as to how QDs are excreted from the human 
body need to be determined.  
2.9. Future perspectives 
QDs have found vast application in biological and biomedical research as the next 
generation fluorescent probes. They are a powerful tool for illuminating many of the 
mysteries that encompass signal transduction pathways and biomolecular interaction 
within cells. Through extrapolating their properties for in vivo molecular and cellular 
imaging, QDs have a potential to lead to major advances in nanomedicine. They can 
revolutionize cancer diagnosis and therapy through early pre-symptomatic diagnosis 
and image guided drug delivery of chemotherapeutic agents. NIR QDs may replace the 
current tracers for SLN biopsy. The most promising aspect of QD application is in their 
use as photosensitizers for PDT. This application is unique as it utilises their inherent 
toxicity via the generation of reactive oxygen species to target cancer cells and micro-
organisms. Overall, there are relentless possibilities for the application of QDs in 
biology and nanomedicine. However, QD technology is still in its infancy and extensive 
research is still required to resolve many of the issues that are limiting their safe 
application in clinical medicine.  
Nanotechnology is a rapidly expanding area of science and nanoparticles such as QDs 
have potential to revolutionize in the area of medicine and research. Once the potential 
toxicity is reduced or eliminated it has the potential for multifunctional applications in 
the field of biomedicine, which includes cancer detection, drug delivery, imaging and 
real time monitoring of cellular processes in a disease state. Explorative work in the 
area of toxicity and safe use of nanoparticles in a clinical setting will contribute to our 
understanding of its properties. In order to reduce toxicity more research and 
investigation on non-cadmium QD and novel biocompatible would be desirable. 
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2.10. Aims 
Aims of this study were firstly to conduct and develop novel QDs using an aqueous 
synthesis method that would emit in the visible to NIR region. Secondly, to 
significantly reduce toxicities associated to traditional QDs by coating with new novel 
agents that are also biocompatible. Thirdly to conjugate QDs with suitable ligands so as 
to produce probes that can be targeted to biomarkers on cancer cells that can also 
function as therapeutic agents. 
 
	  50	  
 
 
 
 
                                                       Chapter 3 
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3.1. Introduction 
An aqueous synthesis method to develop highly luminescent cadmium based 
nanocrystals and their characterizations are described in this chapter. A series of water-
soluble semiconductor QDs with high photoluminescence quantum yield (QY) have 
been synthesised and the biocompatibility, toxicity and finally bioconjugation properties 
have been evaluated throughout this thesis. 
Investigation of QD’s properties is vital and necessary because of their potential 
biological applications. For instance, as described in chapter 2, the broad excitation 
wavelength and symmetric emission wavelength can help the clinician to obtain visible 
images of targeted sites whereas using the current organic dyes faint images with short 
half-life will be obtained. Additionally using NIR emitting QDs and exciting with NIR 
excitation can penetrate deep tissues for strong images avoiding autofluorescence from 
tissues (Rizvi et al., 2010). 
In this chapter some useful and applied biophysical and biochemical techniques to 
characterize QDs are presented. Each of the techniques by itself provides direct and 
indirect information, however, the combined use of several of them can contribute to 
detailed size and structures of the fabrication methods used in the synthesis of QDs. The 
emphasis is on the biophysical nature of what is measured in each technique and the 
way in which the data are used to obtain spectral and biochemical information. These 
techniques exploit the interaction of electromagnetic radiation with the nanocrystals 
under investigation. The characteristic interactions in Fourier transform infrared (FTIR) 
are related to the energy and wavelength absorbed and hence the emission wavelengths 
related to the nanomaterials and size. Additionally, in vitro cell culture techniques are 
linked to the chemical interaction with uptake and membrane interaction and estimating 
viability. 
Despite the growing importance of obtaining accurate estimates of size, size distribution 
and concentration of QD particles in an increasingly wide range of applications, existing 
techniques for obtaining such data (e.g. Electron Microscopy and light emission, 
absorbance and scattering) can prove time consuming and complex, thus results difficult 
to interpret, particularly in samples which are heterogeneous in composition or which 
contain a range of particle sizes, e.g. are polydisperse. 
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3.2. Materials 
All reagents in this study were used directly without further purification whilst all other 
reagents were of analytical grade. Water for all reactions and solution prepared were of 
highly purified and filtered by reserve osmosis (EASYpure RO). 
Materials Sources 
1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide 
(EDC) 
Sigma-Aldrich 
Alamar Blue ™ Serotec, Kidlington, UK 
Ammonium sulphate Sigma-Aldrich 
Cadmium chloride (CdCl2) 99.99% Sigma-Aldrich 
Centricon Sigma-Aldrich 
Culture plastic ware  Costar 
Dichloromethane (DCM) Rathburn 
Dimethyl sulfoxide (DMSO) Sigma-Aldrich 
Dulbecco’s-modified eagle medium (DMEM) Sigma-Aldrich 
Duterium oxide (D2O) Sigma-Aldrich 
Endothelial cell growth medium supplement       
mix C-39215 (HUVEC) 
PromoCell GmbH  
Endothelial cell growth medium with supplement 
mix 5% FBS supplemented with growth factors. 
PromoCell GmbH 
Ethanol Sigma-Aldrich 
Ethylenediaminetetraacetic acid (EDTA) Sigma-Aldrich  
Foetal calf serum (FCS) Gibco BRL 
Freund’s adjuvant (FA) Sigma-Aldrich 
Glutaldehyde Sigma-Aldrich 
Keyhole limpet haemocyanin (KLH)  Sigma-Aldrich 
Mercaptopropylisobutyl polyhedral oligomeric 
silsesquioxane (MPOSS) 
Hybrid Plastics 
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Mercaptosuccinic acid MSA (98%) Sigma-Aldrich 
N-(3-Dimethylaminopropyl)-N´-ethylcarbodiimide 
hydrochloride (DCCI)  
Sigma-Aldrich 
 
N-hydroxysuccinimide (NHS) Sigma-Aldrich 
N-N-Dimetylformamide (DMF) Sigma-Aldrich 
Neutral Red assay Sigma-Aldrich 
Paraformaldehyde (powder 95%) Sigma-Aldrich 
PBS/Tween20 Sigma-Aldrich 
Phosphate buffered saline (PBS) Sigma-Aldrich 
Rhodamine G Sigma-Aldrich 
Sodium borate Na2B4O7 (98%) Sigma-Aldrich 
Sodium borohydride NaBH4 (98%) Sigma-Aldrich 
Sodium citrate C6H5Na3O7.2H2O Sigma-Aldrich 
Sodium sulphite Na2SO3 (98%) Sigma-Aldrich 
Sodium telluride Na2TeO3 (99.99%) Sigma-Aldrich 
Sodium tetraborate decahydrate, B4Na2O7 (99.5%) Sigma-Aldrich  
TBTU, Fmoc-amino acids Sigma-Aldrich 
Tetrahydrofuran THF (99.9%)  Sigma-Aldrich 
Trifluoroacetic acid (TFA) Sigma-Aldrich 
  
3.3. Analytical techniques and instruments 
3.3.1. Transmission electron microscopy (TEM) 
TEM (Phillips CM 120) was used for visualisation and to obtain the size of particles. 
The disadvantage of TEM is high costs and complex sample preparation procedure. 
Hence, TEM was used only to determine the size and shape of coated QDs and 
uncoated nanocrystals.  
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To determine the size and shape of the MPOSS coated QDs and uncoated QDs, a set of 
1:100 serial dilutions were made of coated QD with PBS and the optimum dilution was 
chosen. A drop of the samples was mounted on to a Piloform (TAAB) coated G300HS 
copper electron microscopy grid (Gilder) and allowed to air dry. The grids were 
examined with a CM120 (Philips) TEM at 3.0 x 105 magnification. 
3.3.2. Ultraviolet-Visible absorbance spectroscopy (λab) 
This device is a very straightforward analytical device, which uses light in the visible 
and adjacent (UV and NIR) ranges. This device measures absorbance of samples, which 
are soluble in their respective solvents. The solvents for diluting samples are often 
distilled water from water-soluble compounds, or ethanol for organic-soluble 
compounds so not all solvents are suitable for use in UV spectroscopy.  
In this study, UV-visible absorption spectra were recorded in a quartz cuvette with a 1 
cm path length. Either Borate-citrate or PBS buffer or distilled water could be used as a 
blank and an absorption spectrum of the clear soluble QDs nanoparticles was obtained. 
Using “Jasco V-630 Spectrophotometer” absorption spectra were recorded from 400 nm 
to 750 nm using a bandwidth of 2.0 nm. Different types of synthesised QDs were 
measured and their absorbance obtained. All optical measurements were performed at 
room temperature under ambient conditions. 
3.3.3. Emission spectrum (λex) spectroscopy 
The emission wavelength was conducted by USB 2000+ Ocean Optics spectroscopy. It 
is rapid and the evaluation of emission wavelength can be done promptly. The 
homogeneity of samples can be analyzed by its FWHM. This device is extremely 
sensitive for detecting emission of QDs. 
Samples were placed in a 1 cm path quartz cuvette. Using an excitation wavelength (λex) 
of 375 nm with slit width of 5.0 nm, spectra were recorded from 400 nm to 800 nm 
regions. The emission spectrum of all synthesised QDs was determined. In addition, 
using different excitation wavelength (λex) allows studying the emission spectrum. This 
equipment is also designed to photostability of the QDs in aqueous solution in real time. 
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3.3.4. Fourier transform infrared spectroscopy (FTIR) 
FTIR spectra were obtained using the Perkin-Elmer 1750 FTIR spectrometer equipped 
with a fast recovery TGS detector and spectra analysis program for data acquisition and 
analysis (Figure 3.1). QD samples were placed in specially designed micro-cell housing 
with specially cut calcium fluoride (CaF2) windows with 5 µm spacer. QDs were 
equilibrated in Deuterium oxide (D2O) and 1 mg/mL were used for measurement. The 
spectrometer was continuously purged with dry air to eliminate spectra from 
atmospheric moisture in the spectral region of interest. A sample shuttle was employed 
to permit the sample to be signal-averaged with the background. Measurements in D2O 
at room temperature were recorded at a QD concentration of 1 mg/mL and 100 scans 
were signal averaged. 
All spectra were recorded at a resolution of 4 cm-1 and aqueous D2O spectra as blank 
were recorded under identical conditions as the sample spectra. Absorption spectra were 
obtained by digitally subtracting the solvent spectrum from the corresponding sample 
spectrum. Where appropriate, water vapour contributions were subtracted from the 
absorption spectrum using previously recorded water vapour spectrum. Resolution 
enhancement using second derivative were calculated over 13 data-point range (13cm-1) 
using the DERIV function to assign features of the vibrational spectra present in the QD 
samples. 
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Figure 3.1: Schematic representation of a FTIR spectrometer. 
FTIR is a technique, which utilizes an interferometer, originally designed by Michelson. The Michelson 
interferometer consists of two plane mirrors at right to each other and a beam splitter at an angle of 45° to 
the mirrors. One mirror is fixed in a stationary position and the other can be moved in a direction 
perpendicular to its front surface at a constant velocity. Between the fixed mirror and the movable mirror 
is a beam splitter, which divides the incoming light from the source, which is 50% is transmitted and 50% 
is reflected.  
3.3.5. Confocal fluorescence microscopy 
Images were acquired by fluorescent microscopy (Nikon Eclipse TE 300). The PCM 
scanning head is mounted on an inverted optical microscope (Nikon Eclipse TE 300), 
which can operate in fluorescence, reflection and phase contrast modes, and it is 
provided with Plan Fluor dry objective (20X/NA=0.5). A He-Ne blue laser at 488 nm 
and green at 543 nm are the sources, housed in a common module, providing the 
excitation beams that are delivered to the scanning head through a single-mode optical 
fiber. Photomultiplier (PMT) tubes are placed within the control unit, and the collected 
light arrives via high-transmission optical fibers. This means that electronic noise at the 
PMT output is greatly minimized. 
3.3.6. Dynamic light scattering and X-ray diffraction 
This technique produces fast results, high sample throughput and direct sample 
measurement as well as no need to dilute samples on column. However, there are some 
Source Collimator 
Fixed mirror 
Sample compartment 
M
oving m
irror 
Detector 
Beam splitter  
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weaknesses such as, evaluating data is complex, there is no any quantitative method and 
finally it is a poor devise for complex, polydisperse sample types (e.g. many biological 
sample types). 
XRD is a rapid analytical technique primarily used for phase identification of a 
crystalline material and can provide information on unit cell dimensions. The analyzed 
material is finely ground, homogenized, and average bulk composition is determined. 
Further elemental composition was obtained with the use of XRD. The main application 
of X-ray powder diffraction is most widely used for the identification of unknown 
crystalline materials such as QDs. Determination of unknown solids is critical to studies 
in geology, environmental science, material science, engineering and biology. XRD 
information are normally obtained using aqueous solution of a prepared CdTe diluted 
with 1 volume of ethanol and centrifuged at 4000 rpm for 10 minutes. The precipitate is 
deposited onto a glass slide and dried at room temperature. 
3.3.7. Zeta Potential 
Measuring the zeta potential of particles in suspension is used to predict stability and 
behaviour when exposed to changes in ionic strength of the solution. Historically zeta 
potential measurement has required the sample to be diluted before measurements, 
which runs the risk of changing the zeta potential. 
To characterize the size and charge on QD’s surface, size distribution and zeta potential 
of QDs are determined with a Mastersizer 2000 Laser Particle Size Analyzer (Malvern, 
UK) equipped with a helium-neon laser (10 mW max, 633 nm). The laser light-
scattering experiments were performed at a scattering angle of 90°. The available 
detection size ranged from 2 nm to 3 µm. 
3.4. Methods 
3.4.1. Cell culture techniques 
3.4.1.1. Primary and secondary cultures  
To propagate isolated or separated cells, specific tissues are first obtained and dispersed 
into its constituent cells, usually with the aid of a proteolytic enzyme such as trypsin. 
After removal of the trypsin the suspension is placed in a sterile plastic petri dish 
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together with a growth liquid medium containing required ions at isosmotic 
concentration, essential amino acids and vitamins, and an animal serum (usually foetal 
calf) in a proportion varying from a few percent to 50%. Sodium bicarbonate is 
commonly used as a buffer, in equilibrium with CO2 (about 5%) in the air above the 
medium. After a variable lag phase the cells attach and spread on the bottom of the dish 
and start dividing mitotically, resulting in a primary culture. Attachment to a rigid 
support or substrate is crucial for the growth of most normal cells (anchorage 
dependence). 
In many instances in the primary culture, the cells retain some of the characteristics of 
the tissue from which they were initiated, and are mainly of two varieties: thin and 
elongated (fibroblast like) or polygonal and tending to form sheets (epithelioid cells). 
The cells multiply or proliferate to cover the bottom of the flask with a continuous but 
thin layer, often one cell thick known as a monolayer. If they are fibroblastic they are 
regularly oriented parallel to each other (Figure 3.2). 
 
 
 
 
 
 
Figure 3.2: Cells arranged in two types: A, thin and elongated (fibroblast like) or B, polygonal and 
tending to form sheets (epithelioid cells) 
 
Primary cell cultures derived from cancerous tissues usually differ from those of normal 
cells and are like transformed cells. The cultures are maintained by renewing the growth 
medium two or three times a week. When the cultures reach 90% confluence the cells 
are detached from the culture vessel wall by either trypsin or in combination with a 
chelating agent EDTA (Ethylenediaminetetraacetic acid, Sigma-Aldrich Company Ltd., 
Poole, UK), and a fraction of this is used to initiate new secondary cultures (transfer or 
splitting) to eventually establish cell strains or cell lines (Figure 3.3). 
A B 
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Figure 3.3: Multiplication of cultures of cells derived from normal tissues.  
The primary culture gives rise to a cell strain, whose cells grow actively for many cells generations; then 
growth declines and finally the culture stops growing and dies. During multiplication of the cell strain 
altered cells maybe produced, which continued to grow indefinitely and originate a cell line. The 
cumulative number of cells is calculated as if all cells derived from the original culture had been kept at 
every transfer. (Adapted from Hayflick L: Analytic Cell Culture. National Cancer Institute Monograph, 
No. 7, 1962, p. 63) 
Cells derived from primary cultures can often be passaged serially a number of times. 
This process usually causes a selection (cloning) for some cell types, which become 
predominant. The cells may then continue to proliferate at a constant rate over many 
successive transfers, and the primary culture is defined as having originated a cell strain 
(often called a diploid cell strain) whose cells appear unaltered in morphologic and 
growth properties. These cells must be transferred at a relative high cell density or split 
ratio to initiate a new culture. Despite this, the transferability of cell strains is limited: 
for example, with cultures of human cells the growth rate declines after about 50 
duplications and the life of the strain comes to an end. 
During the multiplication of cell strain some cells become transformed or altered, that is 
they acquire a different morphology, grow faster, and become able to start a culture 
from a small number of cells or high split ratio. The clone derived cells from one such 
cell, in contrast to the cell strain in which it originated, has unlimited or infinite life; it is 
designated as a cell line. 
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3.4.1.2. Cell transformation  
Oncogenic viruses, radiations, and certain chemicals can induce mutation like changes 
in cultured cells that affect their growth and other properties. Such transformation 
(Figure 3.4) can also develop during the serial passage growth of cell lines without any 
exposure to the above, mentioned agents. Radiation and chemicals may induce 
transformation, as well as cancer in vivo, by initiating mutations (somatic mutations) 
because they were absent in the germ cells. 
 
 
 
 
 
 
 
 
 
Figure 3.4: Transformation of cell lines during the serial passage. 
Transformation can develop during the serial passage growth of cell lines without any exposure to the 
agents. A, C and E show cell proliferating with time whereas, B, D and F are amplified to show 
phenotypic changes after time. Radiation and chemicals may induce transformation, as well as cancer in 
vivo, by initiating mutations (somatic mutations) because they were absent in the germ cells. 
3.4.1.3. Cell culture and treatments 
3.4.1.3.1. Cell culture types 
Human umbilical vein endothelial cells (HUVECs) originally isolated from umbilical 
cords. HUVECs the grown in cell culture medium (CCM) prepared using PromoCell 
Endothelial cell growth medium with supplement mix (PromoCell GmbH) at 37 ºC with 
5% CO2. Following confluences, cells were removed using 0.25% trypsin-EDTA and 
split in a 1:2 ratio. For this study the passage number 3 was selected. HUVECs 
originally were purchased from American type cell culture (ATCC) however, it was 
provided for this research from this department. 
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The supplement consisted of 5% inactivated foetal bovine serum (FBS), endothelial cell 
growth supplement 4%, epidermal growth factor 10 ng, basic fibroblast growth factor 
100 ng, heparin 9 µg and hydrocortisone 100 µg. The medium has been developed for 
low serum for the in vitro cultivation of endothelial cells from large blood vessels. It has 
been optimized for human cells but can also be used in bovine, porcine and rat 
endothelial cells. 
The prostate cancer cells (PC-3) were originally isolated from bone metastasis of a 
grade IV prostatic adenocarcinoma from a 62 year old male Caucasian. The cells exhibit 
low acid phosphates and testosterone-5-alpha reductase activities. Dr Ramesh of this 
department kindly provided this cell line for this toxicity experiment. 
Colon cancer cells (SW620) were originally isolated from the tissue of a 52 year old 
Caucasian male (blood group A, Rh+). A recurrence of the malignancy resulted in a 
widespread metastasis from the colon to an abdominal mass. The established cell line 
consists mainly of individual small spherical and bipolar cells lacking microvilli. 
Breast cancer cells (MCF-7) known as “Michigan Cancer Foundation-7” is a breast 
cancer cell line. This cell line is known to retain several characteristics of differentiated 
mammary epithelium including the ability to process estradiol via cytoplasmic 
oestrogen receptor and the capability of forming domes.  
3.4.1.4. Cryopreservation of cells 
For long-term storage of cells, trypsinized and neutralized in growth medium were re-
suspended in 10% DMSO (dimethylsulfoxide, Sigma-Aldrich). Cells were dispensed in 
1 mL cryotubes placed in polystyrene box and cooled to -70 ºC, followed by transfer to 
liquid nitrogen after 24 h. 
To retrieve cells from cold storage, the cryotubes containing the cells were quickly 
thawed at 37 ºC, followed by one wash in complete appropriate growth medium before 
seeding into 25 cm2 flasks in complete growth medium. 
3.4.1.5. Subcultivation techniques 
All cells were grown to 70-80% confluence in 75 cm2 flask and maintained by 
subcultivation using the following protocol. All reagents and growth medium were 
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brought to room temperature. Medium from growing cell flask was aspirated and PBS 
solution 100 µL/cm2 of vessel surface was added to wash the cells with gentle agitation 
for approximately 15 to 30 seconds. 
The PBS solution was aspirated and Trypsin/EDTA solution 100 µL/cm2 of vessel 
surface was added. The HUVECs were allowed to detach at room temperature (5 
minutes) as recommended by the manufacturers. All other cells were incubated at 37 ºC 
to facilitate detachment (3-5 minutes). All flasks were examined under microscope for 
detachment. At the first sign of detachment, the flask was gently tapped on the sides of 
the vessel to loosen the remaining cells and then after, the cells were further dispersed 
by pipetting up and down for few times. 
The trypsin neutralization solution (0.05%) trypsin inhibitor from soybean and 0.5% 
bovine serum albumin at 100 µL/cm2 of vessel surface was added. This formulation of 
trypsin, neutralization solution was only used for the primary HUVECs cell as 
recommended by manufacturers. For all other cells the normal growth medium with 5% 
heat inactivated FBS were sufficient. The detached cells were aspirated and transferred 
to centrifugation tube. The cells were centrifuged for 3 minutes at 220 x g. 
The supernatant were discarded, and 1 mL of the appropriate growth medium were 
added to the cells and re-suspended by pipetting up and down. The cells were plated at 
desired seeding density in new cell culture vessels containing appropriate growth 
medium pre-warmed to 37 ºC, 5% CO2. 
3.4.2. Cell Viability Assessment 
3.4.2.1. Preparation of synthesised QDs preparation in MEM medium  
The following QDs; CdHgCoTe, CdHgCoTe/MAS, CdHgCoTe/MAS/MPOSS were 
mixed with neat ethanol in a ratio of 1:2 v/v and centrifuged for 15 minutes at 4000 rpm 
separately. The supernatant was discarded and the precipitate were dried under vacuum 
and weighted. The resulting dried QDs were all suspended in MEM medium with 
HEPEs buffer at pH 7.4 and adjusted to contain 1 mg/mL as a stock for experimental 
use. 
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3.4.2.2. Preparation of precursor materials: Cadmium Chloride (Cd2+) and 
Mercury Perchlorate (Hg2+) ions for toxicity studies 
Stock solutions of CdCl2 and (Hg(ClO4)2), QD precursor materials were prepared at 1 
mg and  dissolved in 1 mL MEM medium in HEPEs buffer pH 7.4. Samples were kept 
at +4 ºC until further experiments where it was diluted to contain amounts in the range 
of QDs preparations. 
3.4.2.3. Seeding of cells in the culture plates for toxicity evaluation 
All cell cultures were incubated in standard growth conditions (37 ºC, 5% CO2) cells 
lines PC3, MCF-7 and SW620 were all maintained in 75 cm2 tissue culture flask in D-
MEM supplemented with 10% foetal bovine serum (FBS) and 1% 
penicillin/streptomycin, 1 mM pyruvate, 2 mM glutamine and 10 mM HEPES. 
HUVECS were grown and maintained in PromoCell endothelial cell growth medium 
with supplement mix (PromoCell GmbH) 5% FBS supplemented with growth factors. 
All cells were suspended in their appropriate growth medium after they have been 
treated with trypsin and centrifuged at 1500 pm for 5 minutes at room temperature. The 
cell count was performed for the four types of cells respectively. Cells were counted 
using a hemocytometer and 1 x 104 cells were plated into each well of a 96-well culture 
plate (Corning USA) 200 µL/well (replicates of 6). All cell cultures were used for 
toxicity assessment after 48 h growth. 
3.4.2.4. Cytotoxicity assays  
The viability of the cells treated with the appropriate QDs was estimated with Alamar 
Blue (AB) and Neutral Red (NR) assays. After 48 h incubation, the growth medium 
were removed and washed 3 times with serum free growth medium. The prepared 
coated and uncoated QDs (CdHgCoTe, CdHgCoTe/MSA, CdHgCoTe/MSA/MPOSS) 
were prepared in MEM with reduced serum 2% to avoid interference of QDs with 
serum components to a final concentration range of 0.1-100 µg/mL at 200 µL were 
added to each well. The selected concentrations of coated and uncoated QDs are as 
following; 0, 0.1, 1.0, 10, 50 and 100 µg/mL where they were added in replicates of 6 
wells in a 96-well plate. The incubated cells were monitored over the time course of 4, 
8, and 24 h.  
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After different incubation periods, 20 µl of Alamar Blue solutions (10 X) was added to 
medium each well and incubated for another 4 h. The viability indicator that uses the 
natural reducing power of living cells to convert resazurin to the fluorescent/absorbing 
molecule, resorufin, indicates the amount of viable cells. 
The amount of absorbance is proportional to the number of living cells and corresponds 
to the cell metabolic activity. The absorbance was read using a 96–well plate reader 
(Helena Biosciences, Sunderland, UK) in a Multiscan MS UV-visible 
spectrophotometer (Labsystems, Ashford, UK). The absorbance at 570 nm was 
monitored using 600 nm as a reference wavelength. 
In parallel, viability was also monitored using an in vitro toxicology assay kit, Neutral 
Red based vital dye (Sigma-Aldrich). The procedures as above for Alamar Blue was 
duplicated for Neutral Red with 20 µL of a 0.33% of Neutral Red solution and added to 
the medium of each well and incubated for another 4 h. At the end of the incubation 
period, the medium was carefully removed and the cells quickly rinsed with PBS. The 
PBS was removed and the incorporated dye was solubilized in 200 µl of 1% acetic acid 
in 50% ethanol. The cultures were allowed to stand for 10 minutes at room temperature 
with gentle agitation. Viable cells take up the dye by active transport and incorporate 
the dye into lysosomes, whereas non-viable cells will not take up the dye. The liberated 
incorporated dye is proportional to the number of viable cells. The absorbance was read 
using a 96–well plate reader (Helena Biosciences, Sunderland, UK) in a Multiscan MS 
UV-visible spectrophotometer (Labsystems, Ashford, UK). The absorbance at 540 nm 
was monitored using 690 nm as a reference wavelength. 
3.4.2.4.1. AlamarBlue assay  
Alamar Blue™ (AB) (Serotec, Kidlington) is a commercially available assay, which 
aims to quantitatively assess cell proliferation, cytotoxicity and viability. Changing the 
colour from dark blue to light pink is the result of the cell metabolism. This color 
change is measured by monitoring absorbance at 570 nm and 630 nm. The advantages 
of this assay are that it is soluble in media, stable in solution, minimally toxic to cells 
and produces changes that are easily monitored (Seifalian et al., 2001). 
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Figure 3.5, demonstrates the reduction reaction, which takes place in functional cells. 
The blue dye resazurin has negligible intrinsic fluorescence and absorbance while its 
reduced product, resorufin, emits a highly fluorescent, pink colour, which can be 
detected by means of a plate reader equipped with a 570 nm filter. 
 
 
 
 
 
 
Figure 3.5: The blue dye resazurin is reduced to the fluorescent pink resorufin by viable, metabolically 
active cells only. The intensity of absorbance is proportional to the number of metabolically active cells. 
 
3.4.2.4.2. Neutral Red Assay 
The key component is the vital dye, Neutral Red (Basic Red 5, Toluylene Red). Viable 
cells will take up the dye by active transport and incorporate the dye into lysosomes, 
whereas non-viable cells will not take up the dye. After the cells have been allowed to 
incorporate the dye they are briefly washed or fixed. The incorporated dye is then 
liberated from the cells in an acidified ethanol solution. An increase or decrease in the 
number of cells or their physiological state results in a concomitant change in the 
amount of dye incorporated by the cells in the culture. This indicates the degree of 
cytotoxicity caused by the test material.  
3.4.2.5. Statistical analysis 
Means and standard deviation (SD) were calculated for all experiments. For comparison 
of data, one-way analysis of variance (ANOVA) was performed and the statistical 
significance determined to 0.05 confidence intervals (P < 0.05). To compare the 
difference of significance of different conditions Tukey’s post hoc test was performed. 
Resazurin Resorufin 
Absorbance at 570 nm 
Reduction 
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3.4.3. Solid-phase peptide (Calreticulin) synthesis  
Calreticulin (CRT) peptides were synthesised manually, using an in-house designed 
glass reaction vessel, using Rink amide resin as the solid phase (Figure 3.6). All amino 
acids used were amino protected with Fmoc amino acid with side-chain protection. 
 
 
 
 
 
 
 
 
 
 
Figure 3.6: Schematic representation of a manual solid phase peptide synthesis 
 
0.5 g of the Rink-amide resin derivatized with Fmoc-amide was placed into the glass 
reaction vessel and de-protection was carried out using 20% piperidine in DMF for 10 
minutes. The resin was thoroughly rinsed with DMF (10 mL/g, 5 x 1 minutes). 
Acylation was initiated using pre-weighed Fmoc amino acids in the presence of HBTU 
in 5 mL bottles. A 2.5 –fold excess (based on the resin loading) of the acylating species 
in 0.2 M methyl morpholine (MMP) in DMF (5 mL) were added to the reaction vessel. 
The cycle for the addition of the activated protected amino acid and de-protection was 
repeated until the desired complete length of the CRT peptide was achieved. Complete 
detachment of the assembled peptide was carried out by adding 95% Trifluoroacetic 
acid (TFA) in H2O (50 mL) containing EDT, phenol and thioanisol as scavengers for 2 
Connecting to 
vacuum 
Nitrogen 
gas 
Waste 
Add starting 
material 
Synthesized peptide 
on solid phase (Beads) 
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h. The TFA and scavengers were removed by rotary evaporation and precipitated with 
cold diethyl ether to further remove any residual scavengers. The precipitated peptide 
was further rinsed in diethyl ether and vacuum dried until powder. The peptide was 
characterized by high performance liquid chromatography (HPLC) and calculated 
molecular weight was confirmed by matrix assisted laser desorption ionisation/ time of 
flight (MALDI/TOFF). The peptide was lyophilized and stored at +4 ºC until further 
use (Figure 3.7). 
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Figure 3.7: Reaction scheme of manual solid-phase synthesis of synthetic CRT peptide   
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3.4.4. Cell cultures treated with Doxorubicin (anticancer drug) 
and cadmium ions 
All cells (HUVEC, MCF-7 and SW620) were seeded in 24-well flat culture plate 
(Corning). After culturing for 24 h, the cells were washed with FBS-free DMEM and 
incubated with Doxorubicin 50 µg/mL and Cd2+ 50 µg/mL in FBS-free culture medium 
at 37 ºC for 1 h. The cells were then washed gently with PBS (X 3 wash) and fixed with 
4% formaldehyde for 20 minutes, and blocked with 1% BSA in PBS/Tween20 (PBS/T) 
for 30 minutes. The fixative was aspirated and washed three times PBS/T and 
conjugation complex (NIR QD-(Anti-CRT)) incubated at room temperature for 2 h. In 
the end, cells were washed three times with PBS/T for 5 minutes each. Cells were 
observed under confocal microscope for the localization of QD-(Anti-CRT) for 
evidence of apoptosis of cancer cells compared to untreated and primary cultures. 
Seeded cells were also repeated this time with incubation with NIR QD-CNT. In this 
arrangement cells were exposed to 650 nm red light-source for 5 minutes. The cells 
were rinsed in PBS and fixed as above. The cells were blocked with 1% BSA in PBS/T 
for 30 minutes. The fixative were removed and washed with PBS and conjugated 
complex NIR QD-(Anti-CRT) incubated at room temperature for 2 h. Excess complex 
were removed with washing with PBS and observed for evidence of apoptosis with 
confocal microscopy.  
3.4.4.1. In vivo detection of targeted NIR quantum dot and non-targeted 
with carbon nanotube 
Six to eight weeks old BALB/c female mice (18-21 g) were provided by Pharmidex 
Ltd. All the experiments were carried out at Pharmidex pharmaceutical Ltd, adhered to 
the 1986 Scientific Procedures Act (UK) and in compliance with the guide for the care 
and use of laboratory animals in Pharmidex Ltd. The animal housing area was 
maintained at 24 ºC with a 12 h light/dark cycle, and animals fed adlibitum with water 
and standard laboratory diet. All animals were acclimatized to the animal facility for at 
least 48 h prior to experimentation. In the study involving in vivo imaging, mice were 
administered 10 mg/kg body weight of QD-CNT in PBS by intraperitoneal (IP) 
injection.  
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Mice treated with targeted LPS-QDs were imaged using the IVIS in vivo imaging 
system (Xenogen). The filter sets used to acquire the images were excitation, 590/30nm; 
emission, 730/80nm for targeted NIR QD. 
However, for the biodistribution studies of non-targeted NIR QD-CNT, the Hamamatsu 
Orca R2 capture system/fire wire was used with the filter set of 705 nm. 
3.4.4.2. Histological analysis 
Coated CdHgCoTe/MSA/MPOSS QDs at a total dose of approximately 10 mg/kg were 
injected into mice by intraperitoneal (IP) injection for the histological studies. Liver, 
spleen, lung and brain were removed from sacrificed animals after 4 h and tissues were 
harvested and fixed in 10% formalin, embedded in paraffin, sectioned and observed 
under confocal microscope. 
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                                                      Chapter 4 
Development and synthesis of a novel 
multifunctional water-soluble ‘Quantum 
Dots’ with biocompatible coatings  
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 4.1. Introduction 
The synthesis and application of semiconductor quantum dots (QDs) with high 
photoluminescence (PL) and especially water-soluble nanocrystals have generated great 
interest since the pioneering work of Alivisatos (Alivisatos, 2004). In comparison to 
traditional organic fluorescent labels, QDs are superior in performance due to numerous 
advantages (Rizvi et al., 2010) (refer to chapter 1). Currently, semiconductor colloidal 
nanoparticles are under intensive investigation for potential applications in multiplexed 
bioassays and in ultrasensitive optical detection and imaging (Alivisatos, 2004). 
An additional main advantage is that the spectral properties of these nanocrystals can be 
conveniently tuned by manipulating particle size and multicolored fluorescence 
obtained with a single excitation light source. The NIR wavelength window (700-900 
nm) is useful for biological imaging and detection as auto-fluorescence and absorbance 
from tissue is reduced in this range. By doping cadmium telluride (CdCoTe) QDs with 
mercury (Hg2+) ions the range of the emission could be extended into the NIR region. 
All synthesised fluorescent emitting QDs in this study are assembled with semi-
conductive materials, which is cadmium-based. Although, cadmium is known to be 
toxic, presence of it in the QD’s core in combination with other metals maybe a 
potential contributor of toxicity in clinical applications. Semiconductor based QDs with 
Cd2+ ions are essential in the formation of QDs as they emit stronger fluorescence with 
stable quantum confinement, compared to non-cadmium based QDs. However by using 
a novel biocompatible coating agent (MPOSS) has solved some of the toxicity issues in 
this proposed technique (chapter 5). 
The complementary characteristics of optical techniques and magnetic resonance 
imaging (MRI), as combinatory probes, which exhibit both fluorescent and (super) 
paramagnetic properties were explored. A strategy employed in this study was to dope 
QDs with paramagnetic ion (cobalt) in the synthesis. Agar phantoms of QDs were 
developed and imaged with MRI. 
The above properties were developed and are desirable in multiplexed labeling and 
simultaneous detection of markers on cells and tissues (refer to chapter 6). It is still a 
big challenge for many researchers to synthesis novel water-soluble QDs with ideal 
combinational optical properties (Yu, 2008). 
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It has been established that fluorescence emitted by QDs is affected by surface defects 
on the nanocrystals and by reducing these defects with an inorganic shell with higher 
band-gap materials or with suitable coatings, the fluorescence intensity can be increased 
and quantum confinement established. Many variations of cadmium (Cd) based QDs 
such as CdTe-CdS, core/shell, CdSe-CdS, core/shell and CdTe-CdS-ZnS, 
core/shell/shell structures have been synthesised and modified by many laboratories 
with a view of improving their photoluminescence and to reduce toxicity. 
A number of water-soluble bifunctional molecules can replace the hydrophobic ligands 
on the surface of QD particles to make them water-soluble (Figure 4.1). Such 
molecules that have already been used in this study include mercaptosuccinic acid. Due 
to their high surface-to-volume ratio, they also can provide for the attachment of 
multiple different chemical/biological molecules (Delehanty et al., 2009). These 
molecules have one end anchored to the QD surface atoms such as –SH, while the other 
end extends outwards to provide water-solubility, as well as bioconjugation ability such 
as –NH2, –OH and –COOH. 
 
Figure 4.1: Coating layer provides multiple functional groups (amine, carboxylic acids and cysteines 
residuals) for covalent conjugation with biocompatible biological molecules. 
 
In the present study, a selection of monodisperse, highly luminescent and NIR emitting 
water-soluble QDs was synthesised including: (1) uncoated CdTe (been used as 
control), (2) CdTe/MSA, (3) CdCoTe/MSA (4) CdHgCoTe/MSA and (5) 
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CdHgCoTe/MSA/MPOSS (Table 4.1). The synthesised QDs were characterized and 
results are presented and discussed. 
4.2. Supplementary Materials and Methods 
4.2.1. Materials 
Sodium borohydrate (NaBH4, 98%), Mercaptosuccinic acid (MSA), Mercuryperchlorate 
(Hg(ClO4)2), Cadmium chloride (CdCl2), Sodium tellurite (Na2TeO3), Sodium borate 
(Na2B4O7), Cobalt chloride, Sodium sulphite (Na2SO3), Tetrahydrofuran (THF) and 
Rhodamine G were all purchased from Sigma-Aldrich. 
All other chemicals were all of reagent grade. Milli-Q grade water (> 18.2 MW) was 
used as the solvent for aqueous solutions. 
Refer to section 3.2. of Chapter 3 for details. 
4.2.2. Aqueous synthesis of quantum dots  
4.2.2.1. Synthesis of MSA and MSA/MPOSS coated quantum dots  
CdTe QDs were synthesised by an improved method of the procedure described in 
reference (Gao et al., 2002). Instead of a magnetic stirring, a homogenizer (KIKA T25 
LABORTECHNIK) at 24000 rpm/min was used for vigorous mixing. Also, sodium 
sulphite (NaSO3) was used as a mild reducing agent during the synthesis. All the 
starting materials were obtained from commercial suppliers and were used without 
further purification. All reactions were carried out in buffer solution composed of 15 
mM Na2B4O7 and 15 mM citrate acid, pH at different values adjusted with 1 M 
NaOH/HCL. 
Synthesis of CdTe (control): For preparing uncoated CdTe QD, a precursor solution 
was prepared by mixing solutions of CdCl2 (1 mM) and Na2TeO3 (0.25 mM). Mixing 
this solution with Na2SO3 (0.25 mM) in 50 mL of above buffers in a flask pre-chilled in 
ice for another 5 minutes. However, uncoated QDs are water insoluble. 
Synthesis of CdTe/MSA: For preparing CdTe/MSA QD, a precursor solution was 
prepared by mixing solutions of CdCl2 (1 mM), Na2TeO3 (0.25 mM) and MSA (3 mM). 
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Mixing this solution with Na2SO3 (0.25 mM) in 50 mL of above buffers in a flask pre-
chilled in ice for another 5 minutes.  
Synthesis of CdCoTe/MSA: The preparation is included precursors CdCl2 (1 mM), 
Na2TeO3 (0.25 mM), CoCl2 (1 mM) and MSA (3 mM) into Na2SO3 (0.25 mM) in 50 
mL of above buffers in a flask pre-chilled in ice. 
Synthesis of CdHgCoTe/MSA: The preparation of CdHgCoTe/MSA included 
precursors CdCl2 (1 mM), Na2TeO3 (0.25 mM) with varying amounts of Hg(ClO4)2 
(0.2, 0.3, 0.4, 0.5 and 0.6 mM) as above, MSA (3 mM) and CoCl2 (1 mM), Na2SO3 
(0.25 mM) in above buffers in a flask pre-chilled in ice. 
Synthesis of CdHgCo/MSA/MPOSS: The preparation of CdHgCoTe/MSA/MPOSS 
included precursors CdCl2 (1 mM), Na2TeO3 (0.25 mM), Hg(ClO4)2 (0.2, 0.3, 0.4 and 
0.5 mM, MSA (2 mM), CoCl2 (1 mM) and Na2SO3 (0.25 mM) and finally, MPOSS (0.1 
mM in THF) into a flask pre-chilled in ice. 
 
 
 
 
 
 
 
 
Figure 4.2: Images of reflux apparatus used for synthesising coated QD before and after excited by UV 
light with emission.  
The above individual mixtures were subjected to vigorous mixing using a homogenizer 
for 5 minutes. After 5 minutes, 20 mg of solid NaBH4 were added rapidly and mixed for 
a further 5 minutes. Finally, the mixture was transferred into a one-neck round bottle 
flask (250 mL) that was connected to a condenser and refluxed with mixing at 100 ºC 
under aerobic conditions (Figure 4.2). 
Under UV 
excitation  
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4.2.3. Characterization of quantum dots 
Fluorescence measurements were carried out at room temperature using (USB 2000+ 
Ocean Optics spectrometer). UV-VIS absorption spectra were recorded by Jasco V-630 
spectrometer to detect the absorption wavelength by using the distilled water as a 
control. Irradiating at 365 nm with a LED-based light with QD samples placed in quartz 
cuvettes performed with a time-course study of photostabilities. 
Transmission electron microscopy (TEM) images were obtained on a (Phillips CM 
120). TEM samples were prepared by depositing nanoparticles on copper grid coated 
with Piloform (TAAB) and examined at 3 x 105 magnifications. 
FTIR spectra were obtained using Perkin-Elmer 1750 FTIR spectrometer purged with 
dry air to eliminate atmospheric moisture absorbance from spectral region of interest. 
Dried QD samples were resuspended and equilibrated in D2O and 100 scans were signal 
averaged in the range of 4000-400 cm-1 wavenumbers on calcium fluoride (CaF2) cell 
with a 6 mm path length were carried out to improve signal to noise ratio. 
FTIR vibrational spectroscopy was used to further characterize the mentioned QDs and 
the surface chemistry of them. All the cadmium based QDs synthesised were initially 
centrifuged to eliminate any insoluble material. The QD solution was then precipitated 
with equal volume of cold ethanol and air-dried. The dried samples were then dispersed 
in D2O for FTIR analysis. 
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4.3. Results 
4.3.1. Preparation of MSA and MSA/MPOSS stabilized quantum 
dots 
The introduction of an improved method of synthesis with a homogenizer for mixing 
and NaSO3 as a mild reluctant in precursor solutions, improved the formation of 
nanocrystals which showed strong luminescence and stability. 
At the start of the synthesis the solution containing the precursors CdCl2, Na2TeO4 and 
MSA showed a faint brown color at 5 minutes. Those containing cobalt (Co) and 
mercury (Hg) would appear as faint pink in appearance, which could be due to the mild 
reducing properties of MSA and Na2SO3. On adding solid NaBH4 powder, the solution 
turned to strong pink color instantly for the precursor with Co depending on the pH 
value of the precursor solutions. However, in precursor solutions without the presence 
of Co it turned to a dark a light green color. 
These initial crude solutions displayed no luminescence presumably due to very small 
nanocrystal formation. Lowering the pH value of the precursor solution or raising the 
reaction temperature accelerated the formation of the nanocrystals. As the heating to 
boiling progressed the crude solution turned to brown colour for all the precursor 
solution and after approximately 2 h, a weak brown luminescent could be observed 
when excited by UV light. Sustaining the boiling and refluxing for approximately 18 h, 
the absorption spectra of QD nanocrystals and emission shifted towards the longer 
wavelengths as an indication of increasing size and quantum confinement. 
Finally, by controlling the reaction time (2-18 h), suitable CdTe QDs with fluorescence 
of different colors were harvested (Table 4.1). Below is the list of synthesised QDs: 
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Table 4.1: Range of fluorescent QDs were synthesised and coated with biocompatible materials 
Quantum dot Coating agent Absorption wavelength (nm) 
Emission 
Wavelength (nm) Size (nm) 
CdTe Control N/A N/A N/A 
CdTe MSA 425 600 2.96 
CdCoTe MSA 455 610 3.01 
CdHgCoTe MSA 495 630 4.67 
CdHgCoTe MSA/MPOSS 610 800 4.87 
The sizes of the QDs could be influenced by controlling the duration of the reflux, 
which was monitored by sampling at time intervals as above for absorption and 
photoluminance (PL). At 18 h of refluxing, the emission peaks of the QDs shifted 
towards the NIR region (Figure 4.3).  
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Samples 
     
 
Schematic 
Structures 
     
Size 2 nm 4 nm 6 nm 8 nm 10 nm 
Reaction time 2 h 3 h 5 h 15 h 18 h 
Emission Peak 495 nm 510 nm 570 nm 610 nm 800 nm 
 
 
Figure 4.3: General description of monitoring the synthesis process of QD over the time course of 18 h showing increasing size and shifting the PL the towards NIR region
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4.3.2. Characterization results 
4.3.2.1. Absorption and emission spectra  
Optical characterization of QDs is usually provided by UV-VIS and photoluminescence 
spectrometer, which offer fast and non-destructive option. The absorption and emission 
spectra of QDs were monitored during the reflux. The absorption and emission spectra 
of all synthesised QDs shown in figure 4.4 and 4.5 respectively at the end of the 
synthesis procedure, irradiated under the UV-light (375 nm). 
After 18 h reflux the absorption and emission peak for CdTe/MSA, CdCoTe/MSA, 
CdHgCoTe/MSA and finally CdHgCoTe/MSA/MPOSS is (425, 600 nm), (455, 610 
nm), (495, 630 nm) and (610, 800 nm) are respectively (Figure 4.4) and (Figure 4.5). 
 
Figure 4.4: Absorption wavelengths of four different QDs dispersions.  
The absorption of (A) CdTe/MSA QDs at 425 nm, (B) CdCoTe/MSA QDs at 455 nm, (C) 
CdHgCoTe/MSA QDs at 495 nm and (D) CdHgCoTe/MSA/MPOSS QD at 610 nm. 
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Figure 4.5: Emission spectra of four different QDs dispersions. 
(A) CdTe/MSA QDs at 600 nm, (B) CdCoTe/MSA QDs at 610 nm, (C) CdHgCoTe/MSA QDs at 630 nm 
and (D) NIR CdHgCoTe/MSA/MPOSS QD approximately at 800 nm. 
The progress of nanocrystal growth was obtained by evaluating the emission 
wavelength of CdHgCoTe/MSA/MPOSS NIR emitting QD at room temperature at 
different refluxing time of 2, 5, 18 h (Figure 4.6). Spectra were measured in as-
prepared CdHgCoTe colloidal solutions, which were taken from the refluxing reaction 
mixture at designated intervals of time. The first emission peak was appeared at 650 nm 
after 2 h of reflux procedure started. The emission peaks shifted to longer wavelength at 
the nanocrystal grows in the course of heating. The peaks at 700 and 800 nm were 
obtained at 5 and 18 h respectively. 
The symmetrical peaks show the homogeneous character of the QDs and nanoparticles. 
This experiment indicted that the no matter how long the refluxing time was, the 
emission peak cannot be extended over 800 nm. 
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Figure 4.6: Photoluminescence spectra of CdHgCoTe/MSA/MPOSS QD of different times of reflux (2, 
5, 18 h) at A) 650 nm, B) 700 nm and C) 800 nm respectively. 
As previously mentioned, the optical properties of QDs can be fine-tuned by size of 
QD, which is a key parameter that determines the spectral position and purity of PL. 
The average size of QD’s is generally estimated using TEM technique. 
4.3.2.2. Transmission electron microscopy characterization  
The TEM images of all water dispersed QDs reveal spherical morphologies. However, 
there is formation of aggregates from uncoated CdTe nanocrystals due to its 
hydrophobicity (Figure 4.7 A). TEM technique can accurately measure hydrodynamic 
diameter of QDs core in these preparations, as the cores are electron dense. Some 
moderately dispersed particles are also present in the MSA coated CdTe nanoparticles 
(Figure 4.7 B) which is intermediate between uncoated (Figure 4.7 D) and coated 
MSA/MPOSS QDs (Figure 4.7 F) with an average size of 3.0 nm in diameter. TEM of 
CdCoTe/MSA QDs dispersed in water showed fairly spherical particles at an average 
diameter of 4.0 nm (Figure 4.7 C). With the presence of MSA on the CdHgCoTe QDs, 
it can be observed that it facilitates dispersal in aqueous medium with average size of 
4.5 nm in diameter (Figure 4.7 E). Interestingly the MSA/MPOSS coated QD 
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nanocrystals with average size of 5.0 nm in diameter (Figure 4.7 F) are well dispersed 
compared to other mentioned QDs. 
Hence, the uncoated CdTe (Figure 4.7 A) and CdHgCoTe (Figure 4.7 D) images show 
some aggregation due to hydrophobicity. However, the coated CdHgCoTe QDs with 
MSA (Figure 4.7 E) and MSA/MPOSS (Figure 4.7 F) are well dispersed due to their 
hydrophilicity. 
 
Figure 4.7: TEM images of different quantum dots. 
(A) TEM image of uncoated CdTe QDs, (B) CdTe/MSA coated CdTe QDs with mean diameter of 
roughly 3.0 nm, (C) CdCoTe/MSA QDs diameter of roughly 4.0 nm (D) CdHgCoTe QDs, (E) 
CdHgCoTe/MSA QD with 4.5 nm, (F) CdHgCoTe/MSA/MPOSS QDs with 5.0 nm in diameter. 
4.3.2.3. Fourier transform infrared spectroscopy (FTIR) 
Figure 4.8 shows all possible vibrational and stretching movements around covalent 
bonds within molecules radiated with infrared. Thus, the presence of small molecules 
has potential to determine the presence of chemical bonds giving rise to characteristic 
infrared bands at a particular frequency. Infrared spectroscopy investigates the diverse, 
chemical bond-dependent vibrations, which can then be identified by a particular 
absorption band within the infrared spectrum. 
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A B 
Bond Frequency (cm-1) Bond Frequency (cm-1) 
Alkyl C-H 2853-2962  2100-2260 
Alcohol O-H 3590-3650  2220-2260 
Amine N-H 3300-3500 
C=C 1620-1750 
C=O 1690-1750 
 
Figure 4.8: a: Asymmetric, b: Symmetric, c: Scissoring, d: Rocking, e: Twisting, f: Wagging. 
On absorption of electrostatic energy within the IR spectrum, the covalent bonds connecting atoms as 
shown above undergo in-plane stretching and bending as well as out-of-plane bending movements. (A) 
and (B) show that the frequency and location of a given vibration in the IR spectrum has a specific range 
for a particular bond, although overlaps occur. The vibrational frequency is related to the atomic mass 
(lighter atoms such as hydrogen vibrate as a higher frequency) and the relative stiffness of the bonds 
(triple bonds are stiffer than double bonds which are stiffer than single bonds) 
Figure 4.9 shows the FTIR spectra for all cadmium-based QDs merged in one graph 
with different vibrational absorptions for MPOSS coating with CdHgCoTe. All QD 
samples were equilibrated in D2O for 1 h before assessing the spectra. For reference, the 
FTIR of uncoated CdHgCoTe and pure MPOSS were obtained. The peaks appearing at 
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2312 and 2316 cm-1 in (Figure 4.9 purple and red) represents the uncoated CdHgCoTe 
and CdHgCoTe/MSA respectively. There is a slight shift in the peaks, which is due to 
the presence of MSA in CdHgCoTe/MSA QD. 
The QDs containing MPOSS were centrifuged in THF and precipitated to remove any 
unbound MPOSS.  The vibrational band at around 2364 cm-1 can be assigned as 
emanating from Si-D bonds vibration after deuterium exchange. When bound to the 
surface of QDs there is a shift to the higher vibration band at around 2387 cm-1. This 
indicates an open structure accessible to deuterium exchange as opposed to a close 
structure of the aggregated free MPOSS. The vibrational band at 2313 cm-1 of the MSA 
coated CdHgCoTe form of the crystal indicates interaction with deuterium. As the 
intensity is stronger than the uncoated CdHgCoTe QD it can be assigned to some 
interaction of the core/shell and deuterium. These assignments are unique for coated and 
uncoated QDs as they can assist in identifying coating interaction with their 
environment. 
 
Figure 4.9: FTIR spectra of uncoated CdHgCoTe (purple), CdCoHgTe/MSA (red), 
CdHgCoTe/MSA/MPOSS (blue) and MPOSS only (black). A vibration peak at around 2387 cm-1 (Blue) 
indicates the presence of MPOSS around the core. 
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4.4. Further results and discussion 
4.4.1. Synthesis of quantum dots 
Traditionally, highly luminescent QDs are synthesised using the organometallic route 
whereby trioctylphosphine-trioctylphosphine oxide (TOP-TOPO) is utilized (Han et al., 
2001). There are however, disadvantages in this method of synthesis as high reaction 
temperatures are needed and the end product is normally insoluble in aqueous medium 
unsuitable for biological applications. 
The new improved method, has not only facilitated its production in an aqueous 
medium in one-pot synthesis but is very convenient, economical, and repeatable with a 
solution to alternative probes for in vitro and in vivo imaging.  
4.4.2. Effects of pH values on synthesizing quantum dots 
The influence of parameters such as buffer with different pH values on QDs has been 
investigated. Maintaining pH values during synthesis has shown to play an important 
part. A range of pH values were applied and investigated while maintaining the molar 
ratios of the precursors. 
Experimental results indicated that pH values significantly influenced the optical 
properties of the QDs, especially the QY. Selecting an appropriate buffer system is 
crucial in the formation of highly luminescent QDs. It is postulated that during the 
evolution of QDs, the following chemical reactions are taking place (Ying et al., 2008). 
(1) TeO3-2 + BH4-           Te2-+ B(OH)3 + H2O 
(2) CdL + Te2-       CdTe + L, where L= MSA 
The above reaction scheme is a simplified scheme, when the true reaction is a complex 
cascade. As Te2- is oxygen sensitive, sodium sulphite was included in the reaction to 
exclude oxygen during the preparation, although the Na2TeO4 is oxygen stable used in 
this study. It is also postulated that the initially formed Te2- may be completely reduced 
on addition of NaBH4. In this instance, the Na2SO3 is only partially reducing and 
addition of the NaBH4 is powerfully reducing, thus rendering the reaction atmosphere 
anaerobic, and preventing re-oxidizing Te2-. As there is an excess of NaBH4 (molar ratio 
of NaBH4/Cd2+ = 5/1) has been selected, most of the excess NaBH4 is initially 
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hydrolysed or oxidized by the slow introduction of oxygen from the air according to the 
below reaction; 
(3) BH4- + H2O        B(OH)3 + OH
- + H2 
(4) BH4
- + O2                      B(OH)3 + H2O  
As depicted by reaction scheme (1), (2), (3) and (4), a substantial amount of B(OH)3 can 
act as a weak acid or OH- will be evolved when water without buffering capacity is 
used, resulting in precipitation. This can be contributed by NaBH4, which shifted the pH 
wildly with no buffering capacity with subsequent low QY and even absence of 
luminescence. It is found to be important that a suitable buffer system is employed with 
enough buffering capacity for the development of the nanocrystals to grow during 
heating and refluxing. 
In this study the buffer system that was selected was one that included 15 mM sodium 
borate and 15 mM sodium citrate, which enabled to sustain enough buffering capacity 
and to accommodate the changes resulting to exogenous addition of NaBH4 solid 
powder. It was observed that when the precursor materials CdCl2, Na2TeO3, Co and Hg 
and MSA were added as a mixture to this buffer solution, there was a small drop in the 
pH (ΔpH ∼ 0.5). On completion of the reactions, the pH values of the assembled CdTe 
containing nanocrystal solutions showed a slight increase (ΔpH ∼ 0.6). 
The pH range investigated was 6.0, 7.2, 8.0 and 9.0. When prepared at the stated range, 
the maximum QY obtained is illustrated in Figure 4.10 shows the pH effects of the 
precursor solution on the QY of the coated CdHgCoTe/MAS/MPOSS QD. It is evident 
that at pH value 7.2, the maximum QYs was greater than 70%. This indicates a great 
improvement compared to other studies where thioglycolic acid (TGA) (pH ∼ 11) (Yao 
He, 2007) or MPA (pH > 8.0) (Liang Li, 2006), when present as thiol stabilizers for 
Cd2+ based QDs. It can be observed that when pH values were adjusted to 6, 8 and 9 
there was a deterioration and reduction in QY. Lower pH values, may be desirable in 
some instances when visible fluorescence is required. In contrast, by using MSA it was 
found to stabilize doped CdHgCoTe QDs in physiological pH, which can be due to the 
dicarboxilic presence, and function in the structure of MSA. The explanation as to why 
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this is, has been described in previous studies whereby strong thiol complexation occurs 
on the surface of evolving CdS clusters in situ than Cd2+ ions in the formation of QDs. 
 
Figure 4.10: Optimising pH values of buffers in the synthesis with quantum yield. 
The optimum pH of 7.2 yielded a QY of > 70 %. 
It can be postulated that a large number of free thiols and Cd2+ ions will be liberated 
from Cd-thiol complex in this buffer region. It can be assumed that the surface coverage 
with MSA is maximized when the QD solution is in this buffer range (7.0-7.2) and it 
can be concluded that available surface trap sites on the QDs surface will be occupied, 
thus increasing the fluorescence efficiency.  
Considering all the above factors, the major contribution has to be the special structure 
of MSA and MPOSS, which occupies and reduces the surface traps of QDs. With the 
former contributing two carbonyl groups, this confers strong stability than other thiol 
compounds (TGA, MPA) and strong emission efficiency. 
4.4.3. Effect of concentration of Hg2+ ions on quantum dots 
By introducing different ranges of Hg2+ concentration (0.2, 0.3, 0.4 and 0.5 mM) into 
CdCoTe/MSA and CdCoTe/MSA/MPOSS QD, an optimum value of Hg2+ ion 
concentration has been evaluated. This is important for obtaining NIR QDs, as absence 
tends to inhibit the red shift. 
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The mercury amount included in the QDs is proportional to the Hg2+ ions initially 
added. Not only increasing the amount of mercury can precipitate the QDs, presumably 
of interaction with the precursors but also too low a concentration will produce faint 
fluorescent (Figure 4.11). Figure 4.11 shows the Hg2+ concentration and time 
dependent emission wavelengths (a) CdHgCoTe (0.2 mM) (b) CdCoHgTe (0.3 mM), 
(c) CdHgCoTe (0.4 mM) and (d) CdHgCoTe (0.5 mM) and (e) CdHgCoTe (0.6 nm).  
As observed, when Hg2+ concentration increases from 0.2 mM to 0.5 mM the emission 
wavelengths shifted towards the NIR (800 nm) region. For instance with Hg2+ (0.2 mM) 
(Figure 4.11 a) the emission wavelength has moved from 495 to 540 nm. The optimum 
Hg2+ concentration at 0.5 mM gave an emission of 800 nm in NIR region. Increasing 
the concentration of Hg2+ beyond 0.5 mM to 0.6 mM, the emission wavelength can be 
seen to decrease (Figure 4.11 d, e). 
Figure 4.11: Optimising the concentration of Hg2+ in the core during synthesis to enable NIR emission 
in aqueous buffer.  
The optimum concentration determined for Hg2+ is 0.5 mM with emission wavelength at 800nm in the 
NIR region. 
4.4.4. Quantum dots and photostability  
Figure 4.12 displays the photostability of all the synthesised QDs in this study. All QDs 
were exposed to UV illumination at 375 nm for period of 10 minutes. The photostability 
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of the QDs were compared with Rhodamine G. Rhodamine G as a reference 
fluorophores, loose approximately 80% of its photostability after 10 minutes of 
exposure under UV light (Figure 4.12 E). Under identical conditions, CdTe/MSA and 
CdCoTe/MSA QDs show photostability with a loss of approximately 30% and 40% 
respectively (Figure 4.12 D, C). On the other hand, CdHgCoTe/MSA QD maintained 
50% of its photostability after 10 minutes (Figure 4.12 B). 
Remarkably, the CdHgCoTe/MSA/MPOSS QD was more resistant to photo-oxidation 
despite long exposure to UV illumination (375 nm) as compared to Rhodamine G and 
the other QDs (Figure 4.12 A). Although all the QDs photodegraded over the period of 
exposure, the rate of decline of the emission intensity of CdHgCoTe/MSA/MPOSS QD 
was considerably less than other QDs.  
Current data shows, CdHgCoTe/MSA/MPOSS shows the highest photostability 
amongst the CdHgCoTe/MSA, CdCoTe/MSA and CdTe/MSA by approximately 80% 
(Figure 4.12). The results indicate that CdHgCoTe/MSA/MPOSS possesses better 
photostability than other QDs indicative of its novel coatings. 
 
Figure 4.12: Photostability of QDs irradiate CdHgCoTe/MSA/MPOSS with better stability in aqueous 
buffer. 
a) CdHgCoTe/MSA/MPOSS), b) CdHgCoTe/MSA, c) CdCoTe/MSA, d) for CdTe/MSA, e) for 
Rhodamin G 
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4.4.5. Hybrid MSA/MPOSS biocompatible coating of the 
CdHgCoTe quantum dot core  
It has been reported by some researchers that coating a larger band gap nanocrystals 
onto a smaller band gap QD core can improve and increase the luminescence, 
photostability and chemical stability of the QDs. For instance, in the synthesis of 
CdSe/CdS core/shell structures (Huifeng Qian, 2007) it was found that PL and 
photostability were significantly enhanced compared to just CdSe core. 
In this study, MSA and MPOSS were coated to the alloyed CdCoHgTe QDs core with 
in situ formation of CdS shell to improve the photostability. Below is the list of coating 
agents that other researchers have used for QD synthesis (Table 4.2): 
Table 4.2: List of coating compounds that have been traditionally used for QD synthesis 
Coating Compounds Quantum Yield (QY) 
Dihydroxylipid acid (DHLA)(Voura et 
al., 2004) 
Octodecylamine (in hexane) 
Mercaptopropionic acid  
Polythylenimine  
Alkylated polycarboxylic acid 
Lipid-PEG 
Diblock copolymer (Smith et al., 2006) 
N/A 
79.3% 
63.4% 
43% 
64.15% 
52.8% 
20.9%(Smith et al., 2006) 
As stated in the introduction chapter, cadmium or other heavy metals may cause cell 
death, if the QDs are damaged. Hence to overcome this probability the development of 
a novel coating of MSA/MPOSS has been introduced to the QD’s core to provide 
water-solubility, stability, higher QY and PL and additionally to reduce possible 
toxicity. 
It has been established that QDs coated with large molecules, such as mercaptoacetic 
acid, mercaptopropionic acid, 11-mercaptoundecanoic acid or 2-aminoethanethiol are 
less toxic than simple molecules. It can be shown from this study that by coating QDs 
with mercaptopolyhedral oligomeric silsesquioxanes (MPOSS), their toxicity can be 
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reduced dramatically (chapter 5). This extra layer can be protective and therefore 
greatly reduces the possible leaching of interior toxic cadmium or any other 
incorporated metal under physiological environment. Introducing MPOSS molecules 
further increases the stability and decreases the cytotoxicity of water-soluble QDs as 
shown by the results in the next chapter.  
Applying appropriate coatings to QDs that is biocompatible and biostable will also play 
a vital role in reducing toxicity. In this study a novel coating has been introduced for the 
first time to QDs. POSS cages are extensively used as pendent to polyurethane (PU) 
polymer chain. POSS is known to molecularly reinforce and improve mechanical and 
physical properties of PUs. The chemical composition of POSS is a hybrid, intermediate 
between that of silica and silicone. The ability of polyhedral oligomeric silsesquioxanes 
(POSS) to serve as nanocomposites in polycarbonateurethanes as implant materials has 
been successfully shown to be biocompatible in human tracheal implant. With this 
promising outlook, POSS was applied as a coating for QDs so as to form a 
biocompatible and robust coating to otherwise toxic nanomaterials. 
POSS units are three-dimensional, cubic shaped, building blocks that embody an 
inorganic inner siloxane core (6 Å3) with the possibility of chemical modification at 
each of the eight corners of the POSS units (Figure 4.13). POSS based materials have 
been shown to resist thermal and chemical conditions and therefore should display high 
in vivo stability. In addition to acquiring chemical functionalization and chemical 
stability, POSS units display other properties that make them suitable as drug delivery 
agents. The small size of the POSS units allows this system as coatings on nanoparticles 
to biologically tissues. These units confer monodispersity when coated and prevents 
aggregation of nanomaterials.  
To investigate the use of POSS as QD coatings, a thiol derivative (MPOSS) was 
incorporated during aqueous synthesis. 
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Figure 4.13: Structure of mercaptopolyhedral oligomeric silsesquioxanes (MPOSS) 
It is very important to consider the characterization of QDs after any alteration on their 
surface. Because any changes on their surface alters the chemical and physical 
conditions of the QD surface atoms, and most cases have shown it dramatically 
decreases the quantum efficiency of the QDs. A combination of MSA and MPOSS has 
resulted in an elegant coating that not only confers stability but also biocompatibility.  
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4.5. Conclusion 
In this study, NIR-emitting QDs were developed using novel materials such as the 
hybrid MSA and MPOSS, encapsulating the core of QD with biocompatible properties, 
which greatly improved stability. The NIR QDs are very useful for biological imaging 
and detection because autofluorescence and absorbance from tissues reach their minima 
in this range. Currently there are number of limited organic dyes available in the market 
such as Cy7, IRDye78 and Indocyanine green (Huifeng Qian, 2007). 
The main part of this study was to synthesise highly luminescent, stable 
CdHgCoTe/MSA/MPOSS core/coating nanoparticles in aqueous method by one-pot 
technique. According to biophysical characterization of coated QDs, the presence of 
MPOSS can be verified by FTIR spectroscopy, while TEM micrographs indicate QDs 
with approximately 5.0 nm in diameter. The photostability of CdHgCoTe/MSA/MPOSS 
QD is high due to presence of MPOSS. 
However, the toxicity of QDs must be solved before practical clinical applications. The 
next chapter will address toxicity issues with development to minimize the toxicity of 
synthesised NIR CdHgCoTe/MSA/MPOSS QD. The stable, unique and superior 
physical properties, and the multifunctionality are the major advantages of 
nanoparticles; through them we can integrate multiple diagnostic and therapeutic agents 
in one system theranostics.  
With increasing research effort into materials synthesis, toxicity mechanisms and 
clearance from the body, QDs, together with other promising nanomaterials will be 
applied in imaging, detection and treatment in the near future.  
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                                                      Chapter 5 
Toxicity assessment of the new near 
infrared ‘Quantum Dots’  
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 5.1. Introduction 
The potential toxicity and hazardous effects of QD nanoparticles are of great concern as 
previously mentioned in chapter 2. It is a well-known fact that QDs have the potential to 
cause greater effect of toxicity compared to the bulk counterparts at the same mass dose 
(Oberdorster et al., 2005). This knowledge can be referenced to their vast amount of 
research that has been carried out over the past two decades, mainly focused on the 
effects of exposure to nanoparticles in the environment as air pollution (Hardman, 
2006). However there is a lack of knowledge on the effect of semiconductor based QDs 
either ingested or injected as drugs or fluorophores.  
Semiconductor QDs have been developed and experimented as fluorescent tags for 
biological and potential medical applications, such as in vitro diagnostic, in vivo 
biological labeling, imaging, targeting, drug carriers and delivery. Despite many 
modifications, the issues of toxicity and clearance of QDs in bio-systems are of concern 
as they have not been fully investigated and there is a need for a comprehensive 
assessment, if QDs are to transcend from scientific curiosity to biomedical applications 
(Austin M. Derfus, 2003). 
Several reports have been published about toxicity and clearance of QDs. One 
consistent common view for toxicity of cadmium containing QDs is that their toxicity is 
closely associated to the concentration of free Cd2+ ions. Current consensus is that 
toxicity of CdTe QDs is correlated to the leaching of free Cd2+ ions (Austin M. Derfus, 
2003) 
Many techniques by different laboratories have been applied to evaluate toxicity in cell 
culture studies. Considerable effort has been invested on development of short-term in 
vitro toxicity assays with cultured cells for the evaluation of acute toxicities of QDs or 
drugs. Such assays would be a first line rapid evaluation and screening of QDs that 
would allow the development and to measure the effectiveness of novel QDs and to 
assess the sensitivities to different cell types. 
In this study, two different in vitro toxicity techniques, Neutral Red and Alamar Blue 
were adopted. The Neutral Red assay is based on the uptake of the dye, a supravital dye 
and its accumulation in the lysosomes of viable uninjured cells. The Alamar Blue assay 
is based on the reduction by viable cell resazurin to the fluorescent/absorbance 
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derivative (resorufin) molecule. Neutral Red assay uses colorimetric measurements 
whereas Alamar Blue assay uses fluorescence for the quantitation of viable cells after 
their incubation with different QD constructs. These results indicate that when QDs are 
appropriately coated with biocompatible coating materials, such as MSA and 
MSA/MPOSS (details in chapter 4) this can significantly reduce toxicity. 
In this chapter, the emphasis is on toxicity of NIR QDs synthesised using the aqueous 
method with and without coatings, evaluated in vitro using human breast (MCF-7), 
prostate (PC3) and colon cancer cells (SW620), with human umbilical vein endothelial 
cells (HUVECs) as normal control cells. It can be shown that the NIR QDs developed 
with MSA/MPOSS have excellent biocompatibility with minimum toxicity for 
application in bio-labeling and imaging. 
This demonstrates that QDs make excellent fluorophores and by introducing suitable 
coatings, cytotoxicity can be reduced to a significant point. With the resolution and 
comprehension of toxicity of QDs, the next chapter will focus on targeting via 
conjugation to antibodies, synthetic ligands and carbon nanotubes as imaging and 
delivery systems respectively (Liu et al., 2008) (Figure 5.1). 
 
Figure 5.1: The schematic surface properties of three kinds of quantum dots: uncoated CdHgCoTe, 
CdHgCoTe/MSA core-shell and CdHgCoTe/MSA/MPOSS quantum dots synthesised in aqueous phase, 
with an aim to evaluate their toxicity study through this experiment. 
 
 
 
 
CdHgCoTe core CdHgCoTe core 
MSA coating 
CdHgCoTe core 
MSA/MPOSS 
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5.2. Materials and Methods  
5.2.1. Materials 
Details have been described in chapter 3.  
5.2.1.1. Cell types used for in vitro toxicity studies 
Toxicity studies were conducted on four different cell cultures in vitro; three were 
established cancer cell lines that were derived from human breast, colon and prostate 
cancer. As a control for normal cells, HUVECs were chosen, as endothelial cells are the 
first line of tissues to encounter QDs in vivo (Table 5.1). Using different derived cancer 
cells for toxicity, would also establish their sensitivity to QDs in this study. 
Table 5.1: This is the list of cell cultures have been used in this study 
List of cell cultures Full name of cell cultures Kind 
MCF-7 Breast cancer cells Cell line 
SW680 Colorectal cancer cells Cell line 
PC3 Prostate cancer cells Cell line 
HUVEC Human umbilical Primary cell 
Briefly, MPOSS coated QDs incorporating Cobalt (Co) and Mercury (Hg) have 
emission wavelength in the NIR region. From the pool of synthesised QDs (chapter 4) 
two (CdHgCoTe and CdHgCoTe/MSA) was selected as comparison to NIR emitting 
CdHgCoTe/MSA/MPOSS QDs for toxicity in this study to highlight their protective 
properties.  
5.2.2. Quantification of quantum dots concentration by serial 
dilution 
Refer to chapter 3, section 3.4.2.4. for full details. 
5.2.3. Preparation of precursor materials cadmium chloride (Cd2+) 
and mercury perchlorate (Hg2+) ions for toxicity studies 
 Refer to chapter 3, section 3.4.2.2. for full details. 
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5.2.4. Quantum dots preparation for toxicity assay  
Briefly all three QDs were precipitated with ethanol, dried and accurately weighted for 
re-constitution in PBS and filter sterilized with membrane (0.2 µm). Initially, a desired 
number of all four different types of test cells were incubated for 48 h. Then after, 
concentrations of three different QDs, CdHgCoTe, CdHgCoTe/MSA and 
CdHgCoTe/MSA/MPOSS in PBS were added and incubated at 2, 8 and 24 h. The 
purified QDs were prepared at five concentrations of 0, 0.1, 1.0, 10, 50 and 100 µg/mL 
in HEPE buffered minimum essential medium (MEM). 
5.2.5. Cell seeding and viability assay 
Briefly, cells were seeded into 96-well plates at a density of 1 x 104 cells per well (200 
µL), and allowed to equilibrate for 48 h at 37 °C in an incubator with 5% CO2. After 
this period cells were washed thoroughly with PBS then exposed to serial dilutions of 
all three QDs at 200 µL and MEM as control. After addition they were incubated at 37 
°C in 5% CO2 for 2, 8 and 24 h. At the end of their respective period of exposure, the 
cells were thoroughly washed with PBS. At this stage the wells were replaced with 
MEM (200 µL) and 20 µL of Alamar Blue and Neutral Red were added in tandem to 
each well and incubated for further 4 h at 37 °C with 5% CO2. Finally, the plates were 
read by a microplate-reader (Labsystems, Ashford, UK). 
Cell viability data was obtained as the percentage of treated cells to untreated cells, 
using the following formula: 
Cell viability (%) = Abs (treated)/Abs (control) X 100 
5.3. Results and discussion 
5.3.1 In vitro toxicity of QDs in cell cultures 
Three different QDs, CdHgCoTe, CdHgCoTe/MSA and CdHgCoTe/MSA/MPOSS 
were compared to each other to assess their toxicity via cell viability, according to their 
appropriate coatings, on four different cell cultures (MCF-7, SW620, PC3 and 
HUVECs). Cancer cells have been widely used here because they are important in 
biomedical imaging using QDs, and they are accepted to be sturdier than normal cells to 
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assess for cytotoxicity. However, even with different normal cell lines, there are 
different levels of resistance to toxic environments and thus these results may not 
represent the maximum exposure time limits. The data obtained are useful, however, for 
setting a standard for toxic response to different types of coatings. In addition, some of 
their compositional materials such as Hg2+ and Cd2+ were also used for toxicity 
assessment. 
5.3.1.1. In vitro toxicity of precursor material of CdHgCoTe/MSA/MPOSS 
Figures 5.2-5.3 show the effect of precursor material (Cd2+ and Hg2+ ions) when 
incubated with four cell cultures at different concentrations, and viability evaluated 
using Alamar Blue and Neutral Red assays at time intervals of 2, 8 and 24 h. The 0 
µg/mL concentration, which is growth culture medium (MEM), has been used as 
control throughout whole toxicity experiments, hence there is a high number of viable 
cells present (100 % cells). 
In figure 5.2 a, b, the graphs show that at 1 µg/mL of Cd2+ and Hg2+, the cell viability 
have been reduced dramatically to approximately 50% for all cell cultures at 2 h 
incubations. It can also be seen that as the concentrations of Cd2+ and Hg2+ increase, 
there is further reduction of cell viability (approximately 30%). 
A similar effect has taken place at 8 h incubations where at 1 µg/mL it has now reduce 
viability to approximately 40% (Figure 5.2 c, d). Again a similar pattern can be 
observed with increased concentrations where the cell viability is reduced to 
approximately 20% (Figure 5.2 a, b). 
At 24 h incubation for both precursor materials, there is further reduction of cell 
viability at concentration of 1 µg/mL at approximately 30 %. At 24 h incubation, there 
is a dramatic reduction of cells (to approximately 10%) where we can assume maximum 
cell death had occurred at 50 µg/mL concentrations. 
Although for Neutral Red similar results were obtained, it can be clearly seen that at 2 h 
incubation with 1 µg/mL the cell viability was at 50% approximately. Similarly, at 
increased concentrations there is reduction of cell viability at an average 30% (Figure 
5.3 a, b).  
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Figure 5.3 c, d shows that at 8 h incubation with both precursor materials (Cd2+ and 
Hg2+) there is further reduction of cell viability from 45% to 25% at concentrations of 1 
µg/mL and 50 µg/mL respectively. Likewise, the 24 h incubation also follows a similar 
pattern whereby at 1 µg/mL there is approximately 20% viability.  
Although, the results follow a similar pattern there is a slight variation in cell numbers 
for the HUVEC cell culture (Figure 5.3 b, d, f). There appears to be an increase in cell 
numbers compared to the other cell lines and this could be due to overestimation using 
this particular assay system (Neutral Red). On the other hand, this could be due to 
HUVECs response to Neutral Red being different to that of the cancer cells used in this 
study. 
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a. Cd2+ toxicity at 2 h, assayed by Alamar Blue          b. Hg2+ toxicity at 2 h, assayed by Alamar Blue 
 
 
c. Cd2+ toxicity at 8 h assayed by Alamar Blue          d. Hg2+ toxicity at 8 h assayed by Alamar Blue 
 
 
e. Cd2+ toxicity at 24 h, assayed by Alamar Blue          f. Hg2+ toxicity at 24 h, assayed by Alamar Blue 
Figure 5.2: Cd2+ and Hg2+ toxicity readings with Alamar Blue. 
Toxicity results using Alamar Blue assay on four cell cultures (MCF-7, SW620, PC3 and HUVECs) 
exposed to Cd2+ and Hg2+ at different time frame at (2, 8 and 24 h) with concentrations ranging from 1 
µg/mL to 50 µg/mL.  
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a. Cd2+ toxicity at 2 h, assayed by Neutral Red          b. Hg2+ toxicity at 2 h, assayed by Neutral Red            
 
 
c. Cd2+ toxicity at 8 h, assayed by Neutral Red           d. Hg2+ toxicity at 8 h, assayed by Neutral Red            
 
 
e. Cd2+ toxicity at 24 h, assayed by Neutral Red          f. Hg2+ toxicity at 24 h, assayed by Neutral Red            
Figure 5.3: Cd2+ and Hg2+ toxicity readings with Neutral Red. 
Toxicity results using Neutral Red assay on four cell cultures (MCF-7, SW620, PC3 and HUVECs) 
exposed to Cd2+ and Hg2+ at different time frame at (2, 8 and 24 h) with concentrations ranging from 1 
µg/mL to 50 µg/mL. 
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The above results indicate the toxicity of Cd2+ ions and Hg2+ ions in solution, which as 
shown can have detrimental effects on cells. This is also a simulation of what may 
happen when these precursor materials are released from cadmium based QD cores. 
5.3.1.2. In vitro toxicity of CdHgCoTe at 2, 8 and 24 hour  
One primary and three different cell types were used for uncoated CdHgCoTe QD 
toxicity assessment. This essentially demonstrates the sensitivities of the different cell 
types to semiconductor coated and uncoated CdHgCoTe QDs. 
Figure 5.4 shows the toxicity in tandem as above, using two types of assay system 
(Alamar Blue and Neutral Red) on all four cell cultures at varied times exposure (i.e. 2, 
8, 24 h) for uncoated CdHgCoTe QDs. The 0 µg/mL concentration, which is growth 
culture medium (MEM), has been used as control throughout whole toxicity 
experiments, hence there is a high number of viable cells present (100 % cells). 
Comparing toxicities using the two different assays, (Figure 5.4) the data in this study 
indicate a pattern that is similar, confirming the accuracy and consistency of the cell 
response. This mode of parallel toxicity study was applied to all the cell models used 
here. Figure 5.4 a, b illustrates the effect of uncoated CdHgCoTe QD toxicity on MCF-
7, SW620, PC3 and HUVECs cell cultures at 2 h exposure. The cell viability was in 
approximately at 70-90% at 0.1 µg/mL concentration for both assays for the four cell 
cultures. On increasing the concentration to 100 µg/ml of the uncoated CdHgCoTe, the 
cell viability has decreased to approximately 40-60%, which indicates that 
concentrations have significant effect on the cell viability. Similar results were also 
obtained at 8 h exposure time (Figure 5.4 c,d). The cell viability at 0.1µg/mL has 
decreased from approximately 70-90% to 60-70% from 2 h to 8 h exposure respectively 
(Figure 5.4 a. c).  
However there are some unexpected observations at 0.1 µg/mL concentration at 24 h 
exposure, cell death is still occurring (Figure 5.4 e, f) at about 60-70%. This slowed 
decline could be to cells equilibrating or resisting the kill at this stage. The uncoated 
CdHgCoTe QD at high concentrations showed cell death within the time frame of 24 h. 
The low cell death at 100 µg/mL at 8 h with Alamar Blue can possibly be due to 
inefficient uptake of CdHgCoTe QD or Alamar Blue reduction by metabolic products or 
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possible operator error. However in the Neutral Red assay (Figure 5.4 d), this seems to 
be absent, as this is based on live cell uptake only.  
The cell toxicity results for the uncoated CdHgCoTe QDs (Figure 5.4) indicates 
approximately 15% less than the free precursor materials (Cd2+ and Hg2+ ions) in 
figures 5.2 and 5.3 with high significance (p <0.05). This could be due to the intactness 
of the uncoated complex that is temporarily stable with a CdS shell (formed in situ) that 
is hydrophobic. Whereas the precursor materials Cd2+ and Hg2+ are hydrophilic, and 
have free interaction with cells with toxic effects. 
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a. CdHgCoTe toxicity at 2 h, assayed by 
Alamar Blue   
b. CdHgCoTe toxicity at 2 h, assayed by 
Neutral Red  
 
 
c. CdHgCoTe toxicity at 8 h, assayed Alamar 
Blue 
d. CdHgCoTe toxicity at 8 h, assayed by 
Neutral Red 
 
 
e. CdHgCoTe toxicity at 24 h, assayed by 
Alamar Blue    
f. CdHgCoTe toxicity at 24 h, assayed by with 
Neutral Red  
 
Figure 5.4: Toxicity of uncoated CdHgCoTe QDs using Alamar Blue and Neutral Red assay  
on four different cell cultures at different time exposure (2, 8 and 24 h) with different concentrations from 
1 µg/mL to 100 µg/mL. It indicates that the uncoated CdHgCoTe QDs are highly toxic.  
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5.3.1.3. In vitro toxicity of coated CdHgCoTe/MSA at 2, 8 and 24 hour 
exposure  
The toxicity assay was repeated as described as above. 
Figure 5.5 indicates the toxicity evaluation CdHgCoTe/MSA QD at 2, 8 and 24 h 
exposure on four different cell cultures (MCF-7, SW620, PC3 and HUVECs). At 0 
µg/mL concentration (culture medium) minus QD free control the cell population is 
defined at 100%. 
The viability of cells decreased at 0.1 µg/mL CdHgCoTe/MSA QD from 70-90% to 65-
80% at 2 h and 24 h exposure time respectively (Figure 5.5 a, e) for all four cell 
cultures, using the Alamar Blue assay. Similar results were observed for Neutral Red 
assay (Figure 5.5 b, f) at same concentration of 0.1 µg/mL. Using Alamar Blue, cell 
viability decreased from 50-70% to 30-50% at the highest concentration (100 µg/mL) at 
lowest (2 h) to highest (24 h) incubation time respectively (Figure 5.5 a, e). 
There is a decreasing cell survival pattern in the overall results (Figure 5.5). However, 
there is increase cell viability for CdHgCoTe/MSA QD (Figure 5.5) as compared to 
uncoated CdHgCoTe QDs (Figure 5.4). As previously mentioned, two types of toxicity 
assay were carried out in this study. Although minor differences were noted in the 
toxicity rankings of the coated QDs in the Neutral Red and Alamar Blue assays, there 
was, for most part, good agreement between the two assays. Overall, both assays 
exhibited similar sensitivities to the QDs.  
Generally, it can be shown that there is still significant toxicity for CdHgCoTe/MSA 
QDs at higher concentrations over longer exposure time. However, comparing the data 
of uncoated CdHgCoTe (Figure 5.4) with coated CdHgCoTe/MSA QD (Figure 5.5), 
the toxicity has been notably reduced to 20% on all four cell cultures (p < 0.05). This is 
significant improvement for CdHgCoTe/MSA QDs and can be attributed to the coating 
around the core preventing leaching of Cd2+ and Hg2+ ions form the core. 
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a. CdHgCoTe/MSA toxicity at 2 h, assayed 
by Alamar Blue  
b. CdHgCoTe/MSA toxicity at 2 h, assayed by 
Neutral Red 
 
 
c. CdHgCoTe/MSA toxicity at 8 h, assayed 
by Alamar Blue 
d. CdHgCoTe/MSA toxicity at 8 h, assayed by  
Neutral Red 
 
 
e. CdHgCoTe/MSA toxicity at 24 h, assayed 
by Alamar Blue  
f. CdHgCoTe/MSA toxicity at 24 h, assayed 
by Neutral Red 
Figure 5.5: Toxicity of CdHgCoTe/MSA QDs using Alamar Blue and Neutral Red assays  
on four different cell cultures at different time exposure (2, 8 and 24 h) with different concentrations from 
1 µg/mL to 100 µg/mL. It indicates that the toxicity of CdHgCoTe/MSAQDs has reduced due to the 
coating of the core with MSA compared to uncoated CdHgCoTe QDs (p < 0.05). 
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5.3.1.4. In vitro toxicity of CdHgCoTe/MSA/MPOSS at 2, 8 and 24 hour 
exposure 
This assay was carried out as described previously whereby the 
CdHgCoTe/MSA/MPOSS QDs were given to MCF-7, SW620, PC3 and HUVEC cell 
cultures at various concentrations over a time course of 2, 8 and 24 h and viability was 
assessed using Alamar Blue and Neutral Red assays. 
Based on the observed changes in cell survivability, the toxicity of 
CdHgCoTe/MSA/MPOSS QDs was this time compared with uncoated CdHgCoTe and 
coated CdHgCoTe/MSA QDs at similar time course of 2, 8 and 24 h with 
concentrations from 0 to 100 µg/mL, using Alamar Blue and Neutral Red assays. 
The cell viability using CdHgCoTe/MSA/MPOSS QDs at the lowest concentration (0.1 
µg/mL) was approximately > 90% (Figure 5.6 a, b) in both assays at 2 h incubation. 
Even at maximum concentration (100 µg/mL) the cell viability was approximately over 
80% at 2 h incubation time (Figure 5.6 a, b). The cell viability in this part of evaluation 
(50%), compared to CdHgCoTe/MSA (Figure 5.5) has increased significantly. 
Higher cell viability was seen for longer incubations (8 and 24 h) at different 
concentrations of CdHgCoTe/MSA/MPOSS QDs. The cell viability was approximately 
over 80% for 100 µg/mL concentration of CdHgCoTe/MSA/MPOSS at 8 and 24 h 
incubations for both assays (Figure 5.6 c, d, e, f). 
The graphs (Figure 5.6) demonstrate high percentage of cell survival of approximately 
over 75% on all culture cells and especially over 90% on HUVECs primary cells 
(Figure 5.6). Interestingly, at 100 µg/mL QD concentration, there was no significant 
toxicity at 24 h incubation, which indicates the excellent biocompatibility and stability 
of the CdHgCoTe/MSA/MPOSS QDs. 
MSA is relatively non-toxic, chemically stable and often employed as the outer coating 
for QDs (Komarala et al., 2006, Zheng et al., 2007). Importantly, it has been shown that 
no free cadmium ions are found on the surface of such layers when used with cadmium 
based QDs, which should favor its use in cellular studies (Derfus AM, 2003, Kirchner et 
al., 2005). A highly fluorescent CdHgCoTe core stabilized with MSA/MPOSS coating, 
synthesised through one-pot aqueous method was introduced as a novel development 
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(Chapter 4).  
Also QDs encounter and are exposed to vascular tissues first when injected 
systemically. The precursor materials Cd2+ and Hg2+ of QDs demonstrated dramatic cell 
loss in this cell culture study. This indicates that toxicological studies are important and 
encapsulating QD’s core with biocompatible coating agents minimizes the toxicity level 
of QDs even at high concentrations. Thus in both assays the free heavy metals Cd2+ ion 
and Hg2+ ion were highly toxic, whereas the coated CdHgCoTe/MSA QD was 
moderately toxic with the CdHgCoTe/MSA/MPOSS QD nontoxic in the concentration 
range tested. 
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a. CdHgCoTe/MSA/MPOSS QD toxicity at 
2 h, assayed by Alamar Blue 
b. CdHgCoTe/MSA/MPOSS toxicity at 2 h, 
assayed by Neutral Red 
 
b. CdHgCoTe/MSA/MPOSS QD toxicity at 
8 h, assayed by Alamar Blue   
d. CdHgCoTe/MSA/MPOSS QD toxicity at 8 
h, assayed by Red  
 
 
e. CdHgCoTe/MSA/MPOSS QD toxicity at 
24 h, assayed by Alamar Blue   
f. CdHgCoTe/MSA/MPOSS QD toxicity at 24 
h, assayed by Neutral Red    
Figure 5.6: Toxicity of CdHgCoTe/MSA/MPOSS QDs using Alamar Blue and Neutral Red assays  
on four different cell cultures at different time exposure (2, 8 and 24 h) with different concentrations from 
1 µg/mL to 100 µg/mL. It indicates that the toxicity of coated CdHgCoTe/MSA/MPOSS QDs has 
improved significantly by biocompatible MSA and MPOSS coatings compared to coated 
CdHgCoTe/MSA (p <0.05). 
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5.3.2 Overview of cell toxicity 
Figures 5.7 a-5.9 b represent the toxicity of CdHgCoTe, CdHgCoTe/MSA and 
CdHgCoTe/MSA/MPOSS QDs with different exposure times of (2, 8 and 24 h) using 
Alamar Blue and Neutral Red assays for each cell type for all experiments. Previous 
graphs represent concentrations at different time scale of exposure. The graphs below 
depict similar patterns as described earlier.  
It can be observed from the Alamar Blue (Figure 5.7 a) and Neutral Red (Figure 5.7 b) 
results that the coated CdHgCoTe/MSA was moderately toxic and the uncoated 
CdHgCoTe QDs were highly toxic. It can also be observed that there are some 
unexpected growth properties of HUVECs using Alamar Blue for uncoated CdHgCoTe 
QDs. It was seen (Figure 5.7 a) that at concentrations 0.1, 1.0 and 10 µg/mL the cell 
viability has increased for HUVEC primary cells at longer incubation (24 h) when 
quantitated by Alamar Blue assays. This may be due to unusual metabolic property of 
HUVECs towards the uncoated CdHgCoTe QDs and overestimation of cell counts to 
Alamar Blue assay. However, there is absence of overestimation when using Neutral 
Red assay (Figure 5.7 b). Therefore, it can be concluded that despite this 
overestimation of HUVECs towards uncoated CdHgCoTe, the CdHgCoTe and 
CdHgCoTe/MSA QDs were still toxic compared relatively with the hybrid coated 
CdHgCoTe/MSA/MPOSS QDs. 
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Figure 5.7: a) Comparison of three types of QDs (uncoated CdHgCoTe, coated CdHgCoTe/MSA, coated CdHgCoTe/MSA/MPOSS) induced toxicity on HUVECs, 
determined by Alamar Blue assay. The coated CdHgCoTe/MSA/MPOSS demostrates  minimum toxicity amongst the uncoated CdHgCoTe and CdHgCoTe/MSA QDs. 
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Figure 5.7: b) Comparison of three types of QDs (uncoated CdHgCoTe, coated CdHgCoTe/MSA, coated CdHgCoTe/MSA/MPOSS) induced toxicity on HUVECs, 
determined by Neutral Red assay. The coated CdHgCoTe/MSA/MPOSS demostrates  minimum toxicity amongst the uncoated CdHgCoTe and CdHgCoTe/MSA QDs. 
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Figures 5.8 a and b represent a comparison of toxicity level of all three types of QDs 
using Alamar Blue and Neutral Red respectively on MCF-7 breast cancer cells. MCF-
7 cells have a similar pattern showing that the toxicity of CdHgCoTe/MSA/MPOSS 
QDs is relatively low compared with two other QDs. This may be attributed to the 
MSA/MPOSS preventing leaching of Cd2+ and Hg2+ from the core (Figure 5.8 a,b). It 
can be observed that the level of toxicity is relatively higher for MCF-7 than with 
HUVEC cells. 
There are two very minor unexpected cell number increases seen in figure 5.8 a, b and 
is consistent with possible human error. Also, the extend of experimental variables 
tested makes it statistically possible that a few of the results would give unexpected 
results. The cell viability increased unexpectedly for uncoated CdHgCoTe QDs at 
concentration of 0.1 µg/mL using Alamar Blue (Figure 5.8 a), and CdHgCoTe/MSA 
QDs using Neutral Red assay at 24 h incubation respectively (Figure 5.8 b). 
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Figure 5.8: a) Comparison of three types of QDs (uncoated CdHgCoTe, coated CdHgCoTe/MSA, coated CdHgCoTe/MSA/MPOSS) induced toxicity on MCF-7, determined 
by Alamar Blue assay. The coated CdHgCoTe/MSA/MPOSS demostrates  minimum toxicity amongst the uncoated CdHgCoTe and CdHgCoTe/MSA QDs. 
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Figure 5.8: b) Comparison of three types of QDs (Uncoated CdHgCoTe, coated CdHgCoTe/MSA, coated CdHgCoTe/MSA/MPOSS) induced toxicity on MCF-7, 
determined by Neutral Red assay. The coated CdHgCoTe/MSA/MPOSS demostrates  minimum toxicity amongst the uncoated CdHgCoTe and CdHgCoTe/MSA QDs. 
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Figure 5.9 a, b represent a comparative toxicity level evaluation of all three QDs 
treated on SW620 colorectal cancer cells using Alamar Blue and Neutral Red assays 
respectively. 
General toxicity can be evaluated in these two graphs illustrating that uncoated 
CdHgCoTe QDs have the highest toxicity followed by CdHgCoTe/MSA QDs and the 
least by CdHgCoTe/MSA/MPOSS QDs.  
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Figure 5.9: a) Comparison of three types of QDs (Uncoated CdHgCoTe, coated CdHgCoTe/MSA, coated CdHgCoTe/MSA/MPOSS) induced toxicity on SW620, 
determined by Alamar Blue assay. The coated CdHgCoTe/MSA/MPOSS demostrates  minimum toxicity amongst the uncoated CdHgCoTe and CdHgCoTe/MSA QDs. 
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Figure 5.9: b) Comparison of three types of QDs (uncoated CdHgCoTe, coated CdHgCoTe/MSA, coated CdHgCoTe/MSA/MPOSS) induced toxicity on SW620, 
determined by Neutral Red assay. The coated CdHgCoTe/MSA/MPOSS demostrates  minimum toxicity amongst the uncoated CdHgCoTe and CdHgCoTe/MSA QDs. 
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Additionally, prostate cancer cells (PC3) showed a similar pattern to all the cell 
cultures used (Figure 5.10 a,b). The toxicity evaluation showed similar results even 
though the cell cultures are of different origin. Minor changes can be observed figure 
5.9 a for uncoated CdHgCoTe QDs at 0.1, 1.0 and 10 µg/mL concentration at 8 h 
incubation, again using Alamar blue assay. However, the minor unexpected cell 
number increases may be accounted due to using these assays. 
The cytotoxicity of CdHgCoTe, (core, uncoated) and water soluble CdHgCoTe/MSA, 
CdHgCoTe/MSA/MPOSS QDs (core, shell/coating,) respectively, directly 
synthesised in aqueous phase, was systematically studied for the first time in this type 
of coated QDs. It can be concluded that the uncoated CdHgCoTe and 
CdHgCoTe/MSA coated QDs were toxic, possibly due to the liberation of Cd2+ and 
Hg2+ ions from the core. In contrast, the CdHgCoTe/MSA/MPOSS QDs were less 
toxic than the MSA coated QDs, even at low concentration with long incubation for 
all cell cultures. This can be attributed to the novel hybrid coatings of MSA and 
MPOSS. This combination is likely to act by preventing the release of cadmium ions 
from the core. Current data indicates that the cytotoxicity of nanomaterials such as 
QDs could be effectively modified through novel surface coating techniques. 
 
 
 
 
 
 
 
 
 
 
5: TOXICITY ASSESSMENT OF THE NEW NEAR INFRARED QUANTUM DOTS 
	   122	  
 
 
Figure 5.10: a) Comparison of three types of QDs (uncoated CdHgCoTe, coated CdHgCoTe/MSA, coated CdHgCoTe/MSA/MPOSS) induced toxicity on PC3, determined 
by Alamar Blue assay. The coated CdHgCoTe/MSA/MPOSS demostrates  minimum toxicity amongst the uncoated CdHgCoTe and CdHgCoTe/MSA QDs. 
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Figure 5.10: b) Comparison of three types of QDs (uncoated CdHgCoTe, coated CdHgCoTe/MSA, coated CdHgCoTe/MSA/MPOSS) induced toxicity on PC3 determined 
by Neutral Red assay. The coated CdHgCoTe/MSA/MPOSS demostrates  minimum toxicity amongst the uncoated CdHgCoTe and CdHgCoTe/MSA QDs. 
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5.4. Overall discussion 
Although QDs have great potential as probes for imaging in biology and medicine, 
certain limitations may restrict their usefulness. The introduction of NIR emitting QDs 
has solved some of the problem associated with autofluorecence by reducing the 
background fluorescence. This presents an attractive alternative for in vivo imaging. In 
this experiment the NIR emitting QDs had in its core, cadmium, telluride, mercury and 
cobalt (CdHgCoTe) with appropriate coatings (MSA and MSA/MPOSS).  
It was first observed that Cd2+ ions could liberate from the surface of cadmium based 
QDs, which led to their cytotoxic effects (Austin M. Derfus, 2004). In another study, it 
was found that it was the capping molecule (TOPO, Trioctylphosphine oxide) of QDs 
that determined the cytotoxicity of QDs (Hoshino A, 2004a). More recently (this 
laboratory) a systematic toxicity investigation was carried out that employed 
CdHgCoTe/MSA and CdHgCoTe/MSA/MPOSS coatings in vitro. It was concluded that 
MSA coated QDs released Cd2+ and Hg2+ ions from the surface chemistry of QDs that 
were responsible for the toxicity of QDs. This can be correlated with toxicity studies 
carried out using the constituent material Cd2+ and Hg2+ in vitro.  
The figures and graphs demonstrate toxicity of free Cd2+, Hg2+ ions and uncoated and 
coated QDs in solution. The precursor studies simulate release of Cd2+ and Hg2+ from 
core and this establishes the lethal dose for the cells. Moderate levels of toxicity was 
demonstrated when QDs were coated only with MSA, compared with uncoated QDs. 
However, toxicity was reduced significantly when biocompatible MPOSS was included 
with MSA as coatings for the QD. It can also be concluded that the results indicate 
heavy metal ions especially Cd2+ and Hg2+ ions are very toxic to cells. The use of hybrid 
coatings such as MSA and MPOSS will ultimate lead to the potential applications in a 
clinical setting with minimal toxicity. 
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5.5. Conclusion 
The aim of this study was to evaluate the toxicity of the NIR QDs with novel coatings 
for potential biomedical application. However, the issues of toxicity and clearance of 
QDs in biological systems are of concern as these two issues are not fully understood 
currently, and must be investigated if QDs are to move from scientific curiosity to 
biomedical applications. Some studies have indicated QDs have been retained inside the 
cells and cannot be eliminated after intravenous application (Fischer et al., 2006). This 
work needs further investigation. 
From these results, it can be concluded that the uncoated CdHgCoTe QDs are 
significantly toxic to all four cell cultures. It can be observed that concentration and 
exposure duration plays a critical role in cell viability. This is possibly that the tri-
metallic complex is breaking into its constituent parts with the release of Cd2+ ion or 
Hg2+ ion and hence the observed cell toxicity. This is most likely that biological 
degradation is occurring with subsequent release of the constituent metals. This clearly 
indicates that coatings are essential to contain the release of these heavy metals. 
Further extensive studies, need to be performed on potential application of this type of 
QDs for in vivo imaging, distribution, and excretion in animal models. The use of 
suitable biocompatible coating agents with proper functional groups as used in this 
study, will offer a promising solution to the current limitations for different applications 
such as diagnostics and therapy of disease.  
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                                                       Chapter 6 
Conjugation of the near infrared ‘Quantum 
Dots’ for in vitro and in vivo bio-imaging 
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6.1 Introduction 
The interaction of nanotechnology with biology and medicine is expected to produce 
major advances in molecular diagnostics, molecular biology and bioengineering (Gao et 
al., 2002). To study these interactions, it is necessary to map the interactions of multiple 
proteins or drugs within an organism. Further, to fully understand and approach the 
complex clinical issues in disease (cancer) diagnosis and treatment, nanotechnologies 
have been developed in several key areas including cell targeting, drug delivery, 
hyperthermia and imaging by fluorescent nanocrystals. 
Fluorescent imaging techniques, particularly NIR fluorescence imaging, with its unique 
advantages over other imaging modalities in sensitivity, multiplex detection capabilities 
and equipment cost, has attracted great attention as a vital tool in the field of tumor 
research (Rao et al., 2007). In the 700-900 nm spectra, the absorbance spectra for most 
biomolecules are low, which provides a clear window for in vivo optical imaging 
(Frangioni, 2003, Chen et al., 2011). However, current imaging techniques using NIR 
fluorescent organic dyes are known to suffer from rapid photobleaching which is not 
desirable for long-term molecular imaging (Frangioni, 2003) and are limited in terms of 
fluorophores conjugated per ligand.  
Recent developments in nanotechnology have contributed significant contributions by 
means of NIR fluorescent nanomaterial based contrast agents (Farmer and Gordon, 
2006). These include NIR dye-containing nanoparticles (Altinoglu et al., 2008), NIR 
fluorescent carbon nanotubes and upconversion fluorescent nanoparticles, have all 
shown superior brightness and photostability compared to organic dyes (Altinoglu et al., 
2008, Xiong et al., 2009). Among the vastly studied NIR fluorescent nanoparticle based 
contrast agents, the NIR QDs are one of popular choice as imaging agents and have 
been successfully applied for cancer molecular imaging in small animal models of 
human cancer. Numerous studies have been conducted where non-targeted QDs were 
applied for cell trafficking (Dubertret et al., 2002), vasculature imaging (Larson et al., 
2003, Stroh et al., 2005), sentinel lymph node mapping (SLN) and neural imaging 
(Stroh et al., 2005, Thorne and Nicholson, 2006, Zimmer et al., 2006). 
To enable QDs to be useful for in vivo imaging and other biomedical applications, the 
required criteria are high sensitivity, biostability and specificity with accurate targeting 
6: CONJUGATION OF THE NEAR INFRARED QDS FOR IN VITRO & IN VIVO BIOIMAGING 
	   128	  
to a specific organ or disease site without being quenched. Specific targeting can be 
achieved by conjugating to targeting molecules to the QD surface. Site specific 
antibodies, peptides, peptidomimetics and small molecules make suitable targeting 
ligands, as large numbers of these molecules can be conjugated to the surface of a single 
QD and such conjugates may exhibit strong binding affinity with targeting efficacy due 
to the polyvalency effect (Hull et al., 1998). 
Medical practice, especially in cancer diagnosis and treatment requires a series of 
clinical procedures to establish completion. In this clinical area, the potential of NIR 
QDs can play a vital part. For example, cell targeting is the primary step for nano-
carriers to be localized in the tumor region. Using fluorescent nanocrystals, the targeted 
cancer cells or biopsy may be imaged in vivo or in vitro with high specificity and 
resolution. In addition, the nanoparticles in vivo may function as drug carriers with 
release mechanism in the vicinity of the tumor. Other development of cancer treatment 
may be applied such as hyperthermia when the nanocrystals are designed to be magnetic 
or photoactive. 
In the field of drug delivery with nanoscale levels, various carriers have been evaluated 
(Wang and Marchant, 2004). Amongst the nano-carriers, multi-wall carbon nanotubes 
(MWCNTs) have been widely investigated for their potential advantages over metal 
nanoparticle systems, with their inherent high cargo loading, structural flexibility and 
biostability. Carbon nanotubes (CNTs) have been well studied in recent years to their 
interesting biological properties. The task was to promote surface functionalization and 
simultaneously provide colloidal stability to the resulting modified CNT in aqueous 
media. These properties as compared with suitably coated QDs could extend the 
circulation time and drug release. In this study, a new strategy to conjugate with QD is 
described. Previous studies have also shown strong optical absorbance of CNTs in the 
NIR region, which makes it a promising tool in photothermal therapy especially in 
cancer studies. 
For a clinical application with simultaneous medical diagnosis and treatment, 
integrating functionalities into QDs, namely fluorescence for imaging, photo or 
magnetic for hyperthermia, and drug delivery would be ideal.  
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There are a variety of covalent and non-covalent strategies that have been developed for 
conjugating biomolecules (e.g. antibodies) and nanomaterials (e.g. carbon nanotubes) to 
QDs. Most materials including biomolecules can be conjugated covalently via cross-
linkers, which form a bridge with functional groups such as; 
-NH2, -COOH or -SH (amino, carboxyl and thiol groups) introduced on the QD surface 
to the functional groups existing on nanomaterials or biomolecules. Currently many 
selective conjugation chemistries are available for introducing desirable functional 
groups for this purpose. 
In this chapter, the design and development of QDs with integrated properties for 
simultaneous potential diagnosis, imaging and treatment are presented. Multifunctional 
QDs were conjugated to antibodies for targeting to cancer cell surfaces. Calreticulin 
(CRT) a calcium regulating protein was selected as a marker for cancer cells undergoing 
immunogenic or non-immunogenic depending on the presence of CRT on plasma 
membrane of the dying cell after toxic stimuli (Obeid et al., 2007). 
Non-targeted multifunctional QDs were also conjugated to outer surface of the multi-
wall carbon nanotubes (MWCNT) using PEG (Polyethylene glycol) as a linker. The 
assembled MWCNT which will be referred as CNT throughout this study, displayed 
unique functionalities due to surface conjugated NIR CdHgCoTe/MSA/MPOSS, 
making them potential probes for in vivo imaging and for introducing 
photohyperthermia simultaneously (Figure 6.6). Hyperthermia is a noninvasive 
approach to cancer treatment, whereby tissues are exposed to higher than normal 
temperatures to enable selective destruction of abnormal cells. 
Photohyperthermia also induced immunogenic apoptosis of cancer cells in vitro by 
presence of CRT on cancer cell surface membrane. A short peptide corresponding to 
CRT was synthesised for generating antibodies (Anti-CRT) as a targeting ligand for 
cancer cell apoptosis detection. NIR fluorescent CdHgCoTe/MSA/MPOSS QD was 
conjugated to Anti-CRT for localization of cancer cells undergoing apoptosis when 
incubated in the presence of Cd2+ and doxorubicin, a known anticancer drug. Apoptosis 
was also detected using Anti-CRT in cancer cells in vitro when NIR 
CdHgCoTe/MSA/MPOSS QD conjugated CNTs when illuminated at 630 nm thus 
inducing NIR hyperthermia. 
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6.2. Supplementary methods  
6.2.1. Materials 
Refer to chapter 3, section 3.2 for further details. 
6.2.2. Method 
6.2.2.1. Solid-phase peptide (Calreticulin) synthesis 
Refer to chapter 3, section 3.4.3 for full details. 
6.2.2.2. Production of anti-peptide IgG antibodies  
To generate anti-sera to human CRT protein, a peptide of 15 amino acid (NH2-Met-Leu-
Leu-Ser-Val-Pro-Leu-Leu-Gly-Leu-Ala-Val-Ala-Pro-Ala-NH2) corresponding to the 
amino terminus (sequence numbers) of this protein was synthesised (described earlier). 
The peptide was conjugated to keyhole limpet haemocyanin (KLH) using glutaldehyde. 
The KLH conjugated peptide was injected into New Zealand white rabbits (1mg/rabbit) 
(Intra muscular, IM) for polyclonal antibody production. The IgG components were 
isolated from antiserum using 50% saturated ammonium sulphate solution. Antibody 
specificity was confirmed by antibody blocking experiments. Anti-CRT was use for 
conjugation experiment and for all detection in vitro studies. 
6.2.2.3. Preparation of QD-(Anti-CRT) conjugation  
Fluorescent CdHgCoTe/MSA/MPOSS QD solution was diluted with equal volume of 
cold ethanol and centrifuged at 4000 rpm for 30 minutes. The precipitated 
CdHgCoTe/MSA/MPOSS QD was vacuum dried to obtain as a powder. The 
precipitated dried QDs (Approximately, 1 mg) were re-suspended in 1 mL phosphate 
buffer saline/tetrahydrofuran (PBS/THF) (1:1 v/v) and centrifuged at 4000 rpm for 
approximately 10 to 15 min. The obtained coated QD (1 mL) solution was conjugated 
to the Anti-CRT using EDC as an acylating agent together with NHS. Briefly, 200 µL 
QD/MSA/MPOSS solution (1 mg/mL) was mixed with 200 µL EDC (1 mg/mL) and 
200 µL NHS (1 mg/mL) in PBS for 30 minutes at room temperature. 100 µL of Anti-
CRT solution (5 mg/mL) was added to the mixture and mixed for 2 h in ice. To separate 
the reagent and unconjugated CdHgCoTe/MSA/MPOSS QDs, membrane centrifugal 
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columns (centricon) with a cut off of 100 kDa with UV monitoring at 280 nm of the 
retained samples was used. The purified QD-(Anti-CRT) defines as 
CdHgCoTe/MSA/MPOSS conjugated to (Anti-CRT) were collected and stored at +4 ºC 
until further use. The sample was further characterized by NIR fluorescence and FTIR 
spectroscopy. 
6.2.2.4. Application of conjugated QD-(Anti-CRT) for detection of 
apoptosis in vitro by confocal microscopy  
Briefly, MCF-7 and SW620 were selected for its cancer cell characteristics and 
HUVECs were selected as a noncancerous control for this study. All three (HUVEC, 
MCF-7 and SW620) culture cells were plated in triplicates into a twelve well plate 
separately and incubated for 24 h in an incubator. The cells were allowed to grow to 
approximately 80% confluence for this study. Cadmium (50 µg/mL) from previous 
studies has been shown to be toxic and was investigated for its mechanism. Doxorubicin 
(50 µg/mL) is a well-known anticancer drug was also investigated and added in a 
twelve well plate with appropriate controls in each plate. After the addition, the plates 
were incubated for further 1 h at 37 °C. After 1 h incubation at 37 °C, the cells were 
rinsed 5 times with PBS and fixed with 1 mL of paraformaldehyde 4% in PBS for 20 
minutes. The wells were aspirated and rinsed with 1 mL PBS (x 3) and blocked using 
bovine serum albumin (BSA) in PBS/Tween20 (PBS/T) (1 mL) for 1 h. The wells were 
aspirated and rinsed with PBS/T (x 1). QD-(Anti-CRT) (1 mL) in PBS/T was added to 
the fixed wells and incubated at room temperature for 2 h. Finally, they were rinsed 
with PBS (x 3). Fluorescence images were acquired using Nikon laser scanning 
confocal microscope (EZ C1) with a x 40 objective. 
6.2.2.5. Functionalization of Carbon Nanotube  
Crude CNTs (0.5 g) were added to H2SO4/HNO3 = 3:1 (v/v). The mixture was dispersed 
in an ultrasonic bath (40 KHz) for 5 minutes and then stirred for 24 h at 100 °C under 
reflux. The mixture was then filtered under vacuum through a 0.22 µm Millipore 
polycarbonate membrane. The membrane was washed with distilled water until most of 
the acid mixtures have been diluted out. The CNT-COOH on the membrane was dried 
and weighted. The filter containing CNT was then suspended in PBS and eluted by 
ultrasonication to disperse the CNT-COOH. 
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6.2.2.6. Conjugation of CdHgCoTe/MSA/MPOSS quantum dot to 
functionalized Carbon nanotube 
The functionalized CNT with carboxyl groups (CNT-COOH) (0.1 g/mL) was dispersed 
in PBS with CdHgCoTe/MSA/MPOSS QD (0.1 mg/mL) with brief sonication to further 
disperse the mixture. The dispersed MWCNTs and QDs were mixed with EDC solution 
(100 µl of 1 M in PBS) and NHS solution (100 µl of 0.5 M in PBS) for 30 minutes. At 
this stage the linker O,O’- Bis(2-aminopropyl)polyethylene glycol 1900 (PEG) was 
added to the mixture to form a peptide bond simultaneously with CNT and NIR 
CdHgCoTe/MAS/MPOSS thus forming (CNT-PEG-CdHgCoTe/MSA/MPOSS)  
species after 1 h. The solution was then centrifuged at 12000 rpm for 2 minutes and 
rinsed three times with PBS using centrifugation and decantation. The final re-
suspended CNT-PEG-CdHgCoTe/MSA/MPOSS were filtered through a 0.22 µm 
Millipore polycarbonate membrane under vacuum to eliminate coupling reagents and 
unreacted QDs. Finally, presence of QDs on CNTs was confirmed by the TEM images 
(Figure 6.10). 
6.2.2.7. Biodistribution study of conjugated NIR QD-CNT 
The biodistribution of QD-CNT was studied in female 6-8 weeks old (18-21 g) BALB/c 
mice (Charles River, Margrate, UK). All the experiments were carried out at Pharmidex 
pharmaceutical Ltd, adhered to the 1986 Scientific Procedures Act (UK) and in 
compliance with the guide for the care and use of laboratory animals in Pharmidex Ltd. 
The NIR QD-CNT solution for intraperitoneal (IP) injection was prepared by dissolving 
the mixture of QD-CNT in normal PBS buffer. Six mice were separated randomly into 
two groups (three mice in each group) and marked with No. 1 and No. 2. Normal saline 
solution as control named as group No. 1 and the conjugated QD-CNT in PBS (0.6 mL) 
was IP administrated into the mice (Table 6.1). Animals were sacrificed by CO2 
administration. 
Table 6.1: Administration of conjugated QD-CNT in mice. 
Group 
Number 
Nanoparticles Injection 
Type 
Dosage (mL) Time course 
(h) 
No 1 Control (PBS) IP 0.6 4 
No 2 NIRQD-CNT IP 0.6 4 
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After sacrificing the animals, fluorescence imaging was performed on each mouse. For 
each of them, a background image was collected. First, the images of the body, 
abdomen and dorsal region were captured by NIR camera with excitation at 640 nm by 
selecting emission, 730/80 nm long-pass filter. Subsequently, the ventral and dorsal skin 
of the mouse was removed and images were collected (Figure 6.13). Different organs 
were removed, dissected and frozen. 
To continue the investigation, histopathological assessment of tissues was conducted to 
determine the presence of QD-CNT. Briefly, the control group (No. 1) and No. 2 group 
were dissected. Four representative organs (liver, spleen, lung, brain) were removed 
from the mice, fixed in 10% formalin overnight, and formalin-fixed tissues were 
sectioned at 8 µm using a cryostat and tissue sections prepared by the Histopathology 
Department, Royal Free Hospital, London. Confocal laser scanning microscopy was 
carried out using the filter set excitation at 488 nm and emissions at 800 nm long-pass 
filter and imaged via a computer. The NIR fluorescence images were acquired with the 
microscope at the same Pseudocolour (red) scale throughout. 
6.2.2.8. Photothermal induced apoptosis induced in cancer cells by 
conjugated NIR QD-CNT 
Similar to section 6.2.2.4, seeded cells were also repeated this time with incubation with 
NIR QD-CNT (5 µg/mL) and unconjugated CNT. In this arrangement cells (HUVECs 
as control) and (MCF-7 and SW620) were exposed to 650 nm laser red light source for 
5 minutes. The cells were rinsed in PBS and fixed as above. The cells were blocked 
with 1% BSA in PBS/T for 30 minutes. The blocking solution was removed and rinsed 
in PBS/T. The NIR QD-(Anti-CRT) was incubated at room temperature for 2 h. Excess 
complex were removed with washing with PBS (X 3 washes) and observed for evidence 
of apoptosis in the presence of conjugated and unconjugated CNTs with confocal 
microscopy.  
6.2.2.9. Confocal fluorescence microscopy 
Details in section 3.3.5 in chapter 3 
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6.3. Results and Discussion 
6.3.1. FTIR Characterization of QD-(Anti-CRT)  
The amino terminus of CRT was synthesised and the anti-peptide antibodies (Anti-
CRT) were generated in the rabbit and conjugated to CdHgCoTe/MSA/MPOSS QDs. 
FTIR spectroscopy was used to evaluate the Anti-CRT conjugation to NIR 
CdHgCoTe/MSA/MPOSS QD. FTIR spectroscopy spectra results confirmed the 
presence of amide I peak of Anti-CRT conjugated to CdHgCoTe/MSA/MPOSS QD 
(Figure 6.1). The region around 1645 cm-1 indicates the amide bond stretch of the 
protein. This region is assigned to the amide bond which is 80% C=O stretching and 
10% from N-H bending and 10% C-N stretching region in deuterium oxide (D2O). 
Additionally, when bound to QDs there is a shift to the higher vibration band, this 
indicates an open structure accessible to deuterium exchange as opposed to a close 
structure of QD to Anti-CRT. This indicates that the protein has maintained its native 
conformation despite the conjugation to the QD. Therefore, the QD conjugated to Anti-
CRT has a strong peak at 1645 cm-1. 
 
Wavenumber cm-1 
Figure 6.1: FTIR Spectra of CdHgCoTe/MSA QD (Blue), CdHgCoTe/MSA/MPOSS QD (Black) and 
(Anti-CRT)-CdHgCoTe/MSA/MPOSS (Red). The 1650 cm-1 indicates amide I region of the Anti-CRT 
protein.  
CdHgCoTe/MSA 
CdHgCoTe/MSA/MPOSS 
(Anti-CRT)-CdHgCoTe/MSA/MPOSS 
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6.3.2. Quantum dots in cell labeling applications 
Semiconductor QDs have been developed as fluorescence tags in biological and medical 
applications such as in vitro and in vivo biological labeling, imaging, targeting 
therapeutic carriers and drug delivery, due to their exceptional fluorescent properties. 
To avoid QD aggregation, improve water-solubility and biocompatibility, and exert 
specific surface chemistry for targeting and delivery, various conformations of 
semiconductor QDs (Liu et al., 2008). 
6.3.2.1. Chemical synthesis of proteins CRT  
A linear, bifunctional peptide was synthesised called Calreticulin (CRT). Proteins and 
polypeptides with important structure-function interrelationship’s isolated from animal, 
plants and microorganisms has been a subject of great interest for many years. Amongst 
them, there are the many membrane-associated proteins such as neuropeptides, toxins, 
growth factors, antibodies and hormones. The realisation that these naturally occurring 
biological molecules have peptide structures encouraged the development of techniques 
for the organic chemical synthesis of proteins and polypeptides with predetermined 
sequence.  
Although subsequent rapid developments in genetic engineering made it possible to 
produce desired proteins, this process can be expensive and is generally unsuitable for 
obtaining desirable quantities with suitable rapidity. This remains attached to the solid 
support throughout the synthesis cycle (deprotection/coupling) and is separated from 
soluble reagents and solvents by simple filtration and washing without incurring 
manipulative losses. The repetitive steps are quick and simple. Once chain elongation 
has been accomplished, it is necessary to detach (cleave) the fully protected peptide 
from the solid support under conditions that are mild to labile residues in the sequence. 
Finally complete deprotection of the residues accompanied by purification and 
characterization are carried out in free solution. The main advantage of a solid-phase 
approach is that reactions are driven to completion by using excess soluble reagents 
promoting high efficiency and yields which can be recovered by filtration and washing 
without manipulative losses. 
The essential feature, which distinguishes solid phases synthesis from other techniques 
is the solid support. The resin support is quite often a polystyrene suspension polymer 
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cross-linked with 1% of divinylbenzene as cross-linking agent. The resulting spherical 
beads when dry have an average diameter of 50 µm with a functional value of 0.2 to 1.0 
mmol/g. These beads in solvents commonly used for peptide synthesis, namely DMF 
and DCM swell 2.5 to 6.2 fold their original volume. Furthermore, as peptide chains are 
extended the dry volume increases to accommodate the increased mass and most 
crucially the swollen volumes continue to increase.  
6.3.2.2. Preparation of QD-(Anti-CRT) conjugation 
Antibody molecules possess a number of functional groups that are suitable for QD 
conjugation. Crosslinking reagents can be used to target lysing primary amine and N-
terminal amine groups. Keyhole limpet haemocyanin (KLH) plays an important role for 
raising antibody for producing Anti-CRT. Once prepared, the QD-(Anti-CRT) 
conjugates can be stored for about 4-6 weeks. Beyond this storage period, staining still 
works but the quality is fairly poor. The problem is that a lot of antibodies need to be 
stored at -20 °C while QD samples at 4 °C. If the QD-(Anti-CRT) conjugates are stored 
at 4 °C for long time, the antibodies lose binding affinity and specificity. 
Unsuccessful conjugation is often due to the presence of other disulfide-containing 
molecules in the antibody medium or buffer. It can be the aggregate formation by too 
many QDs presented in buffer, too much of a reagent, e.g., EDC, wrong reaction buffer 
(e.g., buffer at an incorrect pH or using a free-amine containing buffer in EDC coupling 
reaction). QD conjugation should be confirmed by running FTIR. 
6.3.2.3. Conjugating QD with Anti-CRT  
Targeting tumor cells or tumor vascular by peptide technology is a promising strategy 
for delivering drugs or for labeling (Zitzmann et al., 2002). In this study, a novel 
method was developed for a novel surface coating and functionalization of QD. Anti-
CRT was developed and conjugated to NIR QD as a probe for labeling applications. 
However, the specific labeling of target (cell surface integrin) on fixed cells in vitro was 
described. Figure 6.2 shows the pathway from synthesizing CRT peptide and raising 
antibodies to CRT and applying to cell culture studies. 
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Figure 6.2: Schematic diagram of preparation of Anti-CRT followed by conjugation to quantum dot. 
Some anticancer drugs may increase immunogenic signal (calreticulin, CRT) on apoptosis. CRT 
expression also increases cancer immunogenicity. Synthetic calreticulin peptide was used to raise anti-
peptide antibodies. 
Anticancer therapies are being developed in which PCD is induced in cancer cells to 
halt or reverse tumour growth. As it has been established that PCD is involved in many 
diseases, imaging of this process would be of great value to diagnosis and guidance of 
therapy. Apoptosis is often described as a silent process whereby apoptotic cells are 
removed by phagocytosis without provoking an immune response i.e. non-
immunogenic. It has been established in previous studies, that when tumours in in vivo 
models cells were exposed to anticancer drugs belonging to the anthracycline family, an 
anti-tumour immune response was initiated (Chakravarthy et al., 2011). Furthermore, in 
a recent study cancer cells when undergoing apoptosis became immunogenic by 
exposing CRT on their plasma membrane (Figure 6.5). It was concluded that only 
certain type of pro-apoptotic drugs (anthracyclines) induced immunogenic apoptosis 
while others induced non-immunogenic apoptosis. In the presence of recombinant CRT, 
   
Cell culture (MCF-7) 
   
 
 
 
 
Calreticulin peptide (N-
terminus, 15 aa long)  
(NH2-Met-Leu-Leu-Ser-Val-
Pro-Leu-Leu-Gly-Leu-Ala-
Val-Ala-Pro-Ala-NH2) 
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the non-immunogenic apoptosis could be converted to immunogenic apoptosis. In the 
present study, a synthetic peptide corresponding to the amino terminus of the CRT 
protein was synthesised and antibodies generated in a rabbit. In the course of this study 
it was discovered that cancer cell lines could also be induced to undergo immunogenic 
apoptosis by Cd2+ and photothermal induction by QD-CNT conjugate (more detail in 
this chapter). The anti-peptide (Anti-CRT) was conjugated to QDs to detect induced 
CRT in cancer cell surface when exposed to Doxorubicin, cadmium and thermal death 
QD-CNT. This study has shown for the first time that QD-(Anti-CRT) may enable in 
assessing the potential anticancer drugs that can induce immunogenic apoptosis in 
tissues or cells. 
At this stage QD-(Anti-CRT) was incubated with three cell types for 2 hours at room 
temperature. In normal non-cancer cells, CRT is found predominantly in the 
endoplasmic reticulum, where it acts as a chaperone aiding proper folding of other 
proteins (Clarke and Smyth, 2007). Incubation of HUVEC with QD-(Anti-CRT) was 
used as control and indicated no evidence of its presence in surface membrane or 
intracellular uptake by confocal microscopy. Exogenous availability of CRT from 
neighboring cells cannot be dismissed as the control cells showed very low level of this 
protein. However, the other two cell lines had indicated a high level of CRT expressed 
when cells were exposed to the elemental forms of Cd2+ and Doxorubicin drug. Figures 
6.3 and 6.4 have shown that Cd2+ could be used to as anticancer drug in this part of 
experiment due to similar results with doxorubicin results. 
6.3.3. NIR emitting QD-(Anti-CRT) targeted to CRT on 
immunogenic apoptotic cancer cells 
Triggering the body’s natural immune response against tumours has great potential as 
alternative to cancer therapy. Many attempts have been tried in the past by others to 
immunize with tumour cells that have been modified deliberately, so as to use it as a 
vaccine. Unfortunately it has not worked as the body has not been sufficiently 
stimulated or tolerance has occurred. Recently a possible route to producing an anti-
tumor vaccine was to treat isolated tumor cells with a particular class of 
chemotherapeutic drugs, the anthracyclines. This approach was shown to induce 
specific immune response of sufficient strength as to eliminate established tumors in 
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mice (Zhang et al., 2007). This work was further extended in demonstrating that tumor 
cells when exposed to anthracyclines produce specific protein marker, calreticulin 
(CRT), which marked them for removal by the immune system. These findings indicate 
that agents that can trigger CRT can be combined with conventional chemotherapy to 
provoke the immune system. For the first time, QDs conjugated to Anti-CRT have been 
employed to the study of cancer cells in vitro when exposed to cadmium ion (Cd2+) or 
Doxorubicin. It can be shown from confocal fluorescence that it is feasible to apply this 
technology to the detection of cancer cell apoptosis (Figure 6.3 and 6.4). Doses of Cd2+ 
ion or Doxorubicin can be shown to stimulate CRT production. By extending these 
studies, antibodies directed against a selected region of CRT can be produced 
chemically and conjugated for imaging of cancer cells. This is illustrated below with 
confocal microscopy where the presence of CRT is evident after exposure to Cd2+ or 
Doxorubicin for 1 h. Figures 6.3 A and 6.3 B show the differential interference contrast 
(DIC) image of MCF-7 and fluorescence as control with absence of CRT on its surface 
respectively. This indicates that cancer cells do not produce CRT when not exposed to 
any toxic materials such as Cd2+ or Doxorubicin. Figures 6.3 C and 6.3 D show the 
contrast and fluorescence of MCF-7 cells after exposure to 50 µM of Cd2+ with 
production of CRT on surface. This is clear indications that cell are undergoing 
apoptosis as described in literature. In the following figures 6.3 E and 6.3 F, it can be 
seen that MCF-7 cell when exposed to Doxorubicin, an anticancer drug, there is strong 
indication that CRT  
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Figure 6.3: Images of MCF-7 cell exposed to Cd2+ and Doxorubicin to detect immunogenic apoptosis.  
A, B) DIC and fluorescent images of MCF-7, in the absence of Cd2+ or Doxorubicin (control). C, D) DIC 
and fluorescent images of MCF-7 cells exposed to Cd2+ ions at 1 h. QD-(Anti-CRT) fluorescence 
indicates presence of CRT protein (Apoptotic marker). E, F) DIC and fluorescent images of MCF-7 cells 
exposed to Doxorubicin at 1 h and CRT detected by QD-(Anti-CRT) G,H). DIC and fluorescent images 
of HUVECs primary cells exposed to Cd2+ for 1 h with absence of CRT with Anti-CRT. I, J) DIC and 
fluorescent images of HUVECs primary cells when exposed to Doxorubicin with absence of CRT protein 
by Anti-CRT. 
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are produced, which confirms previous in vivo studies. Figures 6.3 (G,H,I,J) illustrate 
HUVECs, which are primary culture as non-cancerous control to indicate that exposure 
to Cd2+ or Doxorubicin does not produce CRT despite undergoing cell death or 
apoptosis. 
Similar procedure as above was carried out for SW620 cancer cells for detection of 
CRT on exposure to the compounds mentioned. The figures 6.4 A and B illustrates 
SW620 cells as control, with no exposure to Cd2+ or Doxorubicin and hence absence of 
fluorescence. However, very weak fluorescence can be observed and is possibly due to 
non-specific binding. The figures 6.4 C and D are the images of SW620 when exposed 
to Cd2+ ion for 1 h washed and fixed and incubated with QD-(Anti-CRT) for 2 h and 
examined with confocal microscopy. Clearly there is strong fluorescence for CRT due 
to apoptosis. Figure 6.4 are the images of SW620 cells when Doxorubicin under similar 
conditions, again showing that cells undergoing apoptosis with CRT expressed on 
surface of cell membrane detected by targeted QDs (QD-(Anti-CRT)). Similar 
procedure with exposure and detection shows that HUVCEs as non-cancerous control 
(Figure 6.4 G-J) do not produce CRT hence absence of strong fluorescence. 
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Figure 6.4: Images of SW620 cell exposed to Cd2+ and Doxorubicin to detect immunogenic apoptosis.  
A, B) DIC and fluorescent images of SW620, in the absence of Cd2+ or Doxorubicin (control). C, D) DIC 
and fluorescent images of SW620 cells exposed to Cd2+ ions at 1 h. QD-(Anti-CRT) fluorescence 
indicates presence of CRT protein (Apoptotic marker). E, F) DIC and fluorescent images of SW620 cells 
exposed to Doxorubicin at 1 h and CRT detected by QD-(Anti-CRT). G, H). DIC and fluorescent images 
of HUVECs primary cells exposed to Cd2+ for 1 h with absence of CRT with Anti-CRT. I, J) DIC and 
fluorescent images of HUVECs primary cells when exposed to Doxorubicin with absence of CRT protein 
by Anti-CRT. 
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6.3.3.1. Doxorubicin and Cadmium as inducers of apoptosis in cancer cells 
in vitro  
Doxorubicin (Doxorubicin Hydrochloride, Sigma-Aldrich) is presently one of most 
successful and widely used anticancer drugs because of its broad spectrum of activity. 
The drug is given by injection into a fast running infusion for treating acute leukemias, 
carcinomas of the breast and ovary as well as soft-tissue carcinomas. Doxorubicin is 
mostly excreted by the biliary tract with an elevated bilirubin level is considered a 
marker for reducing the dose. Higher cumulative doses are associated with 
cardiomyopathy, and potentially fatal heart failure can occur (Thurston, 2006). Not only 
Doxorubicin anticancer drug was used for this study but also Cd2+ was used for 
inducing apoptosis in the cancer cells. 
The novel coated QDs with MSA and MPOSS were used in the investigation of 
programmed cell death (PCD) in cancer cells. This phenomenon of organized cell 
suicide takes many forms, of which apoptosis is well known and studied. PCD is central 
in many biological roles such as physiology and pathology of multicellular organisms.  
Cell proliferation and death are held in fine balance during homeostasis and are 
disturbed in a diseased state. However, in these conditions PCD is increased and in 
cancer it is polarized towards proliferation. The great challenges in cancer studies are to 
develop drugs that cannot only induce PCD but also the elimination by the immune 
system. 
There are some cancer therapy drugs, which are available commercially such as the 
anthracyclines, which have been already shown to induce a specific immune response of 
sufficient strength to eliminate tumor cells. According to previous studies (Obeid et al., 
2007), these drugs also cause tumor cells to expose on their surface a specific protein 
marker, called calreticulin (CRT), which tags them for removal by the immune system. 
CRT (calcium-binding protein) was used as a molecular target as it is known that 
certain anticancer drugs especially the anthracyclines such as Actinomycin, 
Cycloheximide and doxorubicin can induce necrotic apoptosis, which in turn can induce 
an immune response (Obeid et al., 2007). According to (Obeid et al., 2007) Doxorubicin 
induces apoptosis with an immunogenic clearance of cancerous cells. Similar behavior 
to Doxorubicin was detected when Cd2+ was used in cancer cells when immunogenic 
apoptosis was also detected by the presence of CRT on the cell surface (Figure 6.5). 
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It must be stated that in previous chapter on toxicity, Cd2+ ions were shown to kill cells 
and perhaps this could be a marker for future toxicity assay studies. There is clear 
evidence that exposure of Doxorubicin and free Cd2+ ion on the cancer cells stimulates 
the expression of the CRT as a marker on cancer cells (MCF-7, SW620) but not with 
HUVECs). Below is a simple depiction towards the path of an immunogenic apoptosis.  
  
Figure 6.5: Schematic diagram showing process of programmed cell death (PCD). 
Induction of apoptosis using drugs, heat or light may promote tumour elimination via the immune system. 
The ideal aim is to develop a cancer vaccine with production of CRT as a modulator for the immune 
response.  
6.3.4. Surface modification of carbon nanotube  
Water-soluble QDs and CNTs can be prepared by surface modification by many 
methods. Thiol molecules are the first choice and commonly used to modify the QD 
surface because of ease and speed. As for the CNTs the method is slightly different in 
that the nanotubes are refluxed at boiling in the presence of sulphuric and nitric acid. 
In addition in this study, a new strategy to derivatize CNT with 
CdHgCoTe/MSA/MPOSS QD is described. This offers the possibility to predefine the 
size, shape, and amount of the nanoparticles attached on CNTs, depending on the 
specific application (Figure 6.6). 
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Figure 6.6: Schematic representation of QD-CNT conjugation.  
This shows the reaction mechanism of conjugation of the NIR CdHgCoTe/MSA/MPOSS to carbon 
nanotube (CNT) via a linker NH2-PEG-NH2 
Immobilization of biomolecules on CdHgCoTe/MSA/MPOSS QD and CNT is an area 
of great interest. Such hybrid materials have numerous applications in the areas of 
biotechnology, immunosensing, and biomedical applications. 
All these modifications not only allow the nanomaterials to be water-soluble or water 
dispersible but also allow the presence of the functional group such as –COOH to be 
linked to other biomolecules or nanomaterials. The coupling agent of choice 1-Ethyl-3-
(3-dimehylaminopropyl)carbodiimid hydrochloride (EDC) commonly known as water 
soluble carbodiimide is a versatile coupling agent that can form an amide, ester or 
thioester bond and thus to cross-link proteins, nuclei acids or to bind molecules to solid 
surfaces in aqueous or organic media. 
6.3.4.1. Mechanism of reaction of the functional group (COOH) with 
coupling agent (EDC)  
The carboxyl group on the QD and CNTs surfaces when activated proceeds similarly to 
other carbodiimide couplings. An o-acylurea intermediate is formed by the reaction of a 
carboxylic acid and the carbodiimide. The o-acylurea is a highly reactive species that 
readily reacts with primary amines, peptide coupling additives or reducing agents. For 
HNO3 + H2SO4 
Reflux 
Carbon nanotube (CNT) Functionalized CNT 
Functionalized CNT 
CdHgCoTe
/MSA/
MPOSS 
EDC + NH2-PEG-NH2 
CdHgCoTe
/MSA/
MPOSS 
Cross-linked QD and CNT 
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the coated water-soluble QDs with MSA/MPOSS-capped water soluble in this study, 
the change in CdHgCoTe/MSA/MPOSS QD size was ~ 5 nm (refer to chapter 4). 
Fluorescence-labeled biomolecules are applied widely in the life science arena. 
Proteins, DNA and synthetic peptides are all involved in biochemical processes and 
therefore for their mapping, conjugation with water-soluble QDs or CNTs is used 
extensively. In this study, tagging was focused on the rabbit Anti-CRT immunoglobulin 
as they possess lysine residues on their constant region, which facilitates coupling of 
carboxyl groups to the amino residues of the lysines. After coupling, the specificity can 
be tested with the CRT peptide. 
Equally using the above method, coupling of the QDs to CNTs was carried out by 
crosslinking with O,O’-Bis(2-aminopropyl)-polyethylene glycol 1900 (Fluka) 
(diaminoPEG). Examples of few coupling reagents were used for conjugating the QDs 
with other biological compounds (Figure 6.7). 
 
 
a b c 
Figure 6.7: list of some of the coupling agents 
a) DCC: efficient low racemization when used with HOBt forms insoluble byproduct b) DIC: efficient 
low racemization when used with HOBt. Most efficient at elevated temperatures. c) EDC:  byproducts are 
water-soluble when used to conjugate proteins with linkers and labels. 
In Solid-phase mode an efficient and unambiguous peptide bond formation requires 
chemical activation of the carboxyl component of the protected amino acid. The 
classical component of the protected amino acid in situ has been DCCI. Reactions were 
carried out at room temperature but the principle limitation is the formation of the 
insoluble DCU during the activation and acylation reaction. Recently, new reagents for 
in situ activation have become widely accepted because of ease, fast reaction even 
between amino acids and side reactions. This is also adaptable for conjugation in 
solution between QDs and antibodies or with cross-linkers such as PEG. A mechanism 
for conjugation scheme is shown in figure 6.8. 
N N N C N N N
NH
Cl-
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Figure 6.8: Mechanisms of conjugation using carbodiimide derivitives 
6.3.5. Characterization of conjugated quantum dots and carbon 
nanotube (QD-CNT) 
6.3.5.1. Emission characteristic of conjugated QD-CNT 
Figure 6.9 compares the fluorescence spectra of uncoupled, NIR 
CdHgCoTe/MSA/MPOSS QD and coupled CNT-QD. As can be seen in this figure, the 
maximum emission of the uncoupled QD (solid line) is at NIR 800 nm. For CNT-
conjugated QD, the maximum emission has shifted to 750 nm (dots), with a broad 
shoulder around 650 nm. This shifting is likely attributable to the background emissions 
from the CNT or aggregates forming to cross-linking in solution. However, an 
understanding of the detailed biophysics of these interactions will require further 
investigation. 
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Figure 6.9: The fluorescent emission spectra of the uncoupled, NIR CdHgCoTe/MSA/MPOSS QD (A) 
and CNT-QD (B). 
The maximum peak at 800 nm is consistent with specifications of this commercial QD. The blue shift 
from CNT-QD and a broad shoulder around 650 nm may result from the interactions and/or background 
emissions of CNT. 
6.3.5.2. Transmission electron microscopy (TEM) of QD-CNT  
The TEM images of CNT and CNT-QD are shown in figure 6.10. The QD exhibits dark 
dots with an average particle size of 5–7 nm, randomly distributed on the surface of the 
CNTs (Figure 6.10 b). This suggests that coupling of CdHgCoTe/MSA/MPOSS QDs 
to CNT was successful. Many particle-like features can be observed on the sidewalls of 
the CNT bundles. 
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Figure 6.10: TEM images of CNT and QD-CNT. a) Uncoupled CNT and b) Coupled CNT with 
CdHgCoTe/MSA/MPOSS QDs with average size of 5 to 7 nm. 
 
6.3.6. Conjugated QD-CNT photothermal induced immunogenic 
apoptosis  
The aim of this experiment was to show that when QD-CNT is incubated with cell 
cultures and exposed to red light (630 nm) for 10 minutes, cell death (apoptosis) due to 
hyperthermia is initiated. Briefly, the set up consisted of incubating cultures in the 
presence of QD-CNT and exposing to light at 630 nm as illustrated in figure 6.11. 
Figure 6.11 A and 6.11 B shows HUVEC cells when in the presence QD-CNT and 
stimulated by light with QD emitting at NIR (800 nm) and absorbed by CNT. There is 
absence of fluorescence when probed with QD-CRT antibodies. This is an indication 
that although cell death was initiated there is no evidence of CRT on cell surface of 
HUVEC primary cells. However, in figures 6.11 C and 6.11 D are the images of MCF-7 
cancer cells when given the same treatment as described above. This time there was 
presence of CRT when probed by QD-CRT antibodies, a clear indication of cell 
undergoing apoptosis. Similarly, the above procedure was carried out for SW620 cancer 
cells, which also produced CRT when probed with QD-CRT antibodies. This 
phonemena appears to be specific for cancer cells only and not to normal cells. This 
indicates that hyperthermia induced by absorption of NIR emitted from QD to CNT 
with production of CRT on cancer cell surfaces. In principle this application can also be 
used for photodynamic treatment (PDT) by stimulating organic dyes for cancer cell 
a b 
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treatment. Figure 6.11 E and 6.11 F are the images of the SW620 cells when exposed to 
light in the presence of QD-CNT. The presence of CRT on all the cancer cells except 
normal cells is a clear indication that immunogenic apoptosis has occurred. Using QD-
CNT as thermal inducers by NIR from QDs also produced CRT when excited by light 
Figure 6.11 (G, H, I, J). However, MCF-7 breast cancer cells exposed to CNT only 
(control) under illumination did not induce CRT protein (no fluorescence) with Anti-
CRT indicating no cell death. (Figure 6.11 G, H). Similar results for SW620 exposed to 
CNT only were also obtained with no fluorescent indicated absence of apoptosis 
(Figure 6.11 I, J).  
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Figure 6.11: A, B) Fluorescent and DIC images of primary HUVECs exposed to conjugated QD-CNT. 
C, D) Fluorescent and DIC images of MCF-7 cells exposed to conjugated QD-CNT. E, F) Fluorescent 
and DIC images of SW620 cancer cells exposed to conjugated QD-CNT. G, H) Fluorescent and DIC 
images of MCF-7 breast cancer cells expose to CNT only. I, J) Fluorescent and DIC images of SW620 
exposed to CNT only. Images of all cancer cells exposed to CNT only indicated absence of CRT proving 
cells have not undergone apoptosis as no QDs was present. 
6: CONJUGATION OF THE NEAR INFRARED QDS FOR IN VITRO & IN VIVO BIOIMAGING 
	   152	  
6.3.7. Biodistribution assessment of conjugated QD-CNT with 
confocal laser scanning microscopy (CLSM) 
QDs and other nanomaterials offer great promise for biomedical applications in such 
areas as tumour research. However, for clinical applications the potential usefulness of 
such materials cannot be evaluated without knowledge of their biodistribution. NIR 
QDs was conjugated to CNT so as to trace their biodistribution in in vivo and ex vivo by 
emitted NIR light. Figure 6.12 is schematic representation of in vivo noninvasive 
detection of injected NIR QD-CNT 
 
 
 
 
 
 
 
 
 
 
Figure 6.12: Schematic representation of a set up for detecting conjugated QD-CNT in a mouse. NIR 
sensitive camera with suitable filters can be used for detection. 
A qualitative biodistribution was determined in mice, a relevant animal model. At 4 h 
after IP administration of QD-CNT (100 µg/ml) 600 µl, (mice n = 3 and control = 3) 
were sacrificed by CO2. Figure 6.13 A shows unconjugated CNT and QD conjugated 
CNT. This shows absence of fluorescence with the unconjugated CNT (control) 
compared to the QD-CNT. Figure 6.13 (B-D) shows injected PBS/unconjugated CNT 
(CNT in PBS) and conjugated QD-CNT localized in liver and spleen. 
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Figure 6.13: Images of mice injected with unconjugated CNT and conjugated QD-CNT in PBS. 
(A) CNT in PBS and conjugated QD-CNT in eppendorf (B) Mouse injected with unconjugated CNT, (C) 
Mouse injected with conjugated QD-CNT with liver accumulation of QD-CNT, (D) Mouse injected with 
QD-CNT with spleen showing NIR fluorescent. 
To locate QD-CNT uptake in various organs, mice were sacrificed and brain, liver, 
spleen and lung were obtained from the dissected animal, and 20 µm-thick frozen 
sections prepared for ex vivo imaging. Fluorescence images of QD-CNT in various 
organs are shown below (Figure 6.14-6.17). The intensity and peak emission 
wavelength of QD-CNT in the tissues were the same as those in buffer. The strong NIR 
emissions under 630 nm support the conclusion that QD-CNT may provide significant 
advantages for deep tissue diagnosis. In each tissue, it can be demonstrated an intense 
fluorescence of QD-CNT at 800 nm excited at 630 nm compared to background. In the 
liver, the complex was observed in the central vein, parenchyma and hepatocytes 
(Figure 6.15). In the spleen, the QD-CNT was observed in both the red and white pulp 
(Figure 6.14). The peak emission wavelength of QD-CNT was around 800 nm in vitro 
when excited by 630 nm from LTD light array. In the QD-CNT treated mice, the 
QD-CNT 
CNT 
D 
A 
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highest emission of the complex was observed in the liver (Figure 6.15), as liver is the 
first organ to encounter any non-toxic/toxic material via the blood. However, other 
tissues have also shown the presence of the QD-CNT. Interestingly, a significant 
amount of QD-CNT was detected in the brain (Figure 6.17), which indicates 
permeation of QD-CNT through the blood brain barrier (BBB). It must be emphasized 
that the tested QD-CNT conjugate did not contain specific cell or organ targeting 
moieties. Therefore the observed biodistribution pattern following i.p. administration 
reflects non-specific binding and elimination for that time span. It is anticipated, 
however, that conjugating with specific targeting ligands such as peptides or antibodies 
will alter the biodistribution pattern. 
In this study, it was investigated how QD-CNT is delivered into various organs of mice 
in vivo when administered intraperitoneally. Liver and spleen, the primary locations of 
the reticulum endothelial system (RES) are also the primary organs of QD uptake, as 
shown by the fluorescence. Detection of QDs coupled to CNT allowed their tracking 
with the possibility of drug delivery. This study was undertaken to show that it is 
possible to detect CNT, which is a good candidate for drug delivery with NIR 
CdHgCoTe/MSA/MPOSS QD as a tracker for biodistribution.    
It can be concluded that the QD-CNT complex, with the highest signal was observed in 
the liver, followed by spleen, lungs and brain. Interestingly, signal were also detected in 
the brain (Figure 6.17), which can only mean that it has crossed the BBB. As it was not 
targeted the spectral profiles indicates there is a good distribution of the QD-CNT. This 
study did conduct a detail study of the constituent material (Cd2+ ion) distribution within 
the organs. This would have necessitated the use of a technique called inductively 
coupled plasma mass spectrometry (ICP-MS). This study investigated the distribution 
of QD-CNT following IP injection into mice as model system for determining the tissue 
localization of QD-CNT, employing confocal microscopy. It can be demonstrated that 
this delivery mode must have entered the systemic circulation and into the brain at 4 h 
after injection. This is a first evidence of QD-CNT nanocomposite entering the brain 
after IP injection. More studies as to the quantitation of QD-CNT and its constituent and 
elimination in in vivo need further investigation for future studies. 
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Figure 6.14: Confocal images of spleen exposed to NIR conjugated QD-CNT for 4 h incubation when 
administrated via IP. 
A, C and D represent the different fluorescent images of spleen when exposed to conjugated NIR QD-
CNT for 4 h as they show even distribution in the spleen tissues. B, D and F are the DIC images. 
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Figure 6.15: Confocal images of liver exposed to NIR conjugated QD-CNT for 4 h incubation when 
administrated via IP. 
A, C and D represent the different fluorescent images of liver when exposed to conjugated QD-CNT for 4 
h as they show strong fluorescent with even distribution in the liver tissues. B, D and F are the DIC 
images. 
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Figure 6.16: Confocal images of lung exposed to NIR conjugated QD-CNT for 4 h incubation when 
administrated via IP. 
A, C and D represent the different fluorescent images of lung when exposed to conjugated QD-CNT for 4 
h as they show even distribution in the lung tissues. B, D and F are the DIC images. 
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Figure 6.17: Confocal images of brain exposed to NIR conjugated QD-CNT for 4 h incubation when 
administrated via IP. 
A, C and D represent the different fluorescent images of brain when exposed to conjugated QD-CNT for 
4 h as they show even distribution in the brain tissue. B, D and F are the DIC images. However, the level 
of distribution is relatively less compared to other tissues. 
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6.4. Overall discussion  
The possibility of conjugating QDs to biomolecules was first undertaken in 1998 and 
has since been applied as fluorescent probes for targeting and visualizing subcelluar and 
cellular membrane signal transducing molecules in cell study. There are many 
conjugation procedures for linking biomolecules to QDs depending on the surface 
linkers (Alivisatos et al., 2005, Alivisatos, 2004). Covalent linking of 
CdHgCoTe/MSA/MPOSS coated QDs using cross-linking agents N-
hydroxysulfosuccinimide (NHS) and 1-ethyl-3(3-dimethylaminopropyl) carbodiimide 
hydrochloride (EDC) have been used with bovine serum albumin (BSA), as was stated 
earlier. 
The present study describes the development and use of QDs Bioconjugated to specific 
antibodies and explored whether these bioconjugates could specifically and effectively 
target cancer cells undergoing immunogenic apoptosis. The bioconjuagte was designed 
and developed for noninvasive examination of NIR QD. The rationale for this study was 
to conjugate in aqueous buffer to produce Anti-CRT for detection of cancer cell 
apoptosis on exposure to Doxorubicin or Cd+2 ions in cell culture. Additionally, by 
conjugating NIR QD with CNT it could be tract as a drug delivery vehicle. It was also 
discovered that NIR emission by QDs was absorbed by CNT with thermal production in 
the vicinity or cancer cells. CNT stimulation directly by NIR to produce hyperthermia 
has been shown by other groups to be feasible in cancer treatments. This study has 
shown that NIR QDs conjugated to CNT can be localized with detection and treatment. 
CRT detection has implications in early detection of necrotic apoptosis in cancer cells 
when exposed to various anticancer compounds such as anthracyclin as an effective 
treatment in the prognosis of cancer. This is important as immunological participation 
may play an important part in cancer management. 
6.4.1. Application of NIR quantum dots in noninvasive imaging 
of lymph nodes 
The current tracers for sentinel lymph node biopsy (SLNB) including the blue dye and 
radiocolloid have various limitations like anaphylactic reaction to the dye and exposure 
of radioactivity to both patients and clinicians. QDs have potential application as a tool 
for imaging SLNs and guiding surgery. It was initially demonstrated, the visualization 
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of SLNs in an animal model via optical imaging of fluorescence emitted by QDs was 
feasible. This study represents a potential medical application of nanocrystals, a step 
forward in clinical application of SLNB in cancer surgery. SLNs are the foremost or 
group of nodes to be infiltrated by metastasizing cancer cells from a primary tumor. The 
advantage of QDs over blue dye is that SLN containing QDs, particularly NIR QDs can 
be visualized through the depth of tissue, even before the incision is made. Previous 
studies has been established that QDs injected into tumors drain to the SLNs rapidly 
(Ballou et al., 2007), which implicates that with tracking of QDs, it might facilitate the 
removal of the primary tumour and the SLN in a single surgery. For the future, the use 
of NIR QD imaging can make important contribution to the surgical management of 
cancer patients. It should have a major contribution in facilitating in SLNB of visceral 
cancers and SLMB in melanoma and breast cancer (Figure 6.18). 
 
 
 
 
 
 
 
 
 
Figure 6.18: A schematic arrangement of QDs emitting in the NIR range have been developed as 
alternative probes for SLNB with set up for live NIR imaging system to track cancer in deep tissues.  
Figure 6.19 shows similar strategy to figure 6.18 by using QDs to track the SLN. The 
CdHgCoTe/MSA/MPOSS QDs with emission wavelength of 800 nm were injected into 
the rat’s paw to track the migration of lymphatic nodes, exposed to UV light after 10 
minutes time frame.  
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Figure 6.19: A) Demonstrates the injection of NIR CdHgCoTe/MSA/MPOSS QD (λEm = 
800 nm) into the lymph of rat’s paw to track the migration to lymph nodes under normal 
light. B) Injection of CdHgCoTe/MSA/MPOSS QD into the lymphatic nodes exposed to 
UV light. C) Movement of CdHgCoTe/MSA/MPOSS QD through lymph nodes after 10 
minutes under UV light. D) Zoomed image in part (C) 
 
 
D 
A 
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6.4.2. Targeted NIR CdHgCoTe/MSA/MPOSS quantum dots to 
damaged liver in mice  
NIR CdHgCoTe/MSA/MPOSS QDs were conjugated to a synthetic Lipid A antagonist 
using EDC and NHS. In this study mice were injected intraperitoneally with 
acetaminophen to induce liver damage with the expression of Toll Like Receptor 4 
(TLR4). Mouse was anesthetized and 200 µl of conjugated NIR 
CdHgCoTe/MSA/MPOSS QD was injected via the mouse tail vain. This study was 
carried out in collaboration with the department of Hepathology, UCL, London 
(permitted, current study). 
 
Figure 6.20: In vivo imaging of NIR QD-Lipid A antagonist at 4 h post-injection (pseudocoloured red). 
The NIR QD is localised in the damaged liver and detected by NIR emission.  
Here, the NIR signal resulting from QD-Lipid A antagonist was clearly visible using the 
small animal IVIS system. NIR QD-Lipid A antagonist mainly targets the Toll-like 
receptor-4 in the liver expressed because of the damage. Ex vivo fluorescence of various 
organs indicated localization. However receptors were also detected in the spleen. This 
work is ongoing at the time of thesis submission.  
6.4.3. Excretion and elimination of quantum dots  
Finally, one theory is that as the particles are released from the lymph nodes and spleen, 
the Kupffer cells of the liver absorb them. The Kupffer cells then transport the QDs to 
the biliary system for their excretion. Some literature suggests that QD metabolism and 
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excretion is more complex and in fact depends heavily upon the chemistry of the QD in 
question. Further study of QD circulation and excretion in vivo will be the subject of 
intense investigation over the next several years. 
6.4.4. Further study and investigation  
Whether QDs have been found to accumulate in mouse organs such as spleen or liver 
after administration is something that needs to be investigated thouroghly. Little is 
known if and how QDs with a variety of sizes and surface chemistries will finally be 
cleared form biological body. However, there are some studies stating that if the 
hydrodynamic size of QDs was smaller than 5.5 nm, the particles were predominantly 
cleared from the mouse body through rapid and efficient urinary excretion; whereas QD 
nanocrystals coated with bigger molecules were associated with the adsorption of serum 
protein on surface, making them more than 15 nm bigger in hydrodynamic diameter, 
thereby precluding their renal excretion (Yu, 2008). 
QDs are highly valuable to preclinical optical imaging. They can be used in vitro and in 
vivo for labeling and also to target tissue-specific cancer biomarkers to identify tumour 
cells in sentinel lymph nodes. In addition the QDs can be targeted as a fluorescent tags 
in cell biology. While ongoing toxicity and clearance studies remain to establish their 
clinical usefulness, current studies indicate potential applications of the QD (Smith et 
al., 2008b) as an image probe to study the binding and extravasation parameters of 
targeted nanoparticles in lymphatic node cancer. 
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6.5. Conclusion  
Nanoparticles with contrast enhancing properties are necessary in the field of molecular 
imaging. QDs can be engineered with multiple components to form one single 
nanoparticle system which will allow the creation of nano-probes capable of several 
imaging techniques, namely multimodal imaging. Molecular imaging is dependent on 
early detection of various diseases and can be constructed to personalized therapy. 
While conventional imaging systems such as computer tomography (CT) and magnetic 
resonance imaging (MRI) facilitate visualization of anatomical and (patho)physiological 
outcome of the disease, molecular imaging is based on the molecular and cellular 
markers of the disease. This is dependent on disease-specific molecular targets as well 
as targeted nanoparticles. Furthermore, these nanocrystals should facilitate the 
visualization in vivo with high definition. 
Recent research has led to nanoscaled, light-emitting QDs as a new class of fluorescent 
labels to be used in biology and medicine. These highly bright fluorescent and stable 
QD probes are well suited for detecting protein biomarkers on cells and clinical tissue 
application. This chapter has shown conjugation methods for different applications. One 
was, to detect the cancerous cells going under apoptosis and secondly non-targeted 
distribution, by fluorescence tracking with CNT. The work on conjugated QD-CNT has 
shown potential applications for cancer detection and localized photothermal therapy. 
The main aim of this study was to demonstrate that QDs could be used for tracking as 
biological tools, with potential for biomedical applications. It can be demonstrated that 
cancer cells in vitro, when induced to undergo apoptosis will produce CRT and NIR 
CdHgCoTe/MSA/MPOSS QD conjugated with Anti-CRT will detect the protein. 
This was successfully applied to cancer cells indicating a marker of early cell death. 
Confocal microscopy as tool can visualize this process with accuracy. This study has 
demonstrated that NIR QDs has the potential for targeted detection and therapy for 
markers in diseased organs. Despite the increasing number of publications on the 
potential use of semiconductor for imaging, cancer detection and therapy, there is still a 
lot of work to be done before this technique is clinically applicable due to safety 
concerns. With this current study and progress in the development, with significant 
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toxic reduction or semiconductor QDs, one can envisage the viable use in a clinical 
setting for the future.   
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                                                       Chapter 7 
Summary, conclusions and future directions 
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7.1. Summary 
The primary objectives of this thesis were to develop an environmentally safe and 
friendly synthesis method to design and develop water-soluble QDs with sustainable 
strong NIR emission, photostability and potentially for biomedical imaging 
applications. To specifically address these objectives, the studies undertaken were 
focused on achieving the following goals: 
1. To establish a technique for aqueous synthesis using the multifunctional 
CdHgCoTe as a model system. 
2. To develop the water-soluble CdHgCoTe QDs with novel hybrid surface 
chemistry to promote PL intensity, stability and biocompatibility. 
3. To evaluate cytotoxicity test and establish the non-toxicity of the 
CdHgCoTe/MSA/MPOSS QDs and compare with toxicities of 
CdHgCoTe/MSA and toxic constituent parts Cd2+ and Hg2+ ions. 
4. To develop and improve conjugation of the water soluble QDs with 
biomolecules and nanomaterials (CNT) for imaging and potential therapy of 
cancer cells. 
 
7.1.1. Concluding remarks of current study 
Chapter 4: Using CdHgCoTe/MSA/MPOSS as a model system, a practical simple one 
step and ‘green’ approach to synthesis method was developed to manufacture the QDs 
in aqueous buffer directly at a temperature at 100 °C under reflux. The QDs obtained 
exhibited an ultra small size of 5 nm diameters with spheroid structure. The QY 
obtained was around 90% highest ever achieved compared to any commercially 
produced cadmium-based QDs. Parameters such as different pH and coatings were 
studied to improve photoluminescence of the QDs. It was shown that this type of QDs 
synthesised at pH 7.0 produced strong PL intensity significantly. The soluble QDs 
displayed excellent photostability under UV irradiation for and in water or PBS buffer 
and also at +4 °C for 2 years.  Introducing a novel hybrid coating MSA/MPOSS not 
only facilitated the dispersal of the QDs in aqueous environment, but also as a 
functional linker for conjugation to biomolecules or to nanomaterials via covalent 
bonding. The convenience of modification and the excellent PL properties in aqueous 
buffer and ease of manufacture paves the way for an economical approach for bulk 
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production of aqueous QDs, attractive for fluorescent probes for noninvasive, long-term 
imaging and tracking in biomedical systems. 
Chapter 5: Using two cytotoxicity assays namely Alamar Blue and Neutral Red were 
carried out for the CdHgCoTe/MSA/MPOSS QDs on different human cancer cells 
(MCF-7, SW620, PC3) and human endothelial cells (HUVECs). The results showed 
that CdHgCoTe QDs with the hybrid coating MSA/MPOSS were non-toxic at 1 µg/mL 
and 100 µg/mL at 24 h. This was compared with the uncoated, CdHgCoTe/MSA QDs 
and the free metals Cd2+ and Hg2+. It can be concluded that the cytotoxicity of the 
uncoated and MSA coated QDs and the extremely low toxicity of the 
CdHgCoTe/MSA/MPOSS were mainly due to the presence of suitable coatings 
preventing the release of toxic Cd2+ and Hg2+ respectively. The absence of significant 
toxicity of the hybrid coatings for QDs may pave the way in reducing the potential 
hazards to the environment and to human health and attractive for clinical in vivo 
applications. 
Chapter 6: The developed novel surface chemistry of QDs was exploited for 
conjugation to ligands and biomaterials. The MSA/MPOSS coated QDs, the peptide 
bond can be created between the carboxyl group of MSA/MPOSS and the amino groups 
of biomolecules (antibodies) or via linkers to CNT using the coupling reagents EDC 
and NHS. As an example, the antibodies against the calcium binding protein 
(calreticulin) were successfully imaged with antibody conjugated QDs when applied to 
cancer cells undergoing immunogenic apoptosis. This was done by exposing cells to 
Doxorubicin and also to conjugated QD-CNT for photoinduction. For CNT with 
carboxyl groups a diamino linker (polyethylene glycol-PEG) can be used as a cross-
linker to form covalent bond between the QDs carboxyl groups. The conjugated QD-
CNT was used to track biodistribution in vivo and also for its hyperthermic induction in 
cancer cells thus inducing apoptosis. 
In conclusion, a unique simple, cheap, environmentally friendly, aqueous synthesis 
method was developed to manufacture stable QDs in water directly by refluxing at 100 
°C. Despite using toxic semiconductor materials Cd2+ and Hg2+ as starting materials, it 
can be shown for the first time that it can be detoxified by a novel hybrid coating which 
includes MSA and MPOSS, thus preserving its small size (5 nm), biocompatibility, 
excellent strong photoluminescence and biostability. The present developed QDs with 
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this kind of hybrid coatings have great potential for a noninvasive multimodal imaging 
applications due to its well-engineered coating material. 
7.2. Future studies 
Semiconductor based QDs with their intrinsic novel physico-chemical characteristics is 
a unique candidate for potential applications in nanomedicine. With its potential 
beneficial multifunctional role, there is great concern as to their exposure to humans and 
the repercussions to human health. Numerous studies and research have been conducted 
in order to understand the mechanism of interaction in a number of in vitro and in vivo 
systems, and a vast information base has been established regarding this interaction and 
its potential biological effects. The current approved nanoparticle systems have in 
certain cases improved the therapeutic index of drugs by enhancing drug efficacy by 
reducing drug toxicity. The term “theranostics” was coined defining current 
developments in specific, individualized therapies for a multitude of diseases, and to 
integrate diagnostic and therapeutic properties into a single entity. The need arose from 
the evidence that diseases such as cancers are heterogeneous, and all current treatments 
are effective for certain patient subpopulations and at certain stages of disease 
progression. The arrival of nanotechnology has offered the possibility to merge 
diagnosis and therapy closer. Nanoparticles in the arena of imaging and therapy have 
been explored separately and well documented that nanoparticle theranostics is almost a 
reality, whereby co-delivery of therapy and imaging is a possibility. It is fortunate that 
many nanomaterials are imaging agents and can be developed as theranostic agents by 
impacting with therapeutic functions on them. The main criterion for such combination 
of imaging and therapy is getting the optimum concentration at targeted area of the 
diseased organ. This common targeting criterion will bring the synergy effect with 
enhancement for both imaging and therapy. 
Localization strategies are immense and to tailor targets, require appropriate surface 
chemistries. In cancer studies, it is a common approach to identify a biomarker that is 
specifically expressed on the membrane surface of cancer cells, and load the ligands 
with drugs to the target. In all these strategies, the unique size scale of the particles 
permits the EPR effect in tumour targeting. In all these applications, strategies have 
been applied to modify surfaces with appropriate coatings to achieve biocompatibility 
and long half live in bioapplications. Currently, many types of nanoplatforms are 
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undergoing intensive exploration for theranostic applications. All of these 
nanoplatforms have undergone development with easy synthesis with functional 
properties. These nanoparticles with reduced toxicity can incorporate unique optical or 
magnetic properties and have proved feasible with many successes. These have 
established an infra structure for further development, as apart from imaging it can also 
function as drug cargoes with suitable therapeutics. It has been demonstrated that 
therapeutics of multiform, including small molecules, proteins and DNA based can be 
conjugated onto nanoparticles as nanoplatforms. Due to its construct and with large 
surface to volume ratios, allows multi-functionality, which permits the evolution of all-
in-one nano-system with desirable features.  
Despite the rapid progress in this field, there is not an approved system for clinical use. 
Each system has its promises and advantages, however, has certain disadvantages to 
circumvent. The major concern is toxicity for QDs, and non-biodegradadable nature of 
CNTs. Alternatives are currently being explored and we have to date developed gold 
NIR QDs, which have shown to be promising in terms of application for theranostics. 
This is still in the experimental stages, since cadmium based QD work was undertaken 
for this thesis. QDs as drug carriers and with specific synthetic peptides as probes or 
antigens can be delivered to specific targets. As more suitable biomarkers are currently 
being discovered for diseased tissues, suitable ligands to these targets designed and 
synthesized with high efficiency. While this route is being explored and improved, it 
has been shown in this work that nanoparticle induced hyperthermia polarized within a 
selected region is possible and is being addressed in this laboratory with NIR gold QDs. 
Finally in addition to achieving and evaluating the toxicity issues in multifunctional 
QDs, integrating imaging and therapy will be a great leap in combination therapy 
defined as “theranostics”. In concept and practicality, nanoparticle-based theranostic 
probes can deliver therapeutics to selected disease areas with imaging function for 
diagnosis while monitoring therapeutic response, in a multi-role tool. In this thesis, the 
works on QDs with its intrinsic positive qualities and ongoing development have shown 
the feasibility for potential clinical applications. 
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Appendices 
1. Cobalt Doped Quantum Dots for Multiplex Imaging (MRI) 
The success of biocompatible QD synthesis doped with cobalt for multimodality MRI 
and photoluminescence offers the integration into a single probe.    
Multiplex imaging using contrast agents based on water soluble highly luminescent and 
NIR QDs incorporating magnetic nanoparticles offers a novel class of materials for bio-
imaging. Incorporating three functionalities in a single nanocrystal offers a sensitive 
imaging agent for three powerful and complementary imaging techniques (fluorescence 
and NIR) and magnetic resonance (MRI). 
The development of a one-pot synthesis where all three functionalities (fluorescence, 
infrared and paramagnetic ions can be integrated into QDs (CdTeCoHg). This approach 
has demonstrated the potential use of QDs for bio-imaging in cancer studies. In addition 
using the novel surface chemistry, potential drug delivery and targeting can be applied 
(Popescu and Toms, 2006, Daneshvar et al., 2008) (Figure A.1). In image-guided 
surgical applications, a surgeon relies on information gathered from preoperative MRI 
or sometimes CT. The development of dual-modality contrast agents that can be 
visualized by standard imaging techniques such as MRI in preoperative image 
acquisition and by optical techniques during surgery such as tumor localization has 
obvious advantages. 
The current water-soluble NIR QD containing paramagnetic particles can be detected 
and visualized by MRI and has potential modifications that could optimize imaging in 
clinically relevant system such as MRI. 
In image-guide surgery applications, a surgeon relies on information gathered from 
preoperative MRI or sometimes CT. The development of dual-modality contrast agents 
that can be visualized by standard imaging techniques such as MRI in preoperative 
image acquisition and by optical techniques during surgery such as tumor localization 
has obvious advantages. 
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Finally, our current water-soluble QD containing paramagnetic particles can be 
detectable and visualized by MIR and has potential modifications that could optimize 
imaging in clinically relevant system such as MRI. 
 
Figure A.1: Agra phantom of QD was developed and imaged with MRI.  
The electron dense core of the CdCoTe/MSA and cobalt containing in the structure of QD, made the 
detection of the QD phantoms possible with MRI  
2. Phantom Design  
Synthesised CdCoTe/MSA QD with emission wavelength of 630 nm was diluted into 1 
µM concentration in phosphate-buffer saline and was placed in 1.5 mL eppendorf tube. 
The QD-containing tube was then packed in plastic container contacting agar to mimic 
the density of human tissues. The images were carried out at Royal Holloway 
University, MRI unit (Siemens).  
In conclusion this preliminary data revealed interesting data and will be applicable for 
development of multimodal imaging application. 
